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ABSTRACT 
Immunoglobulin catabolism has been studied by the 
use of 1 2 5 I and 131 I, 14 C and antibody labels. Particular 
attention was paid to the IgG class of immunoglobulin because 
of the suggested relationship between the serum IgG concentration 
and the rate of catabolism and the relative importance of IgG 
in the immune response. 
It was found that the half-life time of 125 I IgG2a 
was significantly shorter than IgG2a having antibody activity 
to ovalbumin and IgG2a internally labelled with 14 C amino 
acids suggesting that radioiodination affected the in vivo 
behaviour of IgG2a. The problems of radioiodination have been 
looked at in respect to tne interpretation of plasma protein 
turnover in_2ivo, the binding of radioiodinated immunoglobulin 
to cells in vitro and its effect on antibody activity. 
It was found that the turnover rate and tissue 
distribution of IgG2a in the rat was very different to polyvinyl 
pyrrolidone, rat serum albumin and sheep IgG2. The turnover 
of IgG2a isolated from DA and Hooded rats was similar in both 
DA and Hooded rats. 
Rats appeared not to be able to discriminate sheep 
IgG from that of its own endogenous plasma proteins whereas 
sheep clearly recognised rat IgG2a as a foreign protein. 
The metabolism of IgG2a was compared in normal and 
IgG2a immunocytoma bearing Lou/M rats using 125 I IgG2a and 
14 c IgG2a. A close relationship between IgG2a and the IgG2a 
immunocytoma was · shown especially when the ability of 
14 C IgG2a to bind to cell suspensions of the IgG2a 
immunocytoma was studied. These results suggest a close 
relationship between IgG synthesis and catabolism. 
Conclusive evidence is offered showing that in foetal 
sheep very little if any catabolism of non-specific IgG (having 
no antibody activity) takes place even if the foetus has been 
antigenically challenged. This was confirmed by the use of 
radioiodinated IgG and antibody IgG. Further evidence showing 
that the metabolism of plasma proteins is different in the foetus 
compared to the adult was that serum albumin was turned over 
extremely slowly in foetal sheep. This suggests that in the 
foetus there is virtually no catabolism of the plasma proteins 
and that a suppressive mechanism may prevent degradation of 
endogenous proteins. This is supported by the findings that 
foetal sheep have the ability to phagocytose antigens and at 
100 days of age have high concentrations of some of the lysosomal 
enzymes in the plasma, liver and spleen. The factors controlling 
the suppressive mechanism have been discussed in relation to 
the changes that occur in the foetus in the perinatal period, 
as the turnover of serum proteins must commence soon after birth. 
A close relationship between the catabolism of IgG and 
the liver has been shown for both sheep and rats. To investigate 
possible routes for the excretion of IgG metabolites, radio-
iodinated IgG2 was injected into sheep and the afferent hepatic 
lymph duct and bile duct cannulated. Significant amounts of 
radioiodinated IgG2 and several smaller molecular weight 
fragments of IgG2 were found in the bile, however no 
metabolites of IgG2 were found in the afferent hepatic lymph. 
The rate of catabolism of IgG2a in rats was not 
altered by neonatal thymectomy or splenectomy when studied at 
80-140 days of age . However, the importance of the lymphoid 
tissues in the catabolism of IgG was not ruled out as the tissue 
distribution of IgG2a in the liver and lymph nodes of thymectomised 
and splenectomised rats suggested that these organs compensated for 
the loss of the thymus and spleen. The importance of the lymphoid 
tissues in the catabolism of IgG was shown by the binding of IgG2a 
to lymphoid cells and the subsequent catabolism of these molecules 
when the lymphoid cell suspensions were incubated at 37° for 
2 ho urs. 
The possibility of immunoglobulin catabolism being 
important in immunoregulation is discussed, especially in light 
of the finding that in antigenically challenged foetal sheep the 
rate of turnover of IgG having antibody activity to the challenge 
antigen was much quicker than non-specific IgG. 
TABLE OF CONTENTS 
CHAPTER 1 INTRODUCTION 
(1) PROTEIN METABOLISM 
(2) PROTEIN CATABOLISM 
(3) IMMUNOGLOBULIN METABOLISM 
(4) IMMUNOGLOBULIN CATABOLISM 
(a) Biological Significance 
(i) Irnmunoglobulin as a serum protein 
(ii) Materna-foetal relationship 
(iii) 
(iv) 
. Man 
. Rat 
. Ruminants 
Maintenance of serum immunoglobulin 
concentration 
Catabolism of immunoglobulin and 
irnmunoregulation 
(b) Catabolic Process 
( i) 
(ii) 
( iii) 
(iv) 
(v) 
Structure of irnmunoglobulins 
Physicochemical and biological 
features of immunoglobulins 
. Human, Sheep and Rat 
Binding of irnmunoglobulin to cells 
Enzymes responsible for catabolism 
Catabolic rate, intermediates and 
end products 
(c) Catabolic Site 
( i) 
(ii) 
(iii) 
(iv) 
Liver 
The reticuloendothelial system 
including the spleen 
Intestine and mucosa 
Kidney 
(d ) Factors Controlling Immunoglobulin 
Page 
1 
2 
3 
5 
14 
15 
15 
16 
17 
18 
19 
21 
23 
25 
26 
27 
28 
29 
29 
30 
30 
31 
31 
32 
Catabolism 33 
(e) Disorders of Immunoglobulin Catabolism 36 
CHAPTER 2 MATERIALS AND METHODS 
(1) EXPERIMENTAL ANIMALS 
(2) BIOLOGICAL SOLUTIONS 
(3) ANTIGENS 
(4) ANTICOAGULANTS 
(5) ANTIBIOTICS 
(6) GENERAL METHODS 
(7) DETAILED METHODS 
Page 
39 
39 
41 
46 
48 
48 
48 
50 
(a) Protein Determinations 50 
(b) Column Chromatography 51 
(c) Affinity Chromatography 53 
(d) Immunoelectrophoresis 54 
(e) Double Diffusion in Agar 55 
(f) Preparation of Pure Immunoglobulins 55 
(g) Preparation of Antisera 57 
(h) Single Radial Immunodiffusion Technique 60 
(i) Labelling of Proteins with Radioactive 
Iodine 61 
(j) Haemagglutination Assays 62 
(k) Lysosomal Enzyme Assays 64 
(1) Subcellular Fractionation of Cell 
Homogenates 65 
(m) Trichloroacetic Acid Precipitation 66 
(n) Iodine: ·separation into Organic and 
Inorganic Form 66 
(o) Radioactivity Measurements 67 
(p) Determination of Half-life Time 68 
(q) Calculation of Tissue Distribution 69 
(r) Preparation of Tissues for Histological 
Examination 69 
(s) Autoradiography and 
Radioimmunoelectrophoresis 69 
(t) Estimation of Plasma Volume 70 
(u) Maintenance of Rat Immunocytomas 71 
(v) Surgical Procedures 71 
CHAPTER 3 THE USE OF RADIOACTIVE IODINE AS A 
PROTEIN LABEL 
(i) 
RESULTS 
(ii) 
RESULTS 
(iii) 
RESULTS 
DISCUSSION 
The problem of free iodine in vivo 
The problem of free iodine in vitro 
Effect of iodination on protein 
molecules 
Page 
75 
76 
80 
82 
86 
CHAPTER 4 CATABOLISM OF IgG2a IN THE RAT AND SHEEP 92 
RESULTS 
Catabolism of IgG2a, RSA and PVP 92 
Catabolism of Rat IgG2a and Sheep IgG2 in Rats 95 
Catabolism of IgG2a in Adult Sheep 96 
Catabolism of IgG2a in HO and DA Rats 96 
Catabolism of Rat IgG2a, Sheep IgG2 and RSA 
in Rats Bearing an IgG2a Immunocytoma 98 
DISCUSSION 100 
CHAPTER 5 PROTEIN METABOLISM IN THE FOETUS 105 
CATABOLISM OF IgG IN FOETAL SHEEP 108 
RESULTS 
Non-Primed Foetus 109 
Antigenically Challenged Foetus 110 
CATABOLISM OF SERUM ALBUMIN IN FOETAL SHEEP 113 
DISCUSSION 114 
CHAPTER 6 CATABOLIC SITE 
RESULTS 
Page 
119 
LIVER 119 
Tissue Distribution of Antibody IgG2a 120 
Catabolism of IgG In vivo 120 
Sheep 120 
Rat 124 
RETICULOENDOTHELIAL SYSTEM INCLUDING THE SPLEEN 125 
DISCUSSION 126 
CHAPTER 7 CATABOLIC PROCESS 133 
RESULTS 
Subcellular Distribution of 12 51 IgG2a 138 
Binding and Subcellular Distribution of 
IgG2a In vitro 139 
Catabolism of 14 c IgG2a in Normal and IgG2a 
Immunocytoma Bearin·g Rats 141 
Catabolism of IgG2a in SPF and Conventional 
Male Wistar Rats 143 
Lysosomal Enzyme Activity in Adult and Foetal 
Sheep 143 
DISCUSSION 144 
CHAPTER 8 CATABOLISM AND IMMUNOREGULATION 
RESULTS 
DISCUSSION 
CHAPTER 9 GENERAL DISCUSSION 
BIBLIOGRAPHY 
APPENDICES 
151 
152 
154 
1 5 7 
16 3 
1 
CHAPTER 1 
INTRODUCTION 
One of the most important features of living organisms 
is the continuous changing of body constituents an~ the balance 
between synthesis and degradation, i.e. a state which appears 
to be static but is in fact dynamic - this phenomenon can be 
described as "homeostasis" (Cannon, 1932). 
Proteins appear to be universally present in all forms 
of life and as a consequence are vital for life. This is borne 
out by the intracellular communication between proteins and 
nucleic acids which constitute the building blocks of all. living 
organisms. Proteins are indispensable to living organisms being 
synthesised from free amino acids. The proteins of living 
organisms can be divided into 3 distinct groups: 
. structural proteins 
. bio-active proteins 
. proteins soluble in the bioloqical fluids. 
Since the discovery of the turnover of proteins by Schoenheimer, 
Ratner, Rittenberg and Heidelberger (1942),the concept that 
protein molecules are continuously being lost and replaced by 
·similar newly synthesised protein molecules has been confirmed 
by many research workers by following the fate of protein 
molecules labelled by various techniques. These labelling 
methods included the use of: the non-radioactive isotope nitroge~ 
. . 
fifteen; the radioisotopes of carbdn, sulphur, iodine and 
hydrogen; and the biological properties of molecules such as 
their antibody or enzymatic activity. 
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That soluble proteins are in a dynamic state has been 
clearly shown in animals by the uptake of radioactive amino-
acids into protein molecules, the distribution of labelled 
proteins between the intravascular and extravascular pools, 
and the degradation of injected soluble protein molecules in 
the body. The study of soluble protein kinetics has contributed 
greatly to clinical medicine as well as to the understanding 
of the fundamental biological behaviour of proteins. 
I would at first like to summarise what is known of 
the metabolism of soluble proteins in biological fluids 
especially that of the immunoglobulins before outlining my own 
studies in this field. 
(1) PROTEIN METABOLISM 
The first studies on protein metabolism occurred 
about the same time as the development of techniques for the 
identification, characterisation and separation of plasma 
proteins. Boundary electrophoresis (Tiselius, 1937) and 
analytical ultracentrifugation (Svedberg and .Pedersen, 1940) 
enabled the separation and quantitation of proteins like the 
serum proteins. Purifying and separating serum proteins by 
tne use of ammonium sulphate, especially that of serum albumin 
(Hewitt, 1936) was also extremely important, as was the develop-
ment of the cold-ethanol method (Cohn, Strong, Hughes, Mulford, 
Ashworth, Melin and Taylor, 1946) for the fractionation of plasma .. 
However, the biggest contribution to protein purification was 
, · 
the use of cellulose ion-exchange resins (Peterson and Sober, 
1956) for chromatography separations. By combining various 
protein purification techniques, with radioisotope labelling, 
several groups helped in the understanding of serum protein 
metabolism (Schoenheimer et al., 1942; Friedberg, Tarver and 
Greenberg, 1948). 
(2) PROTEIN CATABOLISM 
Once it was established that proteins were in a 
constant state of turnover, an answer was sought to the 
following 2 questions -
(a) Why are proteins continually catabolised? 
(b) What is the mechanism of protein degradation? 
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It would appear that an answer to the first question 
is not forthcoming and that the only way to answer this is to 
clarify how protein degradation relates to homeostasis in 
animals. An answer to the second question has been partially 
achieved by labelling homologous or heterologous protein 
molecules with radioisotopes in vitro and following their 
subsequent behaviour in vivo by monitoring such parameters as 
whole body radioactivity, plasma radioactivity to measure 
intravascular clearance, lymph radioactivity to measure the 
extravascular behaviour of the protein molecules, and organ and 
.cellular distribution to determine whether a relationship exists 
between the protein molecules and various tissues. However this 
has not been done for the majority of purified plasma proteins 
and the only information obtained to date in most instances has 
been an estimate of how q uickly pro~eins are cat~bolised. An 
explanation to the reasons for protein degradation, the site(s) 
of catabolism of protein, the intracellular mechanism of 
4 
protein degradation and the regulatory rnechanisrn(s) of protein 
degradation remain unresolved. 
A large number of organs have been considered as 
possible sites for protein catabolism. These include the 
liver , kidney, intestine, and the reticuloendothelial 
system all being closely involved with the intravascular 
compartment . Most of tho.sci data ha\J'l, been obtained by removing 
the organ from the body and following the turnover rate of a 
labelled protein 
and McCoy , 1965 ; 
(Katz, Rosenfeld and Sellers, 1960; Truax 
Seward and Morgan, 1970; Sniderman, Carew, 
Chandler and Steinberg, 1973). Others have tried to use 
in vitro organ perfusion systems to determine the contribution 
of the perfused organ to the total body catabolism of the 
protein (Cohen, Gordon and Matthews, 1962). Unfortunately no 
evidence supports any one particular organ as the catabolic 
site of protein and despite the use of radioactively labelled 
proteins little data~ available on the catabolism of protein 
. . in vivo. 
The failure to answer these questions may be a 
result of the intracellular catabolic process which appears 
to be extremely rapid making it difficult to detect 
.'rintermediates" in the catabolic process. These intermediates 
if detected would allow a possible insight into the catabolic 
process. 
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(3) I:M.MUNOGLOBULIN METABOLISM 
Research on immunoglobulin metabolism started when 
techniques for the purification of serum proteins were 
developed. Tiselius and Kabat (1938) found that they-globulin 
fraction of the serum proteins had a biological activity 
important in the immune response. The concept of "immunity" to 
foreign materials was first suggested by Jenner (1798) and 
Pasteur (1885) who described this phenomenon as a defensive 
mechanism mediated by a humoral factor in the biological 
fluids. The identification of this mediating factor was 
established by Von Behring and Kitasato (1890) who showed that 
the serum from animals previously immunised against tetanus 
and diphtheria toxins when injected into normal animals had the 
ability to protect them against intoxication by the tetanus 
and diphtheria toxins. Another important finding was reported 
by Frankel and Sobernheim (1894) when they showed that the 
protective substance found in the serum of animals, vaccinated 
against vibrios, resisted heating to 70°. They found that when 
serum was submitted to this temperature it completely lost its 
bactericidal property but remained as protective as the 
unheated serum when injected into susceptible animals. This 
established that there were two important factors in humoral 
.immunity, that of a heat resistant substance (immunoglobulin) 
and ah at sensitive substance originally termed Alexin 
(Buchner, 1890) , later to be named "Complement". 
Before immunoglobulin.s were characterised and their 
ability to bind to antigen was shown, several important 
findings had already been made. Metchnikoff (1905) considered 
humoral factors to be involved in the defensive mechanism 
6 
against an organism as follows: "I was led to assume a certain 
stimulating action of the serum of the defensive elements of 
the animals especially on phagocytic systems", and he concluded 
that "it is only natural that we should attribute it to the 
existence of a stimulating action (stimulin) of the serums of 
vaccinated animals on the phagocytes of the normal animals". 
This "stimulin" hypothesis was not fully correct in that the 
enhancement of phagocytosis by serum results from the action 
of a serum component on bacteria rather than on leukocytes 
but it is clear that a cellular function for antibody was 
suggested by Metchnikoff (1905). He was one of the earliest 
researchers to consider the immune process as the defensive 
mechanism of the body being mediated by collaboration of 
humoral factors in the serum with cells. 
Ehrlich (1897) working with bacterial toxins suggested 
the "side-chain" theory to explain the mechanism of action of 
"Antikorper" (antibody) activity. He postulated that cells 
possess "side-chains" or "receptors" made up of atoms or 
substances having an affinity for toxins and other antigens. 
Reactions occurring between cells and antigens rendered the 
receptors useless in their normal function leading to the 
production of more receptors some of which were cast off from 
the cells into the blood stream and it was these circulating 
receptors that protected body cells by reacting with antigen 
in the blood stream. Ehrlich (1897) did not propose that any 
specific cell was responsible for the immune response, however 
this concept was of importance in understanding. ·antibody and 
• ' 
antigen binding and in the development of a receptor hypothesis 
for protein and non-protein molecules. 
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The prediction (Ehrlich, 1897) that an antibody-like 
substance would show specificity in binding foreshadowed the 
conclusions reached by Landsteiner (1945) and the Uniterian 
hypothesis proposed by Dean (1917) and Zinsser (1921) suggesting 
that a single antigen induced the formation of only one kind 
of antibody . Landsteiner, working with the antigen 'azoprotein' 
(Landsteiner and Lampl, 1918; Landsteiner, 1945), showed that 
the biological specificity of the immune response depended upon 
the structural specificity of molecules. These findings 
together with the discovery by Tiselius and Kabat (1938) that 
they-globulin fraction had antibody activity led to a greater 
understanding of the physicochemical nature of immunoglobulin 
molecules and a predominance of research in "humoral immunology". 
With Landsteiner ' s (1945) studies of serological specificity it 
became clear that an enormous variety of cell receptors would 
need to exist and for this reason Ehrlich's (1897) side-chain 
theory was discarded. 
The template theory of antibody synthesis was proposed 
by Breinl and Haurowitz (1930), Alexander (1931) and Mudd (1932) 
who suggested that antibody synthesis was evoked by antigen and 
that protein synthesis was initiated by the structure of antigen 
as a lock-and-key mechanism . This hypothesis was further 
. 
. developed by Pauling (1940) who stated that the antibody forming 
cells were genetically endowed to produce immunoglobulin which 
showed no specificity until antigen caused a change in specific 
conformation. This idea was further strengthened by the 
discovery of the mechanism of p~otein synthesis · (cf Reviews 
by Hoagland, 1960; Chantrenne, 1961; Harris, 1961) suggesting 
that antigen may play a role in the antibody forming process 
by inferring upon them-RNA the property to produce a specific 
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peptide (Ilaurowitz, 1965). This template theory contradicts 
that of Ehrlich's (1897) side-chain theory which predicts 
antigen induces antibody formation selectively by combining 
with a specific receptor which is prepared a priori on the cell 
surface to each antigen and the specificity of an immune 
response does not lie with the antigen but on the cell surface. 
Several findings have questioned the validity of the template 
hypothesis. It has been shown that antibodies to each antigen 
differ in respect of amino-acid composition. The number of 
antibody molecules formed against an antigen is enormously 
large. Once immunised, despite the disappearance of antigen 
from the body, an animal retains the capacity to synthesise 
specific antibody molecules and even though antigen is trapped 
by phagocytic cells antibody is not produced in these cells. 
All of these points argue strongly against the template theory 
being correct. More importantly the template theory does not 
explain the phenomenOflof non-responsiveness to self-components. 
The indirect template theory (Burnet and Fenner, 
1949) attempted to explain non-responsiveness to self-
components by predicting the presence of self-markers on body 
components, protecting self-components from the immune system. 
To account for the persistence of the antibody producing 
.Capacity this theory postulated~genocopy of the antigenic 
determinant had been incorporated in the genome of the stem 
cell concerned . This hypothesis strengthened the importance 
placed upon the responding cell in antibody synthesis and 
Burnet (1957) further modified this .. hypothesis to that of the 
clonal selection theory . 
Completely disregarding the template theory Jerne 
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(1955) proposed the natural selection theory which resulted 
from his observation that in unstimulated animals a small 
amount of antibody (natural) could be found. He postulated 
that pre-existing antibody molecules combined with antigen 
forming antigen-antibody complexes which triggered cells to 
produce antibody. He also suggested that natural antibody 
against an individual ' s own antigens would be removed in the 
early stages of ontogeny. This allowed for an explanation of 
non-self recognition and tolerance being mediated by humoral 
natural antibody. However evidence existed which could not be 
explained by the natural selection theory. For example, 
agammaglobulinaemia patients still have the ability to defend 
themselves against infections and antigens. 
In tuberculin types of immune responses it is not 
possible to passively transfer the immune response with serum 
though it is possible to do so with lymphocytes. Further 
evidence of the importance of cellular immunity came with the 
finding that in transplantation immunity and tolerance, 
lymphocytes played a far more important role than humoral 
antibody. 
Interestingly though, Jerne (1955) said in relation 
~o antibody synthesis ''the crucial point of the natural-
selection theory is the postulate that the introduction of 
antibody molecules into appropriate cells can be the signal for 
the production of more of their kind. This notion is 
unfamiliar. As nothing is known about the mechanism of 
antibody synthesis in a cell, it would seem a priori m0re 
reasonable to assume that an animal can translate a stimulus, 
introduced by protein molecules which it has itself at one time 
produced into an increased synthesis of this same type of 
molecules , than to suppose that an animal can utilise all 
sorts of foreign substances and can build them functionally 
and semi-permanently into the most intimate parts of its 
globulin-synthesising cells" . This concept of a positive 
feedback mechanism by antibody in antibody synthesis has not 
been shown to be correct . However , the possibility still 
remains that antibody may play a role in antibody synthesis. 
Recent evidence does suggest that antibody synthesis may be 
regulated by antibody or its fragments (Uhr and M~ller, 1968; 
Bystryn , Graf and Uhr, 1970; Schwartz, 1971; Fitch, 1975; 
Weigle , 1975 ; Kulberg, Evnin and Tarkhanova, 1976). 
The natural selection theory gave way to the clonal 
selection theory proposed by Burnet (1959) which postulated 
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that a clone of cells (population of cells formed by repeated 
mitotic division of a single cell) has the ability to respond 
to an antigen which is restricted at the level of the genome. 
The specific clone after antigenic stimulation then proliferates 
to produce a vast number of antibody forming cells. On this 
basis it is necessary to have at least 10,000 different clones 
to react with antigen. He postulated that this number of 
clones could arise by mutation of lymphoid cells commencing 
~n ontogeny , and that clones having a potential to react against 
body components would be eliminated at a particular stage of 
embryonic life. Numerous studies have subsequently supported 
the clonal selection theory especially those confirming the 
one cell - one antibody theory and the finding that lymphocytes 
have immunoglobulin-like receptors on their surfaces allowing 
them to recognise and react with antigen (Naor and Sulitzneau, 
1967; Ada and Byrt, 1969; Nossal, Ada, Austin and Pye, 1969; 
Wigzell and Andersson, 1969). 
Lymphocytes are considered by most to be more 
important than antibody in the immune response. Three of the 
most significant findings in 1cellular immunology have been 
11 
the discovery by Gowans (1959) that lymphocytes are continuously 
recirculating from the blood to lymph throughout the entire 
body , the finding by· Miller (1962) that the thymus is a crucial 
organ in the immune response and the work of Nowell (1960) 
showing the transformation of small lymphocytes to blastoid 
cells by phytohaemagglutinin. Most research in cellular 
immunology is now centred on 'thymus-derived' (T cell) and 
' bursal-equivalent' (B cell) lymphocytes. 
I would briefly like to outline how research on 
immunoglobulin metabolism developed. As mentioned before work 
started with the finding by Tiselius and Kabat (1938) that 
they-globulin fraction of serum was associated with the 
immune response. Schoenheimer et al. (1942) studied imrnuno-
globulin metabolism by the use of 15 N-labelled amino acids and 
Humphrey and McFarlane (1954) repeated this work using 
14 C-lysine and 14 C-phenylalanine labelled amino acids in 
actively and passively immunised rabbits, while Glenny and 
Hopkins (1923); Neill, Gaspari, Richardson and Sugg (1932); 
IIeidelberger,Treffers, Schoenheirner, Ratner and Rittenberg (1942); 
Wiener (1951); Barr, Glenny and Randall (1949); Germuth, 
Oyama and Ottinger (1951) observed the half-life times of 
passively administered antibody . in animals using.antibody 
activity as a marker for immunoglobulin. Most of the · 
metabolism studies were done following t~e discovery of 
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radioactive iodine as a marker for protein (Livingood and 
Seaborg, 1938) and the development of radioiodination techniques 
(Eisen and Keston, 1949). Dixon, Talmage, Maurer and 
Deichmiller (1952) prepared y-globulin by alcohol and 
ammonium sulphate precipitation and used 131 I as the label. 
They found similar half-life times in several different 
animals for homologous y-globulin labelled with 131 I and 
homologous y-globulin possessing antibody activity. Similar 
half-life times were calculated for y-globulin in the rabbit 
using both radioactive iodine and 14 C labelled y-globulin as 
a means of comparison of two different markers (Campbell, 
Cuthbertson, Matthews and McFarlane, 1956). 
Sell (1964) studied the effect of various metabolic 
conditions on the turnover of y-globulin in mice by using 
hyperimrnunised, normal and germfree animals. The turnover of 
Bence-Jones proteins and immunoglobulin fragments were 
studied in mice by Wochner, Strober and Waldmann (1967) and the 
metabolism of 7S y-globulin fragments was studied in rabbits by 
Spiegelberg and Weigle (1965). With the introduction of the 
iodine isotope 125 I in the early 1960's several studies were 
done comparing the turnover of differen~ immunoglobulin classes 
in the same animal (Cohen et al., 1962; Tee and Watkins, 1967; 
Nansen, 1972). 
Following the discovery of the myeloma proteins, 
their amino-acid composition, physicochemical and immuno-
chemical characteristics were quickly established (Rundles, 
Cooper and Willett,1951; Putnam, 1953). It was also found that 
in myelomatosis there was hyperproduction of myeloma protein 
and proliferation of "plasma cell" like cells suggesting that 
13 
the synthetic site of immunoglobulin was not in the liver like 
most other serum proteins (Miller, Bly, Watson and Bale, 
1951 ; Miller and Bale , 1954), but in plasma cells. This had 
been a contentious issue since the studies of McMaster and 
Hudack (1935) and this important concept was resolved by 
various workers (Burnet and Fenner , 1949 ; Wager and Chase, 
1952; Coons , Leduc and Connolly, 1955; Askonas and Humphrey, 
1958 ; Nossal, 1958 ; Attardi, Cohn, Horibata and Lennox, 
1959) who showed that in@unoglobulins are produced in lymphoid 
tissues . This work contributed significantly to research on 
irnmunoglobulin metabolism especially that of irnmunoglobulin 
synthesis as did the discovery by Watson and Crick (1953) of 
the structure of nucleic acid and the understanding of the 
mechanism of protein synthesis . 
That irnmunoglobulin metabolism is intimately involved 
in the two arms o f the immune response, that of humoral and 
cellular immunology , has been illustrated by the detection of 
immunoglobulin on the surface of lymphocytes. This was 
previously suggested by Burnet (1959), but Mitchison (1967) 
was the first to consider the presence of immunoglobulin on 
the surface of lymphocytes as being necessary as a receptor 
for antigen to initiate antibody synthesis. Several other 
s~udies had been done to support this view (Sell and Gell, 
1965; Van Furth, Schuit and Hijamans, 1966; Sell, 1967). It 
is interesting that passively administered antibody can inhibit 
an immune response and immunoglobulin on the surface of lympho-
cytes was considered the most likely means by which this could 
be explained (Finkelstein and Uhr, 1964; Wigzell, 1966). · The 
presence of surface immunoglobulin on living mouse lymphocytes 
has been clearly shown by the use of immunofluorescent and 
radioautographic techniques (Raff, Sternberg and Taylor, 
1970). 
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In a normal immune response antibody is thought to 
be produced by an interaction of phagocytic cells with thymus-
derived and bone marrow-derived lymphocytes. However, the 
mechanism by which antigen information is transferred to 
antibody producing cells is unclear . It is here that surface 
immunoglobulin or an immunoglobulin-like molecule on the 
lymphocyte surface may be important (Mitchison, 1967). It is 
also one way in which antibody may have a regulatory role in 
the immune response (Uhr and Moller, 1968; Schwartz, 1971; 
Fitch , 19 7 5) . In the case of a tuberculin type immune response 
and in transplantation immunity, thymus-derived lymphocytes 
play the predominant role and it is not possible to transfer 
the immune response with humoral antibody. There is some 
evidence suggesting a role for cell surface immunoglobulin in 
cell-mediated immunity (Perlman, Perlman and Wigzell, 1972). 
The regulatory role of antibody, antibody metabolites 
and cell surface immunoglobulin on the immune response remains 
obscure but it is obviously an important area of study. 
(4) IMMUNOGLOBULIN CATABOLISM 
Compared to the amount of research into immunoglobulin 
synthesis, very little has been done on immunoglobulin catabolism 
The most likely reason for this is ±hat very few·people have 
considered catabolism important in the immune response · and that 
experiments designed to study catabolism have failed to find 
the formation of any metabolites of immunoglobulin or the 
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enzymes responsible for imrnunoglobulin breakdown. 
The discovery by Porter (1958) and Edelman and Gally 
(1962) of the structure of imrnunoglobulin by splitting the whole 
molecule into fragments using chemical agents or enzymes 
contributed greatly to the understanding of imrnunoglobulin 
structure and of the binding of immunoglobulin to antigen. 
However, it is not possible to extrapolate the findings of 
in vitro destruction of imrnunoglobulin molecules to an in vivo 
catabolic process. Very little information is available on 
the enzyme equivalents of papain and pepsin which may be 
responsible for the catabolism of imrnunoglobulin in vivo 
(Lapresle and Webb, 1960; Barrett, 1967; LoSpalluto, Fehr 
and Ziff, 1969; Motas and Ghetie, 1969). 
(a) Biological Significance 
(i) Imrnunoglobulin as a serum protein 
Imrnunoglobulins are serum proteins and generally behave as 
other serum proteins. The mechanism of catabolism of the 
serum proteins is unknown and a study of imrnunoglobulin cata-
bolism may be one way of determining the general regulation 
mechanisms of serum proteins, but imrnunoglobulins possess two 
untque properties that are not found among the other serum 
proteins. Firstly, imrnunoglobulin is synthesised in lymphoid 
tissue particularly in plasma cells and lymphocytes, while most 
of the other serum proteins are synthesised in the liver. 
Secondly, imrnunoglobulins synthesised in an immune. response to 
an ~ntigen , bind specifically to that antigen. Besides th~se 
two differences it can be assumed that imrnunoglobulins will be 
catabolised as an energy source as other serum proteins are 
and may be under the same general regulatory mechanisms of 
protein metabolism. 
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(ii) Materna-foetal relationship. The transfer 
of maternal irnrnunoglobulin to the foetus or newborn animal is 
important to the neonate in the first weeks of life in protecting 
it from disease . The problems of how maternal immunoglobulin 
crosses the placenta and the catabolism of irnrnunoglobulin in 
the foetus or neonate are important in the understanding of 
irnrnunoglobulin metabolism. 
The transmission of immunity from mother to young was 
demonstrated originally in mice by Ehrlich (1892), and by 
Klemperer .(1893) who showed that passive immunity to tetanus 
toxin was transmitted from mother to offspring in the fowl. 
The transfer of maternal irnrnunoglobulin may occur pre-natally 
via the placenta , post-natally by way of the colostrum or by 
a combination of both routes. 
divided into 3 groups: 
A . antibody via the . 
and guinea pig) 
B antibody via the 
rat 
' 
cat and dog) 
C . antibody via the . 
ruminants). 
On this ba·sis animals may be 
placenta (man, monkey, rabbit 
placenta and colostrum (mouse, 
colostrum (horse, pig and 
The functional difference in these 3 groups lies in 
the placental structure especially that which exists between 
the chorion and uterus, and more particularly in the minute 
histological relationships existing at the junction of these 
components. 
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In the following discussion of materno-foetal 
immunoglobulin transmission I would like to refer only to that 
which occurs in man, rat and ruminants . 
. Man 
From light and electron microscope studies 
(Wislocki and Bennett, 1943; Strauss, 1967; Tighe, 
Garrod and Curran, 1967; Boyd, Hamilton and Boyd, 
1968) the syncytial trophoblast of the placental 
villi of the human placenta appears to be an actively 
absorptive membrane. The presence of antibody to 
diphtheria toxin in cord blood was reported by 
Fischl and von Wunscheim (1895) while Polano (1904) 
observed diphtheria antitoxin in infants whose mothers 
had diphtheria antibodies in their sera. Experimental 
results (Magara, 1936) were obtained by immunising 
women during pregnancy with diphtheria "anatoxin" 
and finding antitoxin in cord blood in about the 
same concentration as that in the maternal blood. 
In humans it is evident that IgM is not trans-
mitted across the placenta while IgG is (Franklin 
and Kunkel, 1958). With the use of radioactive 
isotopes it was shown that IgGl and IgG2 were 
transmitted 10-20 times more readily than albumin, 
whereas little, if any alpha- and beta-globulin was 
transmitted (Bangham, Hobbs and Terry,. 1958; 
, · 
Bangham , 1960) . This suggested that the tr~nsmission 
of immunoglobulin from mother to young was highly 
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specific. More recent studies have shown this to 
be correct (Gitlin, 1964; Gitlin, Kumate, 
Urrusti and Morales, 1964; Fulginiti, Sieber, 
Claman and Merrill, 1966; Kohler and Farr, 1966; 
Schultze and Heremans, 1966; Stiehm and Fudenberg, 
1966; Allansmith, McClellan, Butterworth and 
Moloney, 1968) and that all the subclasses of IgG 
are transferred across the placenta at approximately 
equal rates. 
No absorption of immunoglobulin from colostrum 
and milk occurs across the gut of the newborn infant 
(Boorman, Dodd and Gunther, 1958; Sussman, 1961). 
It is possible though that the antibodies in 
colostrum and milk, especially those associated with 
secretory IgA (S-IgA), function mainly in the lumen 
of the alimentary canal and are important in the 
local immunity of the intestine . 
. Rat 
The transmission of antibody in the rat appears 
to be a function of the yolk-sac but the evidence is 
not conclusive (Lambson, 1966; Beck, Lloyd and 
Griffiths, 1967). Placental transfer of protein in 
the rat has been shown indirectly by the transfer of 
passive immunity from mother to foetus (Culbertson, 
1938; Bruce-Chwatt and Gibson, 1956). Direct 
evidence was obtained using radioactively labelled 
protein (Morgan, 1964) by showing that albumin and 
transferrin were transferred equally readily from 
the maternal circulation to that of the foetus while 
immunoglobulins were transferred about 3 times more 
readily than both of these proteins. Culbertson 
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(1938) found that newborn rats of normal mothers 
fostered upon mothers immune to Trypanosoma lewisi 
rapidly became resistant to infections with the 
parasite and that at least 15 days after birth 
newborn rats could still absorb antibodies via the 
intestine into the circulation. A change ' in 
selectivity of absorption of protein from · the lumen 
of the intestine with time after birth was reported 
by Jordan and Morgan (1968) who found that radio-
actively labelled y-g lobulin, albumin and transferrin 
were absorbed equally readily 1 day after birth but 
there was a relative increase in the absorption of 
proteins with a slow electrophoretic mobility up 
till 21 days of age, meaning that albumin absorption 
ceased first, then a-globulin but the S- and 
y-g lobulins still showed transmission at 14 days . 
. Ruminants 
It is now well established that the transfer of 
immunity from mother to young in ruminants occurs by 
the intestinal absorption of immunoglobulin ingested 
in the colostrum d..Yv..t\k by the newborn ruminant. 
All available evidence suggests that transmission 
of immunity does not occur before birth in ruminants, 
homologous antibodies to a wide variety of antigens 
not being transmi tte~ across the plac·e·nta of the 
sheep (Mason, Dalling and Gordon, 19 3 0; Oxe-r, · 19 3 0; 
Schneider and Szathmary , 1939; Cummings and Bellville, 
1963) and that the transfer of protein to the newborn 
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ruminant occurs only by way of the colostrum 
(Famulener, 1912; Reymann, 1920). Studies of 
Askonas, Campbell, Humphrey and Work (1954) using 
antibody to type III pneumococcus isotopically 
labelled with 35 S-methionine, in which the transfer 
of immunoglobulin from blood into secretion of goats 
was followed, convincingly demonstrated that 
immunoglobulin entered colostrum and milk without 
degradation and resynthesis. There is now ample 
evidence available to show that the intestine of the 
newborn ruminant is capable of absorbing almost any 
large water soluble molecule including foreign 
proteins and polyvinyl pyrrolidone (Deutsch and 
Smith, 1957; Balfour and Comline, 1959; Pierce, 
1961; Lecce and Morgan, 1962; Pierce, Risdall and 
Shaw, 1964; Brandon and Lascelles, 1971). 
In conclusion, it would appear that there are three 
different types of transfer of maternal immunity and that 
these are due to structural differences in the placenta and 
the intestine of the newborn mammal. This suggests that 
foetuses of these 3 different groups of animals develop 
in utero in 3 vastly different environments. The foetal rat 
.will be exposed to maternal antibody and serum proteins, 
and to pathogens and antigens crossing the placenta; the 
human foetus will be exposed to only maternal IgG, while the 
normal sheep foetus develops in a germfree, antigen free 
environment. These differences must be taken into account 
when interpreting experiments in foetal animals. 
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(iii) Maintenance of serum irnmunoglobulin 
concentration. The factors that regulate changes in concentra-
tion of plasma proteins are rather complex and as yet poorly 
understood. It is obvious that at any given time, the concentra-
tion of a plasma protein is a function of its net rate of 
synthesis , its distribution , and its catabolism. The multipli-
city of genetic and non-genetic control mechanisms that affect 
the balance between synthesis and catabolism complicate 
analysis of this problem. Only at present are the regulatory 
mechanisms for protein synthesis becoming clearer and with the 
isolation techniques available for purifying proteins, 
together with the various methods for labelling proteins with 
radioisotopes , it is possible to follow the distribution and 
degradation kinetics of proteins 
. . 
ln VlVO. 
Immunoglobulin classes differ in the degree that 
their serum immunoglobulin concentration regulates their rate 
of turnover. The rate of turnover of IgG appears to be 
dependent upon its serum concentration (Zak and Good, 1959; 
Waldmann and Schwab , 1965) while the rates of turnover of IgM, 
IgA , IgD and IgE appear to be independent of their respective 
serum concentrations (Fahey and Sell, 1965; Frommel, Perey and 
Good , 19 7 0) . The higher the concentration of IgG in the serum 
.the faster it is turned over and conversely the lower the 
serum concentration the slower it is turned over. Brambell 
(1966) proposed an interesting hypothesis to explain 
this relationship between serum IgG and its rate of turnover. 
Brambell ' s (1966) hypothesis is based on the observations of 
Fahey and Sell (1965) who used hyper immunised, normal ·and 
germfree mice and on evidence obtained on the transfer of 
immunoglobulin from mother to young (Brambell, 1966). 
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Brambell (1966) proposed that this phenomenon could be explained 
by a mechanism which is essentially a saturable protection 
system specific for IgG molecules , their attachment to an 
intracellular membrane protecting them from lysosomal degradation. 
However it should not be overlooked that this hypothesis was 
derived mainly from the observations of Fahey and Sell (1965) 
who used 3 groups of mice differing greatly in their degree of 
lymphoid development as well as their metabolic condition. 
It could be equally suggested from this work that there is a 
relationship between the catabolism of IgG and the degree of 
lymphoid maturation (Brandon, 1976). 
Brambell (1966) postulated the existence of receptor 
sites specific for IgG from results on the transfer of immuno-
globulin across the intestine of newborn rodents but it is only 
in the first 3 weeks of life that newborn rodents can transfer 
immunoglobulin from the intestinal lumen into the blood 
circulation, transfer being mediated by binding of immunoglobulin 
to intestinal receptors followed by interiorisation and then 
either transport or destruction (Figure 1.1). When this is 
extrapolated to the catabolism of IgG there is no evidence to 
suggest that the intestine is of any importance and no studies 
suggest the existence , in any animal, of receptor sites 
~pecific for IgG to protect them from lysosomal destruction. 
Nevertheless ample evidence does exist showing a relationship 
between low IgG serum concentration and a slow turnover rate for 
IgG (Fahey and Robinson, 1963; Solomon, Waldmann and Fahey, 
1963) and this must be considered when postulating possible 
means of immunoglobulin catabolism. 
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Figure 1.1. Theoretical model proposed by Brambell (1966) 
to explain the selective transfer of immunoglobulin across 
epithelial membranes and the relationship between the serum 
immunoglobulin concentration and catabolism of IgG. 
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(iv) Catabolism of irnrnunoglobulin and 
irnrnunoregulation. One of the phenomena that occurs when antigen 
is injected into an animal is the production of specific anti-
body to the antigen. The triggering of immunoglobulin synthesis 
is thought to commence with uptake of the antigen by phagocytic 
cells which then transfer information to thymus-derived 
lymphocytes and bone marrow-derived lymphocytes. The latter 
are thought to develop into a population of imrnunoglobulin 
producing cells (Miller and Mitchell, 1968; Nossal, Cunningham, 
Mitchell and Miller, 1968). 
In spite of the amount, class and the heterogeneous 
nature of irnrnunoglobulin synthesised during an immune response 
there appears to be a very intricate regulation of imrnuno-
globulin synthesis. This regulation could be mediated by 
several mechanisms 
. the fate and presence of antigen 
. by cells involved in the immune response 
. the serum imrnunoglobulin concentration 
. metabolites or intermediates of imrnunoglobulin. 
In most cases after challenge with antigen the level of antibody 
after reachina a peak decreases gradually in the circulation 
and finally disappears. Some antigens such as bacterial lipo-
polysaccharide, which remain in the animal for a long time, 
result in cyclic antibody synthesis (M~ller, 1965). 
In a normal immune response the disappearance of 
antibody from the circulation may be attributed to its complexing 
with antigen, a decrease in the synthetic rate or its catabolism. 
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Therefore, either directly or indirectly the catabolism of 
immunoglobulin may be important in the regulation of the immune 
response by the removal and destruction of antibody from the 
circulation or by antibody and its metabolites affecting 
immunoglobulin synthesis. In respect to the latter point the 
serum immunoglobulin concentration is important in the turnover 
of IgG (Brambell, 1966). However this observation applies only 
to the turnover of nonspecific immunoglobulin but still may be 
important in the regulation of specific antibody metabolism. 
Little evidence is available on the regulation of the immune 
response by antibody or its metabolites. It has been shown 
(Uhr and Baumann, 1961; Graf and Uhr, 1969; Bystryn, Graf 
and Uhr, 1970) that specific antibody does affect immuno-
globulin synthesis in vivo by removing specific antibody from the 
circulation of rabbits by both immunoadsorption (Graf and Uhr, 
1969) and by exchange blood transfusions (Bystryn et al., 1970; 
Bystryn, Schenkein and Uhr, 1971). After the titre of 
specific antibody in the circulation was lowered a rapid 
increase in the serum titre of the specific antibody was 
observed and in several cases the original titre was exceeded. 
This result was explained by the release of free antigen from 
the immunogen containing compartment which stores antigen-
antibody complexes (Figure 1.2) (Bystryn et al., 1970; 
,Bystryn et al., 1971). However the problems of antibody 
catabolism which occur following the release of free antibody, 
as well as those of antigen-antibody complexes, were not 
considered nor was the possibility that immunoglobulin or its 
metabolites may affect antibody synthesis. The · importance of 
itnmunoglobulin metabolism in immunoregulation remains unresolved. 
The fate of immune complexes is another important area as this 
Ag 
-
-
IMMUNOGEN-
CONTAINING 
COMPARTMENT l~UNOGENIC 
G+1 Ab~ STIMULUS 
-1 l ANTIBODY- Ab 
GAb A~ - SECRETING CRCULATO'J 
1 ~ - COMPARTMENT 
~b Ag] '' '" 
1 ~ 
Ab+Ag 
,. + Ab 
Figure 1.2. Theoretical model to explain the regulation of 
antibody synthesis by serum antibody (Bystryn et al., 1971). 
Under normal conditions it is proposed that the circulating 
antibody and antibody in the immunogen-containing compartment 
are in equilibrium. However, when the serum antibody con-
centration is reduced this promotes dissociation of complexes 
towards free antibodies which concomitantly increases the 
release of free antigen which in turn stimulates the immune 
cells as nepicted by the heavier arrows. 
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cannot be considered a different problem to that of immuno-
globulin catabolism until the catabolic process of immunoglobulin 
is determined. 
Some recent work in vitro on the immunosuppressive 
activity of antibody (Fitch, 1975; Tew, Greene and Makoski, 
1976) is interesting as it has also been shown that metabolites 
of immunoglobulin do affect immune responses in vivo (Kulberg 
et al., 1976) and that immunoregulation appeared to be a function 
of the Fab portion of the immunoglobulin molecule, not the Fe 
region (Pincus, Lamm and Nussenzweig, 1971; Pincus, Miller 
and Nussenzweig, 1973). Although not directly related to 
immunoregulation, recent work (Yoshida, Yoshinaga and Hayashi, 
1968; Hayashi, Yoshinaga and Yamamoto, 1974) has shown that 
IgG slightly modified by SH-protease (Leukoegresin) plays an 
important role in inflammation. This may be of importance in 
the biological significance of immunoglobulin metabolism. In 
conclusion it would appear that the catabolism of immunoglobulin 
is intimately involved in immunoglobulin synthesis suggesting 
that it is also involved in immunoregulation. 
(b) Catabolic Process 
The mechanism of the catabolism of immunoglobulin is 
considered in this section by comparing the results obtained 
with papain and pepsin digestion in vitro to that obtained 
in vivo, starting with a description of the physicochemical 
and biological properties of immu.nogl:obulins. 
(i) Structure of irnmunoglobulins. A basic 
feature of the irnmunoglobulin molecule is a four-chain 
structure , comprising 2 light (L) and 2 heavy (H) chains. 
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The Hand L chains contain amino acid residues which form the 
antigen-binding site , each H-L pair producing one binding site. 
The four-chain structure thus yields 2 sites (Figure 1.3a). 
An irnmunoglobulin molecule may have more than 4 chains. 
For example molecules of the IgM class have from 16 to 24 
chains depending on the animal species . Serum IgA may exist as 
a polymer and also as S-IgA which is found in colostrum, tears, 
saliva and other secretory fluids. 
Papain selectively attacks each H chain at the 
N-terminal end of the interheavy chain disulphide bonds 
liberating three large fragments. Two are called Fab fragments 
(fraction antigen binding) and the other one an Fe fragment 
(fraction crystallisable) . Each Fab fragment has one antigen 
binding site, i . e. it is univalent. Fab fragments therefore 
cannot precipitate macro-molecular antigens or agglutinate 
particulate antigens but they can when present in excess, block 
precipitation or agglutination. Figure 1.3b shows the site of 
attack of rabbit or human IgG by pepsin at pH 4 to 4.5. The 
initial product of digestion is F (ab 1 ) 2 . Only the interheavy 
chain disulphide bond(s) join the 2 univalent fragments after 
peptic digestion and these bonds are very easily reduced, 
liberating 2 univalent fragments , Fab ' , which are slightly 
larger than Fab fragments . Because of the susceptibility of a 
particular region in the middle of the II-chain tci attack by 
papain , pepsin and other enzymes, it is generally thought 
that this region is loosely folded. This area has been desig-
nated the hinge region because the 2 univalent (Fab) 
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Figure 1.3a. Over-all arrangement of the Hand L chains 
Heavy 
chain 
Light 
chain 
and disulphide bonds of human IgGl. The Fab and Fe 
fragments as shown were produced by digestion with trypsin. 
PCA: pyrollidone carboxylic acid 
CHO carbohydrate 
CHI, CH2, CH3 : regions where homology occurs in the 
constant region of the heavy chains 
Pepsin 
Papai 
Fe 
Figure 1.3b. Arrangement of the polypeptide chains and 
interchain disulphide bonds of rabbit IgG. The cleavage 
sites of enzymic digestion by pepsin and papain are shown 
(from Nissonoff et al., 1975). 
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fragments can move in space in relation to one another. As 
is shown in Figure 1.3a half the Hand L chains at the N-
terminal end have been designated as the variable region 
because different amino acids sequences are found in each 
immunoglobulin. The other parts of the Land the H chain have 
been called the constant region because the amino-acid 
composition and sequences are constant among the immuno-
globulins. As shown in Figure 1.3a the homologous regions 
in the constant region of H chains are designated CHl' cH 2 and 
cH 3 and a single intrachain
 disulphide bond occurs within each 
homologous region and in a three-dimensional structure each 
homologous region appears to be folded into a compact domain. 
A single interchain bond links the CL and cH 3 regions and two 
disulphide bonds link the heavy chains (Edelman, Cunningham, 
Gall, Gottlieb, Rutishauser and Waxdal, 1969; Nisonoff, Hopper 
and Spring, 1975). 
(ii) Physicochemical and biological features 
of immunoglobulins . 
. Human, Sheep and Rat. As shown in Table 1.1 the 
classes of human immunoglobulins are IgG, IgM, IgA, IgD and 
IgE with IgG having 4 subclasses. In the sheep the classes 
currently identified are IgG, IgM and IgA with IgG having 2 
subclasses. In the rat the classes identified are IgG, IgM, 
IgA and IgE with IgG having at present 4 subclasses. 
The physicochemical and biological properties of the immuno-
globulins in the 3 species are listed in Table 1.1. It is 
evident that a great degree of similarity exists in t he immuno-. . 
globulin classes between the different species of animals. 
TABLE 1.1 
Physicochemical and biological properties of human, sheep and rat irnmunoglobulins 
Human 
Concen- Synthetic Carbo-
tration T\ F.C.R. Rate hydrate C.F. P.T. P.C.A. m. w. in plasma (Days) (%) (mg/kg/ Content 
(mg/lOOml) Day) % 
IgG 150,000 800-1700 25-35 2.9 IgG 
Gl 500-1200 23 7 25 + + + Gl 
G2 200-600 23 7 + + - G2 
-
G3 50-100 16 17 3.4 + + + 
G4 20-100 23 7 - + + 
-
IgM 900,000 50-200 5 18 7 11.8 + - - IgM 
IgA 160,000 150-400 6 25 24 7.5 IgA - - -(370,000) 
IgE 190,000 0.01-0.14 3 89 0.02 11.0 - - -
IgD 150,000 0.30-4.00 2 37 0.4 4.0 - - -
C.F. (Complement Fixation): Muller-Eberhard (1968). 
P.T. (Placental Transfer): Virella, Silveira-Nunes and Tarnagnini (1972). 
P.C.A. (Passive Cutaneous Anaphylaxis): Spiegelberg (1974). 
The concentrations and half-life times were obtained from the following: 
Sheep 
Concen-
tration T~ 
in plasma (Days) 
(mg/lOOml) 
IgG 
1859 7.85 Gl 
1455 8.08 G2a 
G2b 
G2c 
137 IgM 
13 IgA 
IgE 
Rat 
Concen-
tration T~ 
i n plasma (Days) 
(mg/lOOml) 
4-8 
585 
800 5-6 
-
260 
560 
130 
20 
Human: Schultze and Heremans (1966); Spiegelberg, Fishkin and Grey (1968); 
Sheep: Cripps and Lascelles (1974). 
Morell, Terry and Waldmann (1970). 
Rat: Campbell et al. (1956); Cohen (1957); Weigle (1957); Jeffay and Winzler (1958); 
Shewell (1960); Kekki and Eisalo (1964); Bazin, Beckers and Querinjean (1974); 
Beckers and Bazin (1975). 
Farthring, Gerwing and 
Tada, Okumura, Platteu, 
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(iii) Binding of imrnunoglobulin to cells. The 
first step in the process of immunoglobulin catabolism would 
most likely be the binding of immunoglobulin to cells responsible 
for catabolism . There is ample evidence to show the binding of 
immunoglobulin to cells,especially if the immunoglobulin is in 
the form of an antigen-antibody complex. The binding site of 
antigen-antibody complexes on lymphocytes has been termed the 
Fe receptor (Uhr and Phillips, 1966; Basten, Miller, Sprent 
and Pye , 1972 ; Cline , Sprent, Warner and Harris, 1972; 
Paraskevas , Lee , Orr and Israels , 1972) as it has been shown 
that the Fe portion of the IgG molecule can bind directly to 
lymphocytes (Paraskevas et al., 1972) and that Fe fragments of 
IgG and whole IgG molecules inhibit the binding of immune 
complexes to lymphocytes (Basten, Warner and Mandel, 1972; 
Cline et al ., 1972) . Recently other cell types such as phago-
cytic cells (Uhr , 1965; Phillips--Quagliata, Levine, Quagliata 
and Uhr , 1971; Arend and Mannik, 1972; Leslie and Cohen, 1974) 
and hepatocytes (Hopf, Meyer zum Buschenfelde and Dierich, 1976) 
have been shown to have Fe receptors on their surface membranes. 
Since the discovery of cytophilic antibody (Boyden 
and Sorkin , 1960) and cell surface imrnunoglobulin several 
explanations have been offered as to their biological signifi-
.c·ance (Mitchell and Abott, 19 6 5; Hanna and Szakal, 19 6 8; 
Nossal, Abott, Mitchell and Lummus, 1968; Basten et al., 1972; 
Niederer , 1974; Ramasamy , Munro and Milstein, 1974). However 
no definite role has been shown for either cell surface imrnuno-
globulin or cytophilic antibody. I~ may be that·cytophilic 
antibody and cell surface imrnunoglobulin are important.in· the 
catabolism of immunoglobulin and in fact represent the initial 
step in the catabolic process. 
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(iv) Enzymes responsible for catabolism. There 
is some evidence showing that immunoglobulin may be digested 
by proteolytic enzymes prepared from animal tissues (Lapresle 
and Webb, 1960; Barrett, 1967; LoSpalluto et al., 1969; 
Motas and Ghetie, 1969; Ghetie and Motas, 1971; Menninger, 
Fehr, Boni and Otto, 1976). This suggests tha~ the digestion 
of immunoglobulin in vitro by the use of pepsin and papain 
may be similar to that which occurs in vivo when immunoglobulin 
is catabolised. In fact there is evidence showing the presence 
of free light chain and heavy chain molecules in the circulation, 
0 
faeces and urine of normal (Berggard and Bennich, 1967; 
Salling, 1975) and immunised animals (Merler, 1966). 
products. 
(v) Catabolic rate, intermediates and end 
It would appear a reasonable assumption that by 
following the catabolic fate in vivo of imrnunoglobulin fragments 
such as Fab and Fe prepared in vitro, it should be possible to 
gain an understanding of immunoglobulin catabolism in vivo 
(Spiegelberg and Weigle, 1965; Wochner et al., 1967; Watkins, 
Turner and Roberts, 1972; Arend and Silverblatt, 1975). It 
has been found that Fe fragments behave more like whole immuno-
globulin molecules in vivo (Fahey and Robinson, 1963; 
Spiegelberg and Fishkin, 1972) than Fab fragments which are 
removed rapidly from the circulation (Waldmann, Strober and 
Mogielnicki, 1972). This suggests that the Fe portion of the 
immunoglobulin molecule is important in the catabolic process. 
The Fe portion of the immunoglobulin molecule has previously 
been shown to have 2 other important biological functions, that 
of controlling placental transfer of immunoglobulin molecules 
and being responsible for p assive cutaneous anaphylaxis 
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(Brambell, 1963). Recent evidence suggests that the cH 3 
domain of the Fe portion plays a critical role in immunoglobulin 
catabolism (Yasmeen, Ellerson, Dorrington and Painter, 1973, 1976). 
It would appear that the Fe portion of the immuno-
globulin molecule is intimately involved in immunoglobulin 
catabolism and that proteolytic enzymes found in animal tissues 
have the ability to digest immunoglobulin molecules. However, 
no intermediate products of in vivo immunoglobulin catabolism 
have ever been detected and the process of immunoglobulin 
catabolism in vivo remains unresolved. 
(c) Catabolic Site 
The catabolic site of the various classes of immuno-
globulin has been the subject of numerous studies but no 
particular organ has been si~~\eJ. out as being the catabolic 
site of the immunoglobulins. 
( i) Liver . The liver was considered to be a 
likely site for the catabolism of IgG by Cohen et al. (1962) who 
used isolated perfused rat livers and showed that 30% of injected 
immunoglobulin was degraded in the liver. In the case of 
,desialylated glycoproteins such as ceruloplasmin, accumulation 
and removal of these molecules hav~been shown to occur 
exclusively in the liver (Gregoriadis, Morell, Sternlieb and 
Scheinberg, 1970; Van Rijk and Van den Hamer, 1976). The 
inununoglobulins can be considered glycoproteins · as they all 
contain carbohydrate, IgG 2.9 %, IgM 11.8 %, IgA 7.5 % and IgE 
11 . 0% . It is possible that the liver may be a site of catabolism 
of immunoglobulin molecules especially those that have been 
slightly modified. 
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the spleen . 
(ii) The reticuloendothelial system including 
The reticuloendothelial system including the spleen 
has not been considered as a site of immunoglobulin catabolism. 
It is now well established that immunoglobulin is synthesised in 
plasma cells and it is possible that immunoglobulin could 
regulate immunoglobulin synthesis in plasma cells through a 
feed back mechanism (Graf and Uhr , 1969; By stryn et al., 
1971; Weigle, 1975). As well as this, phagocytic cells residing 
in the reticuloendothelial system can engulf both endogenous 
and foreign protein molecules, so their importance in the 
catabolism of immunoglobulin cannot be overlooked. 
(iii) Intestine and mucosa. The loss of immuno-
globulin via excretory processes cannot be ignored. That S-IgA 
was selectively transferred into the saliva and colostrum was 
originally shown by Chodirker and Tomasi (1963). These S-IgA 
antibodies are known to contribute to the local immune defence 
mechanisms . It has been observed that small intestine fluid 
and bile contain significant quantities of IgG and IgA 
(Chodirker and Tomasi, 1963; Tomasi and Zigelbaum, 1963; 
Tomasi , Tan , Solomon and Prendergast, 1965) and when considering 
the turnover of immunoglobulin this route must be recognised. 
Inc reased catabolism of plasma proteins is known to occur by 
.leakage into the gastrointestinal tract with the subsequent 
digestion of these proteins by the intestinal enz ymes, this 
often being the cause of hypoproteinaemia (Citrin, Sterling and 
Halsted, 1957). 
The presence of plasma proteins especially serum 
albumin has been demonstrated in the gastrointestinal tract of 
normal patients (Holman , Nickel and Sleisenger, 1959; Campbell, 
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Cuthbertson, Mackie, McFarlane, Phillipson and Sudsaneh, 1961; 
Waldmann, 1961) as has irnrnunoglobulin (Plaut and Keonil, 1969; 
Haneberg and T¢nder, 1973). A study in dogs (Andersen, Glenert 
and Wallevik , 1963) estimated that 1.3% to 29 % of the plasma 
pool of irnrnunoglobulin was catabolised per day via the intestine 
and by injecting hypertonic magnesium sulphate into the intest-
inal lumen of dogs, concluded that capillary permeability may 
determine the amount of IgG catabolised. 
(iv) Kidney. The kidney has an important and 
complex role in the regulation of serum protein metabolism. 
Various renal diseases are accompanied by typical changes in 
the protein concentration of serum and urine. For example, 
the fractional metabolic and catabolic rates for IgG are normal 
in patients with tubular disease , being O .30%/hr and 0.29 %/hr 
respectively (Waldmann et al., 1972), whereas the metabolism of 
lambda L-chains in five patients with tubular disease differed 
considerably from that of normal individuals (Waldmann et al., 
1972) . 
The metabolism of a typical large serum protein, IgM, 
is normal in patients with nephrotic syndrome. Moreover the 
fractional proteinuric rate for IgM in these patients is 
negligible. Thus the metabolic defect in patients with 
nephrotic syndrome is characterised by an abnormal glomerula r 
permeability to proteins of intermediate size leading to an 
increased fractional proteinuric rate of these proteins. 
Metabolism of proteins of molecular weight less than 45,000 i s 
unaffected by this pathological condition as these proteins 
normally have a high glomerular permeability. 
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Bence-Jones proteins are readily detected in the urine 
of myelomatosis patients (Solomon , Waldmann, Fahey and 
McFarlane , 1964) suggesting that the kidney may play an 
important role in the removal of immunoglobulin fragments. 
Rabbit immunoglobulin fragments I and II (prepared in vitro by 
the use of papain) when injected into rabbits, are rapidly 
excreted into the urine (Spiegelberg and Weigle, 1965), while 
only small amounts of intact rabbit IgG and rabbit IgG papain 
fragment III are excreted via the urine . From these results it 
was concluded that circulating immunoglobulin and the Fe 
portion of the immunoglobulin molecule are not removed by the 
kidneys while the Fab fragment is removed rapidly from the 
circulation via the kidneys. 
(d) Factors Controlling Immunoglobulin Catabolism. 
A breakdown of the numerous factors that may be 
important in the control of immunoglobulin catabolism are 
listed in Table 1 . 2. 
The nitrogen requirements of the body are important 
when considering turnover , as the body continuously needs to 
synthesise protein for which energy is required, and 
reutilisation of protein provides a good source for this. 
Dixon et al . (1952) showed that in thyroxine treated rabbits 
with metabolic rates twice that of normal, the half-life 
time of IgG was significantly lower than that of the controls. 
But they also pointed out that the metabolic rate is not the 
only factor controlling IgG turnover. For example, the turnover 
of IgG in children is longer than in adults in spite of the 
higher metabolic rate of children. This has also been shown in 
General 
Lymphoid 
Table 1.2 
Metabolic Conditions 
i) Basal metabolic rate 
ii) Age 
iii) Body weight 
iv) Pathological changes 
Tissues 
i) Synthetic rate of immunoglobulin 
ii) Functional activity of the reticuloendothelial 
system 
Changes in Immunoglobulin Structure 
i) 
ii) 
iii) 
Denatured 
Desialylated or broken down to fragments 
Immune complexes 
Function of Catabolic Sites 
i) Liver 
ii) Kidney 
iii) Intestine 
iv) Lymphoid tissue. 
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foetal sheep (Brandon, 1976) where the turnover of passively 
injected IgG is very low but the metabolic rate of the foetus 
is high (James, Raye, Gresham, Makowski, Meschia and Battaglia, 
1972). It was suggested by Allison (1960) that there is a 
relationship between the body weight of an animal and the half-
life time of albumin and IgG, the bigger the animal the slower 
the turnover. 
Maturation of the lymphoid tissue is probably an 
important factor in immunoglobulin catabolism. Brambell 
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(1966) based his hypothesis for the catabolism of immuno-
globulin on evidence obtained by Fahey and Sell (1965) who 
studied the turnover of IgG in germfree, specific pathogen free 
(SPF), normal and hyperimmune mice. They found a very long 
turnover time for IgG in germfree and SPF mice but a rapid 
turnover of IgG in hyperimmune mice and concluded that the 
serum IgG concentration regulated the turnover of IgG. 
However they overlooked that in germfree and SPF animals there 
is very little development of the lymphoid system while in 
hyperimmune animals there is an extensive proliferation of the 
lymphoid system. It can be equally suggested from their data 
that there is a relationship between immunoglobulin catabolism 
and the degree of lymphoid development as well as with serum 
immunoglobulin concentration. 
When a relationship between lymphoid development and 
the turnover of immunoglobulin is looked at more closely there 
are 2 important factors that need to be considered. They are 
the synthetic rate of immunoglobulin and the phagocytic activity 
of the reticuloendothelial system. It is possible that 
circulating immunoglobulin may regulate immunoglobulin synthesis 
.a·nd details of this will be discussed in Chapter 8. It has been 
suggested that catabolism of endogenous proteins may occur in the 
same manner to that of denatured or of aggregated proteins 
which are known to be catabolised by cells of the reticulo-
endothelial system, predominantly ip the Kupffer·cells of the 
liver (Benacerraf, Halpern, Stiff el, Cruchaud and Biozzi, · 1955; 
Benacerraf, Biozzi, Halpern, Stiffel and Mouton, 1957). 
However Freeman, Gordon and Humphrey (1958), by blocking the 
reticuloendothelial system with carbon particles, concluded 
that distinct , though possibly overlapping, cell populations 
or mechanisms are involved in the catabolism of native and of 
denatured proteins by the liver. 
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Proteins are said to be 'denatured' when they lose 
their native structure. Polypeptide chains have no structure 
and as such cannot be denatured whereas a 3 dimensional 
arrangement of molecules can be and it is with this type of 
structure that the term denaturation is used (Schultze and 
Heremans , 1966) . Any factor that affects the secondary, 
tertiary or quaternary structure of a protein may be responsible 
for protein catabolism. Disulphide bridges are easily affected 
by several agents but at present little work has been done on 
the turnover times of denatured irnrnunoglobulin molecules. 
It has been shown that changing the structure of protein 
molecules by excessive labelling with iodine leads to a shorter 
half - life time (Freeman, 1959; McFarlane, 1956, 1964) and 
it is well documented that fragments of irnrnunoglobulin, 
and immune complexes behave differently to the whole 
molecules. 
(e) Disorders of Irnrnunoglobulin Catabolism 
No irnmunoglobulin disorders have been found solely 
involving impairment of catabolism. This does not mean however 
that catabolic disorders do not occur. It is possible that in 
disorders involving increased or decreased synthesis of irnrnuno-
globulin the catabolic process may be at fault. The catabolic 
process may also malfunction in diseases involving particular 
organs, for example the kidney, liver and reticuloendothelial 
system. 
~7 
In disorders involving excessive synthesis of immuno-
globulin such as repeated infections and myelomas (Liljedahl, 
Olhagen, Plantin and Birke, 1963; Solomon et al., 1963; Andersen, 
1964 ; Olhagen, Birke, Plantin and Ahlinder, 1964), it may be the 
failure of the catabolic process to handle the excessive 
quantities of immunoglobulin produced that leads to high levels 
of immunoglobulin in the body. This has been shown to be the 
case recently for myelomas producing IgE (Waldmann, Iio, Ogawa, 
McIntyre and Strober, 1976). Equally in the production of 
low amounts of immunoglobulin the catabolic site ·may fail to 
compensate for this and continue to catabolise at a normal 
rate, which would lead to an even lower level of plasma 
immunoglobulin. 
Changes in the function of various organs do affect 
immunoglobulin turnover. Liver disease induces general meta-
bolic disturbances especially in plasma protein metabolism. 
Hypergammaglobulinaemia is often accompanied by both acute and 
chronic liver disease (Havens, Dickensheets, Bierly and Eberhard, 
1954; Eisenmenger, 1955; Cohen, 1963; Andersen, 1964; 
Olhagen et al., 1964), with variable increases in serum IgG, 
IgA and IgM being reported in acute viral hepatitis (Dudley, 
O'Shea, Ajdukiewicz and Sherlock, 1973), chronic hepatitis of 
viral or idiopathic origin (Husby, Blo~hoff, Skrede, Elgio and 
Gjone, 1973) and in hepatic cirrhosis including that attributed 
to alcohol (Wilson, Onstad and Williams, 1969). Increased serum 
IgE levels have been described in atopic states (Johansson, 1967), 
38 
parasitic infections (Johansson, Mellbin and Vahlquist, 1968; 
Hogarth-Scott, Johansson and Bennich, 1969; Dessaint, Capron, 
Bout and Capron , 1975) and in several liver disorders (Vanepps, 
Husby , Williams and Strickland, 1976). The changes associated 
with liver disease may reflect an alteration in the ability of 
the liver to catabolise immunoglobulin . 
Excessive loss of immunoglobulin may occur through 
the kidney in severe nephrotic states, the small intestine in 
the so-called "protein-losing enteropathy" syndrome and via the 
skin after extensive burning. However, in all these conditions 
there is a general leakage of plasma proteins and the loss of 
albumin is often proportionattly higher than that of immuno-
globulin. In disorders involving the reticuloendothelial 
system immature development or malfunction of the spleen are 
usually observed and it is possible that immunoalohulin may be 
important in these processes . 
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CHAPTER 2 
MATERIALS AND METHODS 
(1) EXPERIMENTAL ANIMALS 
(a) Rats . Rats were obtained from several sources. 
All rats used were bred within the Animal Breeding Establishment 
of the John Curtin School of Medical Research and fed a diet 
of Rat and Mouse Cubes · (Bunge Pty Ltd, Australia). 
(i) Wistar. Wistar Outbred rats from a closed 
colony maintained by the Laboratory were bred in either 
Conventional or Specific Pathogen Free (SPF) conditions. 
(ii) DA and Hooded. Inbred DA strain rats were 
bred by brother-sister matings of pairs obtained from the Walter 
and Eliza Hall Institute, Melbourne, the colonies originally 
being developed by Dr . W. K. Silvers. Inbred Hooded strain rats 
were obtained from the CSIRO, Division of Animal Physiology, 
Prospect , N. S . W. but were originally from Glaxo Laboratories, 
U.K . Hooded strain rats were maintained by brother-sister 
I':1.a tings. 
(iii) Lou/Mand Lou/C. The origin of these 
inbred rats is unknown,probably being derived from a Wistar 
stock maintained at the University of Louvain, Belgium. 
Inbreeding began in 1956 by Dr. C. peckers and since 1969 the 
rats have been selected for the incidence of irnrnunocytoma·s 
by Dr. H. Bazin . Their histocompatibility has been checked 
regularly by skin grafting. The rats used in experiments were 
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obtained from Dr. H. Bazin in 1973-74 /Lou/M/Wsl · (? + F12), 
Lou/C/Wsl : (? + F13)/ and have been maintained in Conventional 
conditions for several generations since by brother-sister 
matings. 
(b) Sheep. Virgin Merino ewes between 2 and 3 years 
of age were used and a local farmer supplied them as required. 
When pregnant ewes were needed with known conception dates, 
Merino rams were fitted with a Sire Sine harness and crayon 
(Hortico Ltd, Port Melbourne, Victoria) and the oestrus cycle of 
ewes synchronised by the use of "Syncro-Mate" pessaries 
(G.D. Searle, Sydney, NSW). The ewes were maintained on pasture 
until 4 to 6 weeks before surgery when they were brought indoors 
and fed lucerne chaff and a supplement of oats. Just prior to 
surgery the pregnant ewes were put into metabolism cages and 
remained in these until the finish of the experiment. 
Most of the foetal sheep used were bred as described 
above. A few foetuses used for making cell suspensions were 
obtained from a nearby abattoir (Canberra Abattoir Pty Ltd, 
Fyshwick, ACT) and were alive when removed from the mother. 
( C) Rabbits. Semi-lop, outbred rabbits (of mixed 
.Oxford-lop, New Zealand White and California stock) for the 
production of antisera were obtained from the colony maintained 
by the Animal Breeding Establishment. They were housed in 
individual cages in air-conditioned rooms and fed a diet of 
commercial rabbit and guinea pig pgllets (Bunge · Pty Ltd, 
ABstralia) with water supplied ad libitum. 
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(2) BIOLOGICAL SOLUTIONS 
(a) All chemicals used were of Analytical Reagent 
grade. 
(i) Physiological saline. 9 g of sodium 
chloride (NaCl) was dissolved in 1 litre distilled water to make 
a 0.9% solution. 
(ii) Phosphate buffered saline, pH 7.3 (PBS). 
8 g of NaCl, 1.2 g of disodium hydrogen phosphate dihydrate 
(Na 2HP0 4 . 2H 20) and O. 39 g of sodium dihydrogen phosphate dihydrate 
(NaH 2Po4 .2H 20) were dissolved in, and made up to, 1 litre with 
distilled water. 
(iii) Hanks balanced salt solution (HBSS) was 
made by mixing solutions 1 and 2 in the proportion of 80 ml 
and 20 ml and making up to 1 litre with distilled water. Solution 
1 contained 100 g NaCl, 5 g KCl, 1.25 g Mgso 4 .7H 2o, 
1.25 g 
MgC1 2 .6H 2o, 1.75 g cacl 2 , 12.5 g 
glucose made up to 1 litre with 
distilled water. Solution 2 contained 1 g phenol red, water 
soluble; 3.76 g Na 2HP0 4 .2H 2o, 3 g KH 2Po 4 made up to 1 litre with 
distilled water. 
(iv) Alsever's solution. 18.66 g glucose, 
8.0 g sodium citrate, 0.55 g citric acid, 4.2 g NaCl were mixed 
in distilled water and heated at 100° for 30 minutes. The pH 
was then adjusted to 6.1 with 10 % w/v citric acid and the volume 
adjusted to 1 litre with distilled water. 
(v) Eagle's Medium. Eagle 's minimum essential 
medium for cell cultures was obtained from the Commonwealth 
Serum Laboratories, Victoria, Australia, in a powdered form. 
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(vi) Gelatin saline solution. To prepare this 
solution 100 ml of calcium magnesium saline was boiled and 5 g 
of gelatin added with constant stirring to prevent burning. 
900 ml of calcium magnesium saline was then added and the pH 
adjusted to 7.2. To prepare the calcium magnesium saline solution 
85 g NaCl, 1.68 g MgC1 2 .6H 2o, 0.28 g CaC1 2 , 12.03,H3Bo3 , 
0 . 52 g Na 2B4o 7 .lOH 2o were dissolved and made up to 1 litre
 with 
distilled water. 
(b) Buffers for Chromatography 
(i) 0.01M phosphate, saline buffer pH 7.3. This 
buffer was used for G-200 Sephadex chromatography and was 
prepared by mixing 0.27 gpotassium dihydrogen orthophosphate 
(KH 2Po 4 ) and 1.14 g Na 2HP0 4 .2H 2o in 1 litre of isotonic saline. 
(ii) 0.40M phosphate buffer, pH 8.0. 71.2 g 
Na 2HP0 4 .2H 2o was dissolved in and made up to 1 litre with 
distilled water. 62.4 g of NaH 2Po 4 .2H 2o was dissolved in and 
made up to 1 litre with distilled water. 947 ml of Na 2HP0 4 .2H 2o 
.and 53 ml of NaH 2Po4 .2H 2o solutions were mixed to give a pH 8.0. 
0.0lM and 0.02M phosphate buffer, pH 8.0 were made by appropriate 
dilutions of the 0 . 40M solution. 
(c) Solutions for Affinity Chromatography 
(i) 0.001M HCl. 0.1 ml of a lOM HCl solution 
was diluted to 1 litre with distilled water. 
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(ii) 0.lM NaHC0 3 buffer in O.SM NaCl. 8.40 g 
of sodium hydrogen carbonate (NaHC0 3 ) and 29.22 g NaCl were 
dissolved and made up to 1 litre with distilled water. 
(iii) lM Ethanolamine in O.lM NaHC0 3 , O.SM NaCl 
buffer. 3.055 ml of ethanolamine was dissolved in O.lM NaHco 3 , 
0.5M NaCl buffer and made up to a final volume of 50 ml. 
(iv) O.lM Acetate buffer, pH 4.0 in lM NaCl. 
13.61 g of sodium acetate trihydrate (CH 3COONa.3H 20) and 
58.44 g NaCl were dissolved and made up to a final volume of 
1 litre in distilled water. 5.77 ml of glacial acetic acid and 
58.44 g NaCl were mixed and made up to a final · volume of 1 litre 
with distilled water. 185 ml of the sodium acetate solution 
and 815 ml of the acetic acid solution were mixed to obtain a 
pH 4.0. 
(v) O.lM Borate buffer, pH 8.5 in lM NaCl. 
38.14 g of sodium tetraborate (Na 2B4o 7 .10 H20) was dissolved in 
800 ml of distilled water and the pH adjusted to 8.5 by the use 
of al.OM HCl solution. 58.44~NaCl was then added and the 
volume adjusted to 1 litre with distilled water. 
(vi) 0.2M Tris HCl, pH 8.0 in 0.5M NaCl. 
24.22 g of trishydroxyaminomethane was solubilised in 700 ml of 
distilled water and the pH adjusted to 8.0 with O.lM HCl. 
29.22 g NaCl was then added and the volume made up to 1 litre. 
(d) Solutions for Protein Iodination 
( i) Iodine monochloride solution . 0.555 g 
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potassium iodine (KI), 0.357 g potassium iodate (KI0 3), 20.23 g 
NaCl and 21 ml of lOM HCl were dissolved in distilled water to 
a final volume of 250 ml. Free iodine was removed from this 
solution by repeatedly shaking with carbon tetrachloride (CC1 4 ) 
until the carbon tetrachloride remained colourless. About 5 
extractions with 10 ml of cc1 4 was usually necessary. After 
careful separation of the cc1 4 used in the final extraction, a 
current of air saturated with water vapour was passed through 
the solution to volatise any suspended cc1 4 . 
(ii) 0.2M Borate buffer, pH 8 . 0 in 0.16M NaCl. 
12 . 37 g of boric acid and 9.35 g NaCl were dissolved in distilled 
water and the pH adjusted to 8 . 0 with O.lM NaOH. This was 
made up to a final volume of 1 litre with distilled water. 
(e) Barbiturate Buffer for Preparation of Agar. 
90 g of sodium dimethyl barbiturate, 65.0 ml of O.lM 
hydrochloric acid and 0 . 5 g sodium azide were dissolved and made 
up to a final volume of 1 litre in distilled water. 
( f) 0.27M Piperazine Buffer, pH 6.5 for Labelling 
Red Cells. 
23.26 g of piperazine hydrate was dissolved in 600 ml 
of distilled water and the pH adjusted to 6.5 with lM HCl. 
The volume was then made up to 1 litre with distilled water. 
(g) Reagents and Buffers for Lysosomal Enzyme Assays. 
(i) 0.05M Citrate buffer, pH 5.0. 0.41 g of 
citric acid and 1.125 g sodium citrate (C 6H5Na 3o7 .2H 20) were 
dissolved in 100 ml of double distilled water. When Triton 
X-100 was required, 100 mg was added to 100 ml of this buffer 
just prior to use. 
(ii) Substrate, p-nitrophenyl phosphate. 
82.5 mg was dissolved in 5.0 ml of citrate buffer giving a 
-3 final molarity of 5.5 x 10 M. This solution was stable for 
0 
only one week and was stored at 4 or lower. 
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(iii) p-nitrophenol standard solution. 174 mg of 
p-nitrophenol was dissolved in 10.0 ml of 0.02M NaOH and made up 
to 250 ml with 0.02M NaOH. Dilutions of this stock solution 
were used for construction of a calibration curve. 
(iv) O.lM Acetate buffer, pH 4.6. 13.61 g 
CH 3COONa.3H 2o was dissolved and made up to 1 litre with
 distilled 
water. 5.8 ml of glacial acetic acid was mixed with and made up 
to a final volume of 1 litre with distilled water. 49 ml of the 
sodium acetate solution and 51 ml of the acetic acid solution 
were mixed to obtain a pH 4.6. When Triton X-100 was required 
1 mg of Triton X-100 was added per ml of buffer. 
(v) O.lM Alkaline-glycine buffer, pH 11.2. 
4.1 g glycine and 3.16 g c 6H5Na 3o7 .2H 20 were dissolved in and 
made up to a final volume of 100 ml with distilled water. 
3.0 ml of concentrated NaOH (1 g NaOH/1 ml H20) was added to 
this solution and the pH adjust~d to 11.2 with a · few drops of 
concentrated HCl . Distilled water was added to make the solution 
up to 250 ml . 
(vi) 0.01M Phenolphthalein S-glucuronide. 
25 mg of substrate was dissolved up in 5.0 ml of O.lM acetate 
0 
buffer , pII 4 . 6 and stored at 4 . This substrate was very 
stable under these conditions . A phenolphthalein standard 
solution was made of 1 mg/ml by dissolving 100 mg of 
phenolphthalein in 100 ml of ethyl alcohol. 
(vii) 0 . 133M Glycine, 0.067M NaCl, 0.083M 
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Na 2co3 buffer , pH 10 . 7. 2.000 g glyci
ne, 0.780 g NaCl and 
1 . 760 g of sodium carbonate (Na 2co3 ) were dissolved in 150 ml 
of distilled water and the pH adjusted to 10.7 with about 15 ml 
of l M NaOH and the buffer made up to a final volume of 200 ml 
with distilled water . 
(viii) p-nitrophenyl-N-acetyl-S-D-glucosaminide, 
8mM . 13.69 mg of p-nitrophenyl-N-acetyl-S-D-glucosaminide was 
dissolved in 5 . 0 ml of O. lM citrate buffer, pH 5.0. This 
0 
solution was stable provided it was stored at O . 
(3) ANTIGENS 
(a) Ovalbumin (OVA). 
Crystallised, lyophilised, salt-free Ovalbumin (Grade 
VI) was obtained commercially (Sigma Chemical Company). The OVA 
was approximately 99% pure by electrophoresis and was used in a 
solution of saline at 1 mg/ml. 1 mg of OVA emulsified in Freund -
Complete Adjuvant (FCA; Difeo Laboratories, Detroit, Michigan, 
USA) was injected into rats and 5 mg of OVA in FCA was injected 
into adult sheep to obtain hyperimmune sera. 
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(b) Keyhole Limpet Haemocyanin (KLH). 
Keyhole limpet haemocyanin in the form of a slurry in 
0.65M saturated ammonium sulphate was obtained commercially 
(B grade , Calbiochem). 1 mg of this preparation in FCA was 
injected into rats and 5 mg in FCA into adult sheep. When used 
in foetal sheep 0.5 to 1 mg of a sterile KLH preparation in 
0 . 5 ml of sterile saline was used. 
(c) Human Serum Albumin (HSA). 
Human serum albumin crystallised, lyophilised and 
salt-free having an electrophoretic purity of 100% was obtained 
commercially (Behringwerke). 
(d) Chicken, Rat and Sheep Red Blood Cells (CRBC, 
RRBC, SRBC). 
Blood was obtained from normal chickens, rats and 
sheep housed in the Animal Breeding Establishment. Blood was 
drawn from the wing vein of chickens, the abdominal aorta of 
rats and the jugular vein of sheep using sterile syringes 
containing Alsever's solution. Blood was washed 3 times in 
PBS and resuspended to the concentration required. 
(e) Polyvinyl Pyrrolidone (PVP). 
This was obtained from The Radiochemical Centre 
(Arnersham, England) and was supplied in a sterile aqueous 
solution, containing 1% benzyl alcohol and sodium succinate 
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buffer. The radioactive concentration was approximately 125 µCi/ 
ml and the PVP had an average molecular weight of 30,000 to 40,000. 
(4) ANTICOAGULANTS 
Heparin (Pularin) or Heparin for injection without 
preservative (5000 i.u./5 ml ampoule) from Evans Medical Ltd, 
U.K., were used as anticoagulants. Heparin for injection at a 
concentration of 10 i.u./ml made up in sterile saline was used 
for the foetal sheep experiments. 
(5) ANTIBIOTICS 
(a) Streptopen (Glaxovet) for injection, an aqueous 
suspension of procaine penicillin B.P. 250 mg (250,000 units) 
per ml and dihydrostreptomycin (as sulphate) B.P. 250 mg per 
ml was given intramuscularly to sheep at the recommended 
dosage for 3 days following surgery. 
(b) 'PSN' containing 30 mg of penicillin G (50,000 
units), 50 mg of streptomycin sulphate (50,000 units) and 
50 mg of neomycin sulphate (80,000 units) dissolved in 1 ml of 
distilled water was the mixture of antibiotics used for tissue 
pulture work. 
(6) GENERAL METHODS 
(a) Collection and Prepa~ation of Animal Samples 
(i) Rats. Blood was obtained from the tail of 
rats (lightly anaesthetised with ether) by cutting it with a 
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single-edged razor blade just a few millimetres from the tip. 
After collecting 0.2-0 . 5 ml of blood the wound was coagulated 
using an electric coagulator. In some experiments where 
proteins were labelled with radioisotopes polyethylene cannulae 
(SP31 , I.D . 0.50 mm , O. D. 0.80 mm, Dural Plastics and Engineering 
Pty Ltd , Dural , N. S.W.) were inserted into the jugular vein, 
carotid artery or femoral vein . Usually at the finish of an 
experiment or when large blood samples were required rats were 
lightly anaesthetised with ether and blood withdrawn from the 
abdominal aorta. 
(ii) Rabbits. Blood was obtained from the 
marginal ear vein. 
(iii) Sheep . Blood was collected from the 
external jugular vein by direct puncture with a needle and 
syringe or by the insertion of a cannula (SVllO, I.D. 1.50 mm, 
0 . D. 2 . 50 mm) into the jugular vein using Nembutal (Abbot 
Laboratories, N.S . W.) as an anaesthetic. The end of the cannula 
was fitted with a stopper that allowed for easy sampling. The 
cannula when not in use was filled with heparinised saline. 
(iv) Foetal sheep. Cannulae (SV55, I . D. 0.80 mm, 
.O . D. 1 . 20 mm) were inserted into both the jugular vein and 
carotid artery at surgery. Blood was collected from the cannulae 
under sterile conditions. The cannulae were washed with and 
left filled with heparinised saline. 
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Blood was allowed to clot in Erlenmeyer flasks and the clot 
broken by gently breaking it away from the glass by the use of 
a spatula. After approximately 4 hours at room temperature the 
serum was poured off into centrifuge tubes and spun at 2000 rpm 
for 10 minutes in a bench centrifuge. Erythrocyte-free serum 
0 
was stored at -16 . In most of the isotope and antibody decay 
experiments heparin powder was used to prevent clotting. Plasma 
was obtained after centrifuging in a bench centrifuge at 2000 rpm 
for 10 minutes. 
Bile and lymph samples collected from sheep and rats 
were centrifuged at 1500-2000 rpm for 10 minutes to separate out 
the cells. Cell free bile and lymph were used for determining 
the amount of radioactivity and protein in them. Lymph was 
usually collected in a sterile bottle containing a small amount 
of heparin powder to prevent clotting. 
(7) DETAILED METHODS 
(a) Protein Determinations. 
The concentration of protein in various fluids was 
measured by the biuret method or by ultraviolet absorption at 
280 mµ. 
(i) Biuret method. Biuret reagent (Gornall, 
Bardawill and David, 1949) was made by dissolving 6.0 g of 
potassium sodium tartrate (NaKC 4H4~ 6 .4H 20) and then 1.5 g of 
c9pric sulphate pentahydrate (Cuso 4 .5H 2o) in 300 ml of distilled 
water. To this solution was added while shaking 300 ml of 2.5M 
NaOH . The solution was then made to a final volume of 1 litre 
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with distilled water and stored in a plastic bottle. For 
determining the protein concentration, 4 ml of biuret reagent 
was added to 1 ml of sample, but most lymph and blood samples 
were diluted 10 fold with isotonic saline prior to measurement. 
Samples were measured against a reagent blank 30 minutes after 
mixing at 540 mµ on a Spectrophotometer (Hitachi, Japan). 
Protein concentrations were estimated from a standard curve 
(Figure 2.1) prepared by use of HSA or sheep IgG. 
(ii) Ultraviolet absorption at 280 mµ. Standard 
curves were constructed for HSA and sheep IgG (Figure 2.2) and 
the protein concentration of samples estimated from them. 
(b) Column Chromatography. 
G-200 Sephadex gel filtration separations were done in 
either a small (1.5 cm x 90 cm) descending column or a large 
(5 cm x 100 cm) ascending/descending column obtained from 
Pharmacia (Uppsala, Sweden). Prior to packing the columnsr 
10 g and 50 g of Sephadex G-200 for the small and large columns 
respectively were allowed to swell in distilled water for 3 days 
0 
at 4 and then washed 3 times in 0.01M phosphate, saline buffer 
pH 7.3 to remove the fines. The procedure for packing was as 
recommended by Pharmacia. The small G-200 column was used for 
fractionating samples of less than 1 ml while the larger G-200 
was used for fractionating up to 20 ml of sample. Constant flow 
rates of 6 ml/hr and 30 ml/hr were obtained by the use of a 
peristaltic pump and effluent fractions of 3 ml ·ctnd 10 ml were 
collected for the small and large columns respectively, All 
G-200 Sephadex fractionations were done in a cold room at a 
0 
constant temperature of 2 . Fractions were collected and the 
absorbance at 280 mµ monitored by the use of an LKB ReCyChrom 
(LKB Bromma , Sweden). Pooled effluent fractions were concen-
trated by either dialysis in dialysis tubing (size 20/32, 
Visking, H.B. Selby), placed in 10% polyethylene glycol in 
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0.9% saline at 4° or on a Diaflo (Amicon Corporation, Mass., 
U.S.A.). Fractions were concentrated to approximately 2 ml and 
stored at -16° until 1>-..ie.J.. j-l.l..rtlt.r-. 
Glass columns (2.5 cm x 60 cm) were packed with 10 g 
(dry weight) of DEAE-Sephadex (A-50). The DEAE-Sephadex was 
allowed to swell in distilled water for 2-3 hours after which 
time it was washed a further 3 times in distilled water prior to 
being equilibrated in the starting buffer (0.01M phosphate 
buffer, pH 8.0). When the column was packed the sample was 
layered above the gel, allowed to flow into the gel bed and the 
elution system collected. A continuously increasing concentration 
of phosphate buffer was achieved by joining a sealed reservoir 
containing 600 ml of 0.01M phosphate buffer, pH 8.0 to another 
reservoir containing 0.40M phosphate buffer, pH 8.0. The sealed 
reservoir served as a mixing vessel and the contents of this 
container were continuously mixed by the use of a magnetic 
.stirrer. A near linear gradient of phosphate buffer was obtained 
by this elution system. A flow rate of 15 ml/hr was maintained 
by the use of a peristaltic pump and fractions of 10 ml collected . 
The absorbance at 280 mµ was measured prior to pooling effluent 
+hQ,~ 
fractions and concentratingk F.ractions were st()red at -16 ° . 
• 
(c) Affinity Chromatography. 
5 g of cyanogen bromide activated Sepharose 4B 
(Pharmacia Fine Chemicals) was washed with 2 litres of 
0.001M HCl (pH 2-3) for 15 minutes on a sintered glass filter 
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inserted into a Buchner flask. The protein to be bound to the 
CNBr-activated Sepharose 4B, for example, Ovalbumin (100 mg), 
was dissolved in 35 ml of O.lM NaHC0 3 buffer containing O.SM 
1 d k at 40. Nae an ept Immediately after washing the CNBr-
activated Sepharose 4B the protein solution was added and then 
mixed gently with a magnetic stirrer at 4° overnight. This 
mixture was then centrifuged at 3000 x G for 20 minutes at 4° 
to separate the Sepharose 4B and the unbound protein. The 
Sepharose 4B was then washed with O.lM NaHco 3 , 0.5M NaCl 
buffer until the eluate had no ultraviolet absorbance. By 
measuring the protein in the eluate it was possible to determine 
the percentage of protein bound to the Sepharose 4B. 
The Sepharose 4B was then reacted with lM ethanolamine 
in O.lM NaHco 3 , O.SM NaCl buffer, resuspended in 20 ml of this 
solution and incubated at room temperature for 2 hours. After 
incubation the Sepharose 4B was washed alternatively with O.lM 
acetate buffer, pH 4.0 in lM NaCl and O.lM borate buffer, pH 8.5 
,{n lM NaCl. This was repeated 3 times to remove the non-
covalently bound protein. The Sepharose 4B was then washed with 
0.2M Tris HCl buffer, pH 8.0 in O.SM NaCl and equilibrated in 
this buffer. 
An adequate volume of plasma (for example, hyperimmune 
rat plasma containing antibodies to Ovalbumin) was gently mixed 
with the Sepharose 4B and stirred at room temperature for 2 hours 
on a multipurpose rotor (Scientific Industry, Springfield, 
Mass., U.S.A.). After this the gel was washed 6 times with 
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0.2M Tris HCl buffer, pH 8.0 in 0.5M NaCl checking each time the 
protein concentration of the supernatant. To separate the 
Sepharose 4B bound protein (in the example antibodies to 
Ovalbumin) 20 ml of 3.0M NaSCN was added to the Sepharose 4B, 
mixed for 15 minutes at 4° and then centriguged at 3000 x G 
for 20 minutes at 4°. The supernatant was immediately dialysed 
at 4° against 0.001M phosphate buffer, pH 8.0, changing the 
buffer at least 3 times. After dialysis the dialysate was 
filtered and concentrated to 1 ml and stored at -16° until used. 
(d) Immunoelectrophoresis. 
Agar coated glass slides were prepared using a 1% 
solution of agar (1.0 g of special agar-Noble, Difeo Bacto 
Laboratories, Michigan, U.S.A., dissolved by boiling in 25 ml 
of barbiturate buffer and 75 ml of distilled water containing 
1/10,000 thiomersal). Samples were electrophoresed for 1 hour 
in agar plates with the voltage set at 250 volts using an LKB 
apparatus (LKB Produktor, Sweden). The antisera were allowed 
to react for 12-24 hours at room temperature in humid chambers. 
Slides were then washed in 1 % saline for 6 hours, a fresh 1% 
.~aline solution for 16 hours and finally rinsed with distilled 
water from a squeeze bottle. The gel was covered with strips 
of wet blotting paper and dried at room temperature. When dry, 
the blotting paper was moistened and removed and the slides 
gently washed in tap water. The slides were then stained for 
10-60 seconds with amido black (9 g of amido black in 150'0 ml 
of rinsing solution) while maintaining a constant rocking motion 
and then rocked to and fro for 2 minutes in each of 4 separate 
volumes of rinsing solution (methyl alcohol, acetic acid and 
distilled water in the proportions 9:2:9). After drying, the 
slides were trimmed and labelled. 
(e) Double Diffusion in Agar. 
The double diffusion in agar reactions were also 
carried out in buffered agar on glass slides. Samples 
were placed in wells (volume 10 µ1) 5 mm apart punched in the 
gel and were allowed to react with antisera for 12-24 hours. 
After this time the slides were processed as above. 
(f) Preparation of Pure Immunoglobulins. 
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(i) Sheep. Pure IgGl was obtained by fraction-
ating sheep colostral whey or sheep serum on DEAE-Sephadex 
using a continuous phosphate buffer gradient (0.01M - 0.40M, 
pH 8.0). The protein in the ascending side of the second maJor 
optical density peak was regularly found to be pure IgGl. Pure 
IgG2 was prepared by elution of sheep serum on DEAE-Sephadex with 
0.01M phosphate buffer, pH 8.0. Pure IgM was prepared by 
concentrating the effluent fractions from the ascending side of 
the exclusion peak of a G-200 Sephadex fractionation of sheep 
.serum and dialysing this fraction against distilled water at 4°. 
The precipitated protein was recovered after centrifugation and 
dissolved in a minimum volume of 2M sodium chloride. It was 
necessary to repeat the above dialysis procedure 6 times to 
obtain IgM free from other proteinq. 
IgA was prepared from milk whey of sheep whose mammary 
gland had been antigenically stimulated by local infusion of 
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killed Brucella abortus organisms about 4 weeks before 
parturition . The whey was concentrated 10-fold and the protein 
fractionated on DEAE-Sephadex using a continuous gradient of 
phosphate buffer (O . OlM - 0.40M , pH 8.0). Fractions from the 
trough region between the second and third optical density 
peaks were concentrated to 1 ml and fractionated on G-200 
Sephadex. Fractions from the ascending side of the exclusion 
peak contained pure IgA . 
(ii) Rat. Pure IgG2a was prepared by 3 different 
techniques . Each preparation of IgG2a used possessed a label 
so that its presence could be detected in the plasma or the body 
tissues . 
IgG2a was prepared from rat serum or plasma by elution 
on DEAE- Sephadex with O.OlM phosphate buffer, pH 8.0 (Figure 2.3a). 
After confirming its purity on immunoelectrophoresis (IEP) and 
double diffusion in agar (DD), the IgG2a was labelled with either 
125 I or 131 I by using the technique of Helmkamp, Goodland, Bale, 
Spar and Mutschler (1960) . A radioimmunoelectrophoresis of 
1251 IgG2a is shown i n F i gu re 2 . 3a . 
IgG2a having antibody activity was isolated from the 
.serum of rats hyperimmunised to various antigens by elution on 
DEAE-Sephadex with 0 . 01M phosphate buffer , pH 8.0. Figure 2.4 
shows a typical optical density profile following elution with 
0 . 01M phosphate buffer, pH 8.0 and the region where antibody was · 
found . Fraction 3 was usually pure - and this f r a ction was us e d 
in experiments . 
Figure 2.3a. Immunoelectrophoretic pattern of normal rat 
IgG2a prepared by elution of whole serum on DEAE-Sephadex 
with O.OlM phosphate buffer, pH 8.0. The bottom well con-
tained normal rat serum and the precipitin arcs were 
developed using rabbit antiserum to normal rat serum. 
; 
Radioimmunoelectrophoretic pattern of 125 I IgG2a developed 
using rabbit antiserum to normal rat serum. 
Figure 2.3b. Immunoelectrophoretic pattern of the culture 
medium of a IgG2a producing immunocytoma cell suspension 
after 2 hours incubation at 37 ° . The bottom well contained 
normal rat IgG2a and -the precipitin arcs were developed 
using rabbit antiserum to normal rat serum. 
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pH 8 . 0 . The dotted line represents the antibody activity in 
each fraction (1 ml) to ovalbumin. 
57 
IgG2a internally labelled with 14 C amino acids 
was prepared by incubating a uniformly labelled mixture of amino 
acids (Arnersham, L-/u- 14 C7 amino-acid mixture Code CFB 104) with 
a cell suspension of a rat IgG2a Irnrnunocytoma (Ir418) in HBSS 
0 for 1 hour at 37 (Figure 2.3b). A G-200 Sephadex fractionation 
of the supernatant following incubation is shown in Figure 2.5. 
Most of the radioactivity was found in the 7S region and it was 
this fraction that was used in experiments. An outline of the 
technique is given in Figure 2.6. The specificity of the 7S 
fraction from the G-200 Sephadex fractionation was checked using 
affinity chromatography. An irnrnunoabsorbent was made using 
CNBr-activated Sepharose 4B coupled to the IgG fraction of a 
rabbit anti-rat IgG2a serum. The IgG from the rabbit antiserum 
was prepared by elution on DEAE-Sephadex using a gradient elution 
of 0.02M - 0.40M phosphate buffer, pH 8.0. 50 mg of the rabbit 
IgG was coupled to 10 g of CNBr-activated Sepharose 4B and packed 
into a column . 30 ~l of a 14 c labelled 7S fraction (33,366 cpm) 
was added to the column and after washing with 0.2M Tris HCl 
buffer pH 8.0 eluted with 3M NaSCN. The elution profile for 
this is presented in Figure 2.7. Of the total counts added to 
the column only 15 . 2% were not retained by the irnrnunoabsorbent. 
It was possible to elute off with 3M NaSCN 53.1% of the bound 
IgG2a. The remaining 31.7% was left on the column. 
(g) Preparation of Antisera. 
(i) Sheep. Anti-whole sheep serum was prepared 
by injecting into rabbits at various intramuscular sites an 
• 
emulsion of 0.5 ml of normal sheep serum and 1 ml of ECA~ This 
was repeated at weekly intervals until a sufficiently good anti-
serum was obtained. 
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number adjusted to 1 x 10 /ml . 1 0 ml of this cell suspension 
was then incubated with 25-50 µCi of the 14 C-amino acid 
mixture for 1 hour at 37 ° . The incubation mixture was then 
centrifuged at 1000 X G for 7 minutes and the supernatant 
c oncentrated to 1 ml on a Diaflo fitted with a PMlO membrane. 
The concentrated supernatant was then fractionated on G-200 
Seohadex . 
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The preparation of antisera against the four sheep 
immunoglobulins - IgGl , IgG2, IgM and IgA involved immunisation 
of sheep wiLh killed Brucella abortus organisms to obtain 
antibodies belonging to each of the immunoglobulin classes. This 
technique ensures the production of antisera with extremely high 
titres and antisera that are anti-immunoglobulin. 
Anti-IgGl was obtained by collecting serum from a 
sheep 14 days after an intramuscular injection of 10 9 killed 
Brucella abortus organisms emulsified in FCA. The serum was heat 
inactivated at 56° for 30 minutes and then fractionated on 
DEAE-Sephadex using a continuous phosphate buffer gradient 
(O.OlM - 0.40M, pH 8.0). The fractions containing IgGl were 
then mixed with Brucella cells in antibody excess. After standing 
for 2 hours at room temperature the Bt'QQ!.llo- 0<"~\S""-S CoG-tJ ~c..tl!. srClJ~C ~G:, 
were washed 6 times with PBS and resuspended in PBS. This 
suspension emulsified in FCA was injected into rabbits. 
A similar method was used to produce anti-IgG2 except 
that the serum used was collected from a sheep which had been 
injected intramuscularly three times with 10 9 killed Brucella 
abortus organisms at 2 weekly intervals. Serum from this sheep 
was heat inactivated and applied to a DEAE-Sephadex column and 
.eluted with 0.01M phosphate buffer, pH 8.0. The IgG2 fractions 
were reacted with killed Brucella organisms and then the same 
procedure followed as for anti-IgGl. 
Anti-IgM was prepared using serum collected from a 
sheep 6 days after the intramuscular injection of 10 9 killed 
Brucella abortus organisms. After heat inactivation the serum 
was reacted with killed Brucella organisms in antibody excess 
and the same procedure followed as for the production of 
anti-IgGl. 
Anti-IgA was prepared by the procedure described by 
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Lascelles and McDowell (1970). Briefly, milk whey collected from 
a sheep whose mammary gland had been antigenically stimulated 
by local infusion of killed Brucella abortus organisms (10 9 ) about 
4 weeks prior to parturition was mixed with Brucella cells in 
antibody excess. After standing 2 hours at room temperature the 
cells were washed 6 times in PBS and rabbits immunised with 
these sensitised cells in an emulsion of FCA. 
(ii) Monospecific anti-IgGl, anti-IgG2, anti-
IgM , anti-IgA. Anti-IgGl was absorbed with IgG2 to render it 
yl specific, anti-IgG2 with IgGl to render it y2-specific, anti-
IgM with IgGl and IgG2 to render it µ-specific and anti-IgA 
with lamb serum (containing no IgA) to render it a-specific. 
(iii) Rat. Anti-whole rat serum was prepared by 
injecting into rabbits, at multiple intramuscular sites, an 
emulsion of 0.5 ml of normal rat serum and 1 ml of FCA at weekly 
intervals for 3 weeks. Anti-rat IgG antiserum was raised by 
injecting rabbits with 5 mg of rat IgG emulsified in FCA at 
~eekly intervals for 3 weeks. 
Anti-rat IgG2a serum was raised by injecting into 
rabbits at weekly intervals for 3 weeks 5 mg of rat IgG2a 
prepared from normal rat serum or 5. mg of immunocytoma IgG2a 
prepared by following the method outlined by Bazin, Beck~rs and 
Querinjean (1974) 
to injection. 
The IgG2a was emulsified in 1 ml of FCA prior 
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(iv) Monosp ecific anti-IgG, anti-IgG2a. Anti-
IgG was absorbed with rat IgM to render it y-specific, and anti-
IgG2a was absorbed with rat IgG2c and rat IgGl prepared as 
described by Bazin et al. (1974) to render it y 2a-specific. 
(h) Single Radial Immunodiffusion Technique (SRID). 
Radial agar (3.0 g ·special agar-Noble in 100 ml of 
barbiturate buffer) was melted in a boiling water bath and then 
0 held at 56 . A mixture of agar and monospecific antiserum was 
prepared by mixing 0.4 ml antiserum, 1.2 ml barbiturate buffer 
and 1 . 6 ml of radial agar. The proportions of the antisera and 
barbiturate buffer were varied according to the strength of 
antiserum, the final volume of the antiserum (<0.4 ml) plus 
the barbiturate buffer always totalling 1.6 ml. Using a warmed 
pipette, 3.0 ml of the agar-antiserum mixture was applied to a 
microscope slide which had been levelled and sealed into an 
immunoelectrophoresis frame using radial agar. After the 
mixture had solidified into a gel a series of twelve wells 
arranged in 2 rows were punched in the agar (each well being 
2 . 5 ITUTl in diameter and spaced 12.5 mm between centres). 
Each well was filled with 5 µl of a sample to be 
.measured except for the 2-4 corner wells which were filled with 
5 µl of a normal sheep or rat serum used always as a secondary 
reference standard (Mancini, Carbonaro and Heremans, 1965). The 
reaction was allowed to proceed for exactly 24 hours afte r which · 
time the same procedure for wa~hing·, drying and· ~taining was 
used as described for the immunoelectrophoresis plates·. After 
staining the precipitin rings were magnifie d by the use of an 
overhead projector, and the projected boundaries outlined on 
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paper of a constant thickness and weight. The paper circles minus 
the area of the well were weighed (to 4 decimal points) and the 
paper weight then used to estimate the concentration in mg/ml from 
standard curves (Fahey and McKelvey, ~965). The standard curves 
were constructed by obtaining pure samples of the different 
immunoglobulin classes. A curve of the logarithm of paper weight 
(Schmid, 1969) using the single radial irnmunodiffusion technique 
was plotted against the logarithm of concentration in mg/ml. 
(i) Labelling of Proteins with Radioactive Iodine. 
The method of Helmkamp et al. (1960) was the only tech-
nique used for labelling proteins with either 125 I or 131 I. By 
using this method it was possible to label protein solutions at 
various molar ratios of iodine:protein accurately by varying the 
amount of iodine monochloride solution added to the reaction 
mixture. In Table 2.1 the amount of iodine monochloride solution 
needed to label, at an efficiency of 100% and 50%, 2 mg of IgG at 
a molar ratio of 4:1 to 0.25:1 (iodine:protein) is given. The usua l 
efficiency of labelling using the technique was around 50 %. 
TABLE 2.1 
Amount of 0.02M ICl added to achieve a molar ratio of iodine: 
IgG from 4:1 to 0.25:1 at a labelling efficiency of 100% and 50% 
IgG (mg) Ratio of I/IgG (100 % Efficiency) 
4 2 1 0.5 0.25 
2 2.5 µl 1.3 µl 0.6 µl 0.3 µl 0.15 µl 
Ratio of I/IgG (50 % Efficiency) 
4 2 1 0.5 0.25 
2 5 .0 µl 2.5 µl 1 . 3 µl 0.6 µl 0.3 µl 
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f • • • h 125 The procedure or labelling proteins wit I or 
131 I was as follows : protein solutions of 2 mg/ml were made up 
in 0.2M borate buffer, pH 8.0 and kept at 4° prior to labelling. 
For each 2 mg of protein 10 µCi of 125 I (for protein iodination, 
The Radiochemical Centre, Amersham , iodide, carrier free in NaOH 
solution, pH 8-11, 100 mCi/ml) or 131 I (for protein iodination, 
Amersham , 40 mCi/ml) were mixed with 1.0 ml of 0 .2M borate 
0 buffer, pH 8.0 and kept at 4 . When IgG was labelled at a molar 
ratio of say 1:1 (iodine:protein) to each 1 ml of 125 I or 131 I 
solution was added 1.5 µl of 0.02M ICl, mixed and rapidly jetted 
into the 1.0 ml of the IgG solution. The mixture was then 
11 d d f 5 . 4° d h h h a owe to stan or minutes at an ten runt roug a 
Dowex (1 x 4,100/200 mesh) Anion Exchange Resin column (8 mm x 
60 mm) to remove any unbound iodine. The efficiency of labelling 
was checked by comparing 10 µ l samples of the 125 I or 131 I 
solutions before and after labelling. Before use the presence 
of free radioactivity was checked by TCA precipitation and 
solutions having 97-98 % of precipitable radioactivity were used. 
(j) Haemagglutination Assays. 
All antibody assays were performed in microtitre V 
bottom trays (Cook Engineering Co ., Alexandria, Virginia, U.S.A.). 
S~rial two - fold dilutions were made with 0.05 ml diluters and 
0 . 05 ml droppers . All antibody titres have been expressed as 
log 2 of the reciprocal of the highest dilution of serum which 
showed complete agglutination . 
(i) CRBC antibody . A 1.0 % suspension of washed 
CRBC was added to serial dilutions of sera in 0 . 25 % (w/v) 
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gelatin saline solution, mixed and incubated at 37° for 1 hour. 
(ii) OVA antibody. Ovalbumin was coupled to three 
times washed SRBC with Crcl 3 by the technique described by 
Poston (1974) . For this method SRBC were washed three times with 
0 . 9% saline and a 1 mg/ml solution of OVA in normal saline 
prepared . A 2.25M stock solution of chromic chloride (B.D.H. 
Chemicals Ltd, Poole , England) which will keep at 4° for up to 
6 weeks was diluted 400 times with normal saline and left at 
room temperature for at least 40 minutes. The SRBC, chromic 
chloride , 0 .27M piperazine buffer , pH 6.5 and OVA were mixed 
in the amounts and order shown in Table 2.2. The reaction 
mixture was agitated occasionally and kept at room temperature 
for 5 minutes from the time of addition of the Crcl 3 . The 
reaction was then stopped by the addition of 300 ml of saline 
and the cells washed three times in saline. The cells were 
centrifuged at 1500 rpm for 5 minutes and resuspended to a 1% 
solution in saline. 
(iii) KLH antibody. It was found possible to use 
exactly the same method for coating KLH to SRBC as that used for 
coating OVA onto SRBC, but better results were obtained using a 
modification of the procedure outlined by Parish and Hayward 
.(1974). Chromic chloride (CrC1 3 ) was dissolved in 0.9 % NaCl 
to give a final concentration of 1 % (mass/vol). The pH of the 
solution was immediately adjusted to 5.0 by the dropwise addition . 
of lM NaOH. The solution was then stored at room temperature for 
3 weeks, its pH being readjusted to . 5.0 with lM · NaOH 3 times a 
week. 
TABLE 2.2 
The amounts and order of mixing the various 
solutions for coating SRBC with Ovalbumin 
(1) Piperazine 
buffer (ml) 
(2 ) Ovalbumin (ml) 
(1 mg/ml in 
saline) 
(3) Sheep Red Blood 
Cells, packed 
(ml) 
(4 ) Chromic Chloride 
0.15% saline 
solution (ml) 
0.62 1.24 2.48 3.10 3.72 4.96 6.20 7.44 9.30 
0.10 0.20 0.40 0.50 0.60 0.80 1.00 1.20 1.50 
0 . 10 0.20 0.40 0.50 0.60 0.80 1.00 1.20 1.50 
0 . 08 0.16 0.32 0.40 0.48 0.64 0.80 0.96 1.20 
6.2 ml of 0.27M piperazine buffer, pH 6.5 was mixed 
with 1.0 ml of a 1 mg/ml solution ·of KLH in 0.9 % saline and 
1.0 ml of Lhree times washed packed SRBC. 0.8 ml of a 0.15 % 
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solution of Crcl 3 (by dilution of the stock solution) was then 
added dropwise with gentle mixing and the reaction mixture kept 
at room temperature for 3 minutes. The reaction was stopped 
after 5 minutes by the addition of 300 ml of saline and the 
cells washed four times in saline and resuspended in a 1% 
suspension of saline. 
(k) Lysosomal Enzyme Assays . 
Samples were measured using the techniques described 
by Courtice, Adams, Shannon and Bishop (1974) and Shannon, 
Quin and Courtice (1977). All tissues were prepared as 3 g/ml 
suspensions in 0.25M sucrose at 4° . Homogenates were made at 
4° with a Potter-Elvehjem type homogeniser by making 10 passes 
with a power driven Teflon pestel for two separate periods of 
30 seconds. Plasma and tissue homogen~tes were appropriately 
diluted prior to measurement. 
(i) Acid phosphatase . 0.8 ml of citrate buffer 
containing 0.1 % Triton X-100, 0.1 ml of homogenate or plasma 
.ctnd 0.1 ml of substrate (p-nitrophenyl phosphate) were mixed 
and incubated for 30 minutes at 37° . 4.0 ml of O.lM sodium 
hydroxide was then added and free p-nitrophenol read at 410 mµ 
against a distilled water blank. 
(ii) B-glucuronidase. 0.1 ml of homogen~te, 
0.8 ml acetate buffer and 0.1 ml of substrate (phenolphthalein 
B-glucuronide) were mixed and incubated for 16 hours at 37°. 
2 . 5 ml of glycine buffer was added to stop the reaction. The 
mixture was centrifuged if there was any interfering protein 
precipitate . The free phenolphthalein was read at 540 mµ 
against a distilled water blank . 
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(iii) N-acetyl-B-D-glucosaminidase. 0.1 ml of 
sample , 0 . 8 ml of O.lM citrate buffer, pH 5.0, and 0.1 ml of 
substrate (p-nitrophenyl-N-acetyl-B-D-glucosaminide) were mixed 
0 
and incubated for 16 hours at 37 . 3.0 ml of glycine, 
carbonate buffer was then added and any precipitated protein 
removed by centrifugation at 2000 rpm for 5 minutes. The free 
p - nitrophenol was read at 410 mµ against a distilled water blank. 
Optical density readings for the samples were trans-
lated into the activity per ml per hour from standard curves for 
each of the lysosomal enzymes. 
(1) Subcellular Fractionation of Cell Homoqenates. 
Cell suspensions were made in Eagle's medium at 4° 
by teasing out cells gently with pincettes from small pieces 
of tissue cut with a pair of scissors. The cell suspension 
after washing 4-6 times at 4° was then homogenised in 0.25M 
.sucrose solution by the use of a Potter-Elvehjem type homogeniser 
ut 4° by making 10 passes with a power driven Teflon pestcl for 
2 periods of 30 seconds. The homogenate was then centrifuged 
at 600 x G for 10 minutes to separate unbroken cells and cell 
debris . The supernatant was centri.fuged at 1000· x G for 20 
minutes and this pellet called the nuclear fraction. The· super-
natant of this was centrifuged at 10 , 000 x G for 30 minutes and 
the pellet of this called the mitochondrial fraction. This 
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supernatant was centrifuged at 100 ,000 x G for 1 hour and the 
pellet called the microsomal fraction. The supernatant of this 
fraction was used for a G-200 Sephadex fractionation and was 
considered to represent the soluble intracellular component of 
the cells. 
(m) Trichloroacetic Acid Precipitation. 
For precipitating out the protein component of 
solutions trichloroacetic acid (TCA) was used. Normally a 
7 or 10% final concentration of TCA was required. For example, 
2 volumes of sample and 1 volume of 30% TCA were mixed and kept 
at 4° for 1 hour. The solution was then centrifuged at 
8000 x G for 30 minutes and C\..S~~\& of the supernatant counted 
to determine the amount of radioactivity remaining in solution. 
(n) Iodine: Separation into Organic and Inorganic 
Form. 
To separate non-protein bound radioactive iodine into 
iodine (inorganic) and iodotyrosine types of iodine compounds 
(organic) the method of Bierman, Stein and Stein (1974) and 
Goldstein and Brown (1974) was followed. Twenty ml of supernatant 
from a TCA precipitated radioiodinated protein solution was 
mixed with 200 µl of 40 % potassium iodide and 1 ml of 30 % 
hydrogen peroxide. This was allowed to stand at room temperature 
for 5 minutes and then 40 ml of Chloroform was added and the 
mixture vigorously shaken for 5 minutes. After centrifugation 
at 720 x G for 20 minutes aliquots of the supernatant were 
counted in a y-counter. 
(o) Radioactivity Measurements. 
( i) y-counter. y-emitters were counted in a 
Packard Gamma Scintillation Spectrometer, Model 578 (Packard 
Instrument Co . , Inc., U.S.A.). 
(ii) S-counter. S-emitters were counted in a 
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Packard Liquid Scintillation Spectrometer, Model 3320 (Packard 
Instrument Co . , Inc., U.S . A.). 
(iii) Tri-Carb Sample Oxidiser. A Packard 
Tri-Carb Sample Oxidiser, Model 306 was used for processing any 
experimental materials containing 14 C for Scintillation counting. 
Materials oxidised included plasma , gel-filtration column 
fractions and animal tissues. The maximum amounts burnt were 
300 µl of solutions or plasma and 500 mg of tissue. Samples were 
burnt for varying times sufficient to achieve complete oxidation. 
Each sample burnt was followed by a memory count. Carbasorb II 
(Packard) was used to absorb the 14 C oxidised to co2 , 9 ml 
being sufficient for each burn. As a scintillator 14 ml of 
Permaflow V (Packard) was added automatically to each counting 
vial by the oxidiser. The oxidiser routinely produced recoveries 
of over 98 % of the sample oxidised and this was constantly 
.checked during the combustion of experimental samples by 
oxidising hexadecane standards and comparing the counts with a 
sample of non-oxidised hexadecane standard in the same 
scintillator. The samples were counted to within 1.5% of the 
standard error in the Packard Liquid Scintillatibn Spectrometer . 
All samples used in experiments were discarded as 
recommended in the Handbook for Radioisotopes issued by the 
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John Curtin School of Medical Research. Animals heavily contam-
inated with radioisotopes were burnt in a furnace. 
(p) Determination of Half-life Time. 
( i) Radioactive decay. The radioactive counts 
in plasma (0.1 ml for rats, 0.5 ml for foetal sheep and 1 ml 
for adult sheep) were expressed as % dose/ml for rats and 
% dose/litre for sheep. These values were plotted on semi-
logarithmic graph paper against time. From the graph it was 
possible to estimate the slope of the curve which was usually 
a linear function. For accurate estimation of the half-life 
time linear regressions were fitted to the data after converting 
it to log. 
e 
Plasma samples collected after allowing for equili-
bration of the labelled protein between the intravascular and 
extravascular compartment were used for calculation of the 
half-life time, using the formula 
where A 
T~ 
log 2 
e 0.693 
A 
slope of the regression curve. 
(ii) Antibody decay . The titre of the antibody 
in the plasma was expressed as a function of log 2 and these 
values were used for estimating the slope of the regression 
curve. The half-life time was calculated using _ the formula 
T L ~2 1 x-
where\ - slope of the regression curve. 
(y) Calculation of Tissue Distribution. 
The radioactivity in known weights of tissue was 
measured and expressed as per cent of injected dose oer gram 
of tissue and as per cent dose per organ by knowing the total 
weight of each organ. For ease of comparison, some of the 
data has been expressed as a percentage of the total radio-
activity recovered in the organs collected. This has been 
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expressed as per cent of each organ of the total radioactivity 
in all the organs collected. 
(r) Preparation of Tissues for Histological Examination. 
Tissues were fixed in Carnoy's solution as soon as they 
were removed from the animals. After fixing overnight the 
tissues were then put through 70 % alcohol, 90 % alcohol, 100 % 
alcohol and xylene solutions and embedded in paraffin. Sections 
were cut at a 5 µ thickness and stained with haematoxylin eosin 
or methyl green pyronin. 
(s) Autoradiography and Radioimmunoelectrophoresis. 
The technique described originally by Kopriwa and 
Leblond (1962) was used for autoradiography. Tissue sections 
prepared as described above but unstained were deparaffinated 
and dipp din Ilford emulsion type KS at 45° and'then dried. 
They were then kept in a dark box with silica gel for an adequate 
exposure time. The slides were developed in D-19 developer 
(Kodak) for 5 minutes at 20 ° and fixed in a rapid fixer for 
5 minutes. The slides were then stained with methyl green 
pyronin after washing them thoroughly with running water. 
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The technique described by Campbell, Garvey, Cremer 
and Sussdorf (1970) was used for radioimmunoelectrophoresis of 
radiolabelled proteins. After immunoelectrophoresis the radio-
iodinated protein was reacted with the appropriate antisera. 
After 24 hours the IEP slides were thoroughly washed until all 
the unreacted protein had been removed. The radioactivity in 
the last wash was equal to background. Usually six washings, 
two with 0.3M NaCl and four with 0.15M NaCl, were sufficient. 
The slides were then dried, cleaned and placed, gel side up, on 
a large piece of adhesive tape. In the dark room a piece of 
x-ray film (Kodak , X-Ray Film, RP/554) was secured to the slide, 
by the use of the adhesive tape, and then stored in a dark box 
at room temperature. After an appropriate time interval the 
slides were exposed, developed in D-19 developer for 5 minutes 
at 20° and fixed in a rapid fixer for 5 minutes. 
(t) Estimation of Plasma Volume. 
The plasma volume of rats, adult and foetal sheep was 
calculated by measurement of% cpm/ml of radioiodinated IgG 
at 1, 3, 6, 10 and 15 minutes after its injection. These 
values were plotted on semi-logarithmic graph paper and the 
curve extrapolated to calculate a O minute value. The plasma 
volume was then calculated using the formula: 
Plasma volume (ml) - Amount of radioactivitx i n jected Radiqactivity p e r ml ·of plasma 
(u) Maintenance of Rat !mmunocytomas. 
For maintaining the immunocytomas (Ir418 IgG2a, 
Ir304 IgG2c , Ir490 IgGl , Ir202 IgM, Ir22 IgA, Irl62 IgE) cell 
suspensions were made of solid tumours in HBSS and 1 ml of a 
7 5 x 10 cells/ml suspension injected to recipient Lou/M rats, 
either intraperitoneally to obtain ascites fluid or subcutan-
eously to obtain solid tumours. It was found convenient to 
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store in liquid nitrogen ascites fluid from the various immuno-
cytomas to enable the growing of tumours when required. To do 
this the technique described by Bazin, Deckers, Beckers and 
Heremans (1972) was used. Briefly , 4 ml of ascites tumour 
fluid was aspirated into a heparinised syringe followed immed-
iately by 1.25 ml of Ringer fluid containing 0.5 % (w/v) glucose 
and 40% (w/w) dimethylsulphoxide (DMSO, Merck). From the mixed 
contents in the syringe 1 ml aliquots were dispensed into 
sterile ampoules, sealed and cooled on dry ice. After 10 minutes 
on dry ice the ampoules were then placed in liquid nitrogen. 
When required for use the ascites tumour fluid was thawed rapidly 
b · · · water bath at 37°. y immersion in a The viability using this 
method was greater than 80% and tumours always grew. 
(v) Surgical Procedures. 
(i) Foetal sheep. Foetal sheep were operated on 
using the technique described by Smeaton, Cole, Simpson-Morgan 
and Morris (1969) and Cole and Morris (1971). Surgery was 
performed under aseptic conditions using closed circuit anaes-
thesia with Fluothane (Halothane B.P. I.C.I. Australia Limited) 
as the anaesthetic agent. 
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The uterus was exposed through a midline abdominal 
incision and immediately placed within a plastic bag to prevent 
its dehydration. The uterus and foetal membranes were excised 
carefully with an electrocauteriser and the foetal fluids 
removed . The foetus was exposed and the external jugular vein 
and carotid artery exposed in the neck region. When the carotid 
artery was exposed special care was taken not to damage the 
vagus nerve . Clear vinyl cannulae were inserted into the 
jugular vein and carotid artery until they reached the heart and 
blood could be easily withdrawn . The cannulae were secured to 
the foetus and after repositioning the foetus back into the 
uterus and leaving a length of cannulae within the uterine 
~ Je>e't.J- Y'f\.e.""'\'.H~S W~Ct. t(;Co~s+1.1\.a...tecl,a..~ 
cavityA the uterus was closed with sutures. Just prior to 
completely closing the uterus the foetal fluids were returned. 
The cannulae were then fixed to the outside of the uterus and 
the uterus returned to the abdominal cavity of the ewe. The 
cannulae were led out through the wall of the abdominal cavity 
and fixed on the back of the ewe. The cannulae were filled with 
heparinised saline (10 i.u./ml) and sealed by tying a knot at 
the end. 
(ii) Bile duct cannulation in adult sheep. 
To cannulate the bile duct, the right lateral lobe of the liver 
.was packed out of the way with wet cotton gauzes, exposing the 
hepatic and cystic ducts and the common bile duct to where it 
joins the duodenum (Figure 2.8). The peritoneum over the common 
bile duct (above the pancreatic duct) was incised and a suture 
placed around the duct and left loose. A clear · vinyl cannula 
(SV 70, I . D. 1.00 mm, O.D. 1.50 mm) was inserted into the· duct 
through a small cut near the suture. The suture was then secured 
and the cannula positioned so that bile flowed easily out of it. 
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Figure 2 . 8 . Schematic representation of the site of 
operation for the insertion of a bile duct shunt and 
afferent hepatic lymph duct cannulations. 
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Where a bile shunt was required another cannula was inserted 
into the common bile duct in the direction of the sphincter of 
Oddi, above the bifurcation of the pancreatic duct (Figure 2.9). 
The two cannulae were joined outside the body by the use of a 
sleeve, after closing the abdominal cavity. 
(iii) Hepatic afferent lymphatic duct 
cannulation in adult sheep. There were usually about 5 or 6 
afferent hepatic lymph ducts of which 1 or 2 were derived from 
the gall bladder (Figure 2.8). Clear vinyl cannulae (SV 35 I.D. 
0.50 mm , O.D. 0.90 nun) were inserted into 2 or 3 of the ducts 
(not those derived from the gall bladder) just before they 
entered the lymph node. Usually one of the ducts remained 
patent for several days. 
(iv) Prefemoral efferent lymphatic duct 
cannulation in adult sheep. The efferent prefemoral lymphatic 
duct was cannulated as described by Smith, McIntosh and Morris 
(1970). 
(v) Bile duct cannulation in the rat. A clear 
vinyl cannula (SV 10, I.D. 0.28 mm, O.D. 0.61 mm) was inserted 
into the common bile duct near the sphincter of Oddi. The cannula 
wa$ fixed onto the connective tissue of the omentum prior to 
· being led out through the wall of the abdominal cavity. 
(vi) Thoracic duct cannulation in the rat. 
To obtain lymphocytes the thoracic duct was cannulated using 
. . 
the technique described by Gesner and Gowans (1962). Af t e r 
surgery the rats were kept in Bollman cages. Lymph was collected 
into flasks containing HBSS and a small quantity of heparin. 
GALL 
HEPA TtC DUCT 
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Figure 2 . 9 . Diagrammatic representation of the positions 
where cannulae were inserted to establish a physiolog i cal 
bile duct shunt . 
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(vii) Neonatal thymectomy and neonatal 
splenectomy. Newborn rats were operated on within 24 hours of 
birth. Anaesthesia was induced by placing them in a beaker 
surrounded by ice. For thymectomy the thorax was incised along 
the sternum and the thymus extirpated with fine cotton buds. 
Splenectomy was done through a 1 cm incision on the left hand 
side of abdominal cavity along the subcostal region. The spleen 
was pushed out of the abdominal cavity by applying pressure to 
both sides of the abdomen. The blood vessels to the spleen were 
tied off before it was extirpated with fine cotton wool buds. 
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CHAPTER 3 
THE USE OF RADIOACTIVE IODINE AS A PROTEIN LABEL 
Radioisotopes were first used in research when Hevesj 
and Paneth (1913) used them as tracers. The development of the 
"Cyclotron" by Lawrence and Livingston (1932) made the use of 
different radioactive elements possible. For biological 
investigations 128 I was initially used but a very short half-
life time of 25 minutes limited its usefulness. Livingood 
and Seaborg (1938) discovered 3 radioactive isotopes of iodine 
which vJt.te, used for the study of iodine metabolism in living 
organisms. Since the discovery of radioactive iodine several 
groups have studied the metabolism of iodine in patients with 
normal or abnormal thyroids (Hamilton and Soley, 1939; Perlman, 
Chaikoff and Morton, 1941). 
The finding that iodine could be attached to protein 
molecules via tyrosine or tryptophane amino acid residues 
(Oswald, 1911; Blum and Strauss, 1932) allowed the use of 
radioiodinated protein molecules for in vivo and in vitro 
metabolism studies. Several groups developed protein iodination 
techniques (Eisen and Keston, 1949; Talmage, Baker and Akeston, 
1954; McFarlane, 1958; Helmkamp et al., 1960; Hunter and 
Greenwood, 1962; Yagi, Maier, Pressman, Arbesman and Reisman, 1963; 
· Marchalonis, 1969) as well as methods for the iodination of living 
organisms and cell membranes (Phillips and Morrison, 1970; 
Marchalonis, Cone and Santer, 1971; Vitteta, Baur and Uhr, 1971; 
Schenkein, Levy and Uhr, 1972). Since the 1960's the use of 
125 1 and 1 3 1 1 has allowed the simultaneous study of 2 different 
labelled protein molecules in the same animal. Due to its 
longer half-life time of 60 days 125 I has proven very useful 
in protein metabolism studies. 
In this chapter the problems of using radioactive 
iodine in biological experiments are described. The three 
areas important to this thesis are: 
( i) 
(ii) 
(iii) 
The problem of free iodine in vivo 
The problem of free iodine in vitro 
The effect of iodination on protein molecules. 
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(i) The problem of free iodine in vivo. When 
radioiodinated protein is introduced into the blood circulation 
of animals and the plasma level of isotope followed over a 
period of time, the problem of free iodine (irt fact, iodide) 
which is released from the protein molecules during catabolism 
must be taken into account when interpreting results. At every 
instant in time free iodine or other iodo-compounds will be 
released at the catabolic site(s) of the protein. Free radio-
active iodine and iodo-compounds are finally excreted via the 
urine or faeces . However reabsorption of free iodine does 
occur in the intestine to eventually return to the blood 
circulation. Consequently the way in which free iodine is 
metabolised is important in the study of protein metabolism when 
iodine isotopes are used as labels. Experiments have been done 
in rats to look at the way in which free iodine is metabolised. 
RESULTS 
Similar quantities of free 125 I and 131 I to those 
used as label on protein molecules were injected intravenously 
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into 6 Wistar rats and the plasma disappearance of these 
two isotopes followed for 14 days . Following injection, free 
iodine disappeared rapidly from the circulation being only 
0.02%/ml by day 7. This represents only 0.4% of the plasma 
level at day 7 of a similar quantity of radioactive iodine 
injected as labelled rat IgG2a (Figure 3.1). The disappearance 
of free radioactive iodine from the circulation appeared to be 
triphasic during the 14 day period of study. In Figure 3.1 
the three phases of elimination can be seen to occur between 
days Oto 3 , days 3 to 7 , and days 7 to 14. The decay curve 
for each of the 3 phases was analysed separately and the 
half-life times are shown in Table 3 . 1. 
TABLE 3 . 1 
Half-Life Time (Days) of 125 I and 131 I 
in Adult Male Wistar Rats. 
Values Presented are Means± s.e. 
T\ (Days) Time (Days) 
1 3 1 I 
0 . 89 + 0.07 
1.89 + 0.09 
3.28 + 0.40 
0.89 + 0.05 
1.87 + 0.14 
4 . 09 + 0 . 45 
0 - 3 
3 - 7 
7 - 14 
0 3 
3 - 7 
7 - 14 
From Table 3.1 it may be concluded that from day 7 to day 14 
there appeared to be an iodine-containing compound in the 
circulation which was eliminated more slowly than the bulk of 
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Figure 3.1. Plasma decay curves of rat 125 I IgG2a and free 
radioactive iodine in normal male Wistar rats. 
78 
free iodine leaving the circulation during the first 7 days. 
It is possible that after day 7 iodine which has been incor-
porated into the thyroid hormones , triiodothyronine (T3 ) and 
thyroxine (T 4 ) , is circulating bound to the thyroxine-binding 
proteins . However , the plasma level of radioactivity 7 days 
after injection of 125 I represents only 0.4% of that following 
administration of a similar quantity of radioactive iodine on 
IgG2a (Figure 3 . 1) . Hence it can be concluded that the very 
small quantity of reutilised radioactive iodine that is present 
in the plasma will not interfere with estimates of turnover 
times of proteins labelled with radioactive iodine. 
To examine the tissue distribution of radioactive 
iodine 6 rats were killed 5 minutes and 14 days after the 
injection of 125 I or 125 I IgG2a. The rats were then perfused at 
4° (the left ventriculum of the heart was cannulated and the 
right atrium incised) with 300 mls of saline. From Figure 3.2 
it may be seen that at 14 days more than 90 % of the 125 I was 
located in the thyroid gland while in the rats injected with 
1251 IgG2aradioactivity was found in organs other than the thyroid. 
To study the uptake of free iodine into the thyroid 12 
6 
rats were injected with 2.3 x 10 cpm of 125 I or 131 I,an amount 
.equivalent to that injected when labelled protein molecules 
were being studied. Three rats were killed at 1, 3, 5 and 11 
days after injection of free iodine. As can be seen in Figure 
3 . 3 free iodine uptake by the thyroid was at most 3% of the 
total injected dose, represent~ng 5~8 x 10 4 cpm~ To determine 
whether the thyroid gland was saturated by this quantity ·of 
4 iodine a dose of 5.8 x 10 cpm was injected intravenously into 
another 3 rats which were killed 24 hours later. From 
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Figure 3 . 2 . Tissue distribution of rat 1 25 I IgG2a and free 
radioactive iodine 5 minutes and 14 days after their 
intravenous injection into normal male Wistar rats. The 
rats were perfus ed with 300 ml of saline (4 ° ) prior to the 
removal of the tissues . 
Figure 3 . 3 it can be seen that 1.6 % of this dose was taken up 
by the thyroid , suggesting that the uptake of circulating 
iodine by the thyroid is random and not a saturable type of 
mechanism. 
Another problem of free iodine uptake is that rats 
injected with radioiodinated proteins eat their faeces which 
contains significant quantities of radioactivity. Usually 4-6 
experimental rats were kept in the same tin and the wood 
shavings on which the rats resided changed at least every 3 
days. To determine the quantity of isotope reabsorbed from 
faeces one control rat having received no injection of 125 I 
IgG2a was kept in a tin with a group of 4 rats which had been 
injected with 125 I IgG2a · (each rat receiving a total dose of 
6 1.5 x 10 cpm). After 12 days all the rats were killed, 
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perfused with cold saline and the tissue distribution and plasma 
radioactivity determined. The results of this experiment are 
summarised in Table 3.2 and show that some radioactive iodine 
is absorbed from the faeces of rats back into the circulation. 
* 
TABLE 3. 2 
Amount of Radioactivity Recovered (% Dose/Organ) From 
Non-Injected and Injected Rats Living in the Same Cage 
Non-injected Injected Non-injected 
rat rats Injected rats 
Thyroid 0 .01 2* 0.799 1.502 
Plasma 0.016* 0 . 228 7.018 % dose/ml 
Stomach 0.002* 0.0Q5 8.000 
Values represent cpm/organ divided by the total injected 
of injected rats. 
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Figure 3.3. Time course of the uptake of free radioactive 
iodine into the thyroid gland of normal male Wistar rats. 
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(ii) The problem of free iodine in vitro. 
In vitro experiments using radioactive iodine were carried out 
on tissues from either experimental or normal animals. Most 
measurements on the binding of radioiodinated plasma proteins 
to cells in vitro rely on the total counts in a cell suspension 
or pellet and it is not possible to distinguish radioactive iodine 
associated with protein from that of the free form. Therefore, 
experiments were done to assess the relative importance of free 
iodine in vitro. 
RESULTS 
When 125 I IgG2a was mixed with a suspension of 2 x 10
8 
spleen or lymph node cells from normal Wistar rats at 4° for 1 
hour, about 2% of the isotope remained with the cells and between 
0 
44 . 4 - 56 . 9% of this radioactivity after incubation at 37 for 2 
hours remained with the cells (Table 3.3). 
TABLE 3.3 
Metabolism of 125 I IgG2a Bound to Cells In Vitro 
$tep I 
·Cells 
Step II 
Supernatant 
Cells 
Spleen Lymph nodes 
Cpm/2 x 10 8 
cells 
884 
381 
503 
% 125 I IgG2a Cpm/2 x 10 8 
cells 
2.07 % 
0.89 % 
1.18 % 
857 
477 
380 
% 125 I IgG2a 
2.01% 
1.12 % 
0.89% 
Step I 150 µg of 125 I IgG2a (42775 cpm) was mixed with 2 x 10 8 
cells (1 x 10 8 cells/ml in Eagle's essential amino acid 
medium) for 1 hour at 4. 0 • ·l\fter washing· 4 times with 
Eagle's medium, the radioactivity in the cell pe~let was 
counted. 
Step II The cell suspensions were incubated at 37° for 2 hours 
and the radioactivity in the supernatant and cell pellet 
counted. 
On preparing cell homogenates it was found that most of the 
radioactivity was intracellular and resided in the cytoplasm 
(details of this will be discussed in Chapter 7). From 
Table 3.4 it can be seen that when cells are mixed with 
125 I IgG2a at 4°, the radioactivity associated with the cells 
remains constant after 4 times washing at 4°. 
TABLE 3.4 
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Effect of Washing at 4° on the Radioactivity Bound to the Cell 
Suspension after Incubation at 4° for 1 Hour with 125 I IgG2a 
Number of % of original %
 of original 
washings dose recovered dose
 bound 
in supernatant to cells 
1 92.00 ND* 
2 5.80 ND 
3 0.38 2.10 
4 0.03 2.00 
s 0.003 1.90 
6 0.002 1.80 
* ND - Not done. 
When radioactive free iodine, equivalent to that on the labelled 
IgG2a, was mixed with similar cell suspensions for 1 hour at 
4° · and washed 4 times at 4°, only 0.16% of the radioactivity was 
associated with the cells (Table 3.5). 
TABLE 3.5 
Cell Suspension of 2 x 10 8 Spleen Cells Mixed 
with Equivalent Doses of 1 25 I IgG2a or 125 I at 4° 
Total dose added 
(cpm) 
Total radioactivity 
remaining after 
washing 4 times (cpm) 
125 I IgG2a 
42774 
883 (2.06 %) 
42775 
69 (0.16 %) 
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When the quantity of free 125 I added to 2 x 10 8 spleen cells was 
reduced by 40% the amount of radioactivity associated with the 
cells fell by approximately 50% suggesting that the concentration 
of free iodine affects the amount attached to cells. 
In the experimental systems used the amount of free 
125 I that could have been added to a cell suspension along with 
the 125 I IgG2a was at most 2-3 % of the total dose (97-98% of 
125 I IgG2a preparations were precipitable with 10 % trichloro-
acetic acid). Hence it is possible that a maximum of 0.16 % of 
the 3% free 125 I added along with the 125 I IgG2a may bind to the 
cells. This suggests that only 0.24 % of 125 I IgG2a which binds 
to cells at 4° is in fact free 125 I. 
(iii) Effect of iodination on protein molecules. 
There would appear to be three ways in which radioiodination may 
affect protein molecules: 
(a) by changing the ~tructure and antigenicity of a 
protein molecule; 
(b) by changing the molecular structure of the 
protein by the use of oxidising agents; 
(c) by alteration of the antibody activity of 
imrnunoglobulin molecules . 
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In 1903 , Obermayer and Pick reported that if horse 
serum is treated with iodine and injected into rabbits, specific 
antibodies against the iodinated proteins could be raised. 
Since then Wormall (1930) studied the effect of halogenation on 
protein molecules and calculated that in iodoproteins the radical 
responsible for antigenicity was the 3:5 dihalogenated tyrosine 
grouping . This was confirmed in 1936 by Snapper and Grunbaum 
who showed that the precipitation of iodoproteins by specific 
antiserum was inhibited by diiodotyrosine. Further studies 
(Haurowitz and Appel, 1939), showed that only protein molecules 
having more than 1% of iodine associated with them could inhibit 
precipitation of iodoproteins by specific antiserum. Little 
eviden ce though supports the view that slightly iodinated 
proteins ( 1 mole of iodine to 1 m.ole of protein, or less) 
behave identically to non-iodinated proteins in vivo. 
It has been recognised that iodination techniques, 
especially those that use oxidising agents, can cause protein 
denaturation . Following iodination , protein molecules show 
.changes in their : electrophoretic mobility (Landon, Livanou 
and Greenwood , 1967; Brenneman and Singer, 1968; Marchalonis 
and Nossal , 1968), biological activity (Landon et al., 1967), 
rate of clearance from the bloodstream (McConahey and Dixon, 
19 G 6) and antibody activity ( Jorinso·n, Day and Pressman, 19 6 0 _; 
Day , Lassiter and Fritz, 1967; 
1973 ; Levy and Dawson, 1976). 
Shumak, Batchelor and Watts, 
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One of the main advantages of radioactive iodine is 
that it is possible to obtain radioiodinated proteins of a very 
high specific activity (Hunter and Greenwood, 1962). However, 
high specific activities depend on the use of greater amounts of 
oxidising agents (McConahey and Dixon, 1966). This prompted 
Marchalonis (1969) to develop enzyme catalysing systems for 
iodinating protein in mild conditions with small amounts of 
radioactive iodine. 
The technique of labelling is extremely important in 
the iodination of proteins. The better techniques would appear 
to be those that do not involve the use of oxidising agents. 
In particular the method developed by McFarlane (1958) and 
further modified by Helmkamp et al. (1960) would appear to be the 
best. This technique makes use of the anionic form of iodine 
instead of the cationic form which is produced by oxidation with 
potassium iodide (Singh and Kashyap, 1958). When immunoglobulin 
molecules are radioiodinated, antibody activity can be lost. 
Johnson et al. (1960) found that when the iodination technique of 
Eisen and Keston (1949) was used, no more than 2 moles of iodine 
could be complexed to 1 mole of immunoglobulin without signifi-
cantly affecting the antibody activity. Similar results were 
reported recently by Levy and Dawson (1976). 
RESULTS 
The turnover of rat IgG2a prepared by three different 
methods was compared to determ~ne whether the t~~hniques of 
l~belling and preparation affect the interpretation oE r~sults. 
IgG2a was prepared from normal rat serum, hyperimmune rat serum 
having antibody activity to Ovalbumin, and an IgG2a immunocytoma 
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cell suspension incubated in vitro with 1 4 C amino acids. The 
plasma decay curves for the three different IgG2a preparations 
are shown in Figures 3.1, 3.4 and 3.5. The half-life times for 
the three different IgG2a preparations are compared in Table 3.6. 
TABLE 3.6 
Half-Life Time in Days of Rat IgG2a in Normal Rats 
Values presented are means± s.e. 
Days after 
injection 
6 
12 
20 
30 
40 
so 
60 
1 2 s I 
(n = 20)* 
4.90 + 0.29 
5.67 + 0.12 
* n - number of rats. 
Antibody 
(n - 5) * (n 
9.34 
8.13 
7.03 + 0.56 
7.20 + 0.35 
8.11 + 1.43 
7.68 + 0.54 
7.94 + 0.50 
14c 
- 4) * 
+ 0.29 
+ 0.63 
The antibody and radioactive iodine experiments were 
done using male Wistar rats, while the 14C amino acid labelled 
IgG2a experiments were done using male Lou/M rats. It is 
evident that the half-life times of the antibody and 14 C 
labelled preparations were significantly longer than that of 
the radioiodinated IgG2a. 
The effect of iodination on antibody activity was 
examin d using sheep IgG2 which· had antibody activity against 
Ovalbumin. The IgG2 was labelled at varying iodine:protein 
ratios with 125 I using the technique of Helmkamp et al. (1960). 
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Figure 3.4. Plasma decay curve of passively administered 
rat IgG2a aOVA in normal male Wistar rats over a 70 day 
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Figure 3 . 5. Plasma decay curve of rat 14 C IgG2a in a 
normal male Lou/M rat. 
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When the ratio of I:IgG2 was 4:1 the antibody activity fell to 
70 % of its original titre but at a labelling ratio of less than 
1:1 (I:IgG2) the antibody titre was between 80-90 % of the 
original activity (Figure 3.6). It was interesting that the 
dilution of IgG2 prior to labelling with an equal volume of 0.2M 
borate buffer, pH 8.0, reduced the antibody activity to 94 % of 
the original titre. 
DISCUSSION 
The results presented here indicate that the reutilis-
ation of free radioactive iodine by the rat thyroid is at most 
3% of the total injected dose. Some of the free iodine entering 
the thyroid will be incorporated into the thyroid hormones, 
T3 and T4 , and secreted into the circulation. 
When radioiodinated proteins are injected into the 
circulation free iodine can be expected to be derived from only 
2 sources in the rat. Initially 2-3 % of the total injected dose 
of radioiodinated protein may be present as 1 25 I, while later 
on the catabolism of the labelled protein will lead to the 
continuous release of free iodine at the catabolic site(s) of 
the protein. However, upon the catabolism of the protein only 
3%. of the iodine which is released will be reutilised by the 
thyroid gland. From Figure 3.1 it can be s een that at d ay 4 
only 0.05 %/ml of the total injected dose of fr e e iodine r e mains 
in the plasma and of this 3% may be reutilised. In a rat with 
an approxima t e plasma volume o f 10 ~ls and a tot a l ex t r a-
c~llular fluid pool Of 20 mls only 0.03 % (OiOOOS X 20 X 3 %) ' Of 
the total injected dose on day 4 may be reutilis ed . This can 
be considered to be negligible even though the a mount of free 
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Figure 3.6. Effect of radioiodination on the antibody 
activity of sheep IgG2 aOVA. 
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iodine reutilised must be cumulative with time. 
The fractional catabolic rate of rat 1 2 5 I IgG2a 
( T~ = 5. 7 days) (Table 3. f> ) is approximately 12 % , meaning that 
12% of the radioactivity in the circulation will be excreted as 
free iodine or iodine metabolites per day via the kidney or 
intestine, the end products being found respectively in urine 
and faeces. Taking for example day 4 after injection of 
1 2 5 I IgG2a about 4%/ml of the total injected dose is in the 
circulation, meaning that 80% (20 x 4%) of the total injected 
dose of 125 I IgG2a still resides in the body. An estimate of 
the absolute rate of catabolism of 125 I IgG2a on day 4 is 9.6 %:. 
(12% x 80) of the total injected dose and if it is assumed that 
all the radioactive iodine released is in a free form (9.6 %), 
3 % of this may be reutilised, representing a possible reutilisa-
tion on day 4 by the thyroid of 0.29 % of the total injected 
dose. This is probably a gross overestimate as the metabolism 
of iodine and thyroid hormones is quite complex as shown in 
Figure 3.7, especially the routes of excretion of free iodine 
and thyroid hormone which appear to be subject to hepatointes-
tinal recirculation. 
The reutilisation of free iodine in rats is not 
considered to be a problem, and the interpretation of d a ta 
involving the tissue distribution of radioiodinated proteins 
is free of complications except when tissues that secrete 
iodine are looked at (intestine,liver, kidney) and these are 
considered in detail in Chapter 6. No attemp t has b e e n made to 
block the thyroids of rats with KI or Lugol's solution to 
prevent the uptake of iodine by the thyroid as it is conside red 
Thyroid 
Kidney 
Pros mo 
Figure 3. 7 . Metabolism of iodine in man. As shown 
circulating iodine may be excreted via the kidney into ·the 
urine or via the liver (in the form of bile) into the 
intestine, to be then incorporated into faeces. Free iod i ne 
may be incorporated into the thyroid hormones T3 and T4 in 
the thyroid, which recirculate in the plasma to be 
subsequently metabolised by the liver or kidney (from Greer 
and Solomon, 1974). 
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unnecessary and furthermore allows an understanding of the way 
in which the metabolites of radioiodinated proteins are 
processed in the body. 
The observation that rats eating their faeces absorb 
into their plasma up to 0.016%/ml of the total injected dose 
over a 12 day period, does not represent a significant problem. 
It is interesting to note that the stomach and thyroid of 
animals injected with 125 I IgG2a contain 14.7 and 66.6 times 
respectively more 125 I than the uninjected animal (Table 3.2). 
From these results it would appear that the stomach as well as 
the thyroid tends to concentrate radioactive iodine (Goldsmith, 
Stevens and Schiff, 1950). 
In sheep the reutilisation of iodine by the thyroid 
does represent a problem. When free radioactive iodine was 
injected into normal and thyroidectomised adult sheep and the 
plasma disappearance of radioactivity followed , after 5 days 
the level of total iodine in the plasma of normal sheep stopped 
falling and commenced to rise. The level of radioactivity in 
the plasma remained at relatively high levels till day 14. This 
does not occur in thyroidectomised sheep where the plasma level 
of radioactive iodine falls at a constant rate over the 14 days 
.of sampling (Sutherland, 1974). This suggests that iodine is 
~ 
reutilised by the thyroid gland of sheep and thatksignificant 
quantitj of radioactive iodine finds its way into the thyroid 
hormones which are secreted into the circulation. In the light 
of these findings it is necessary ~o prevent the· uptake of free 
radioactive iodine into the thyroid of sheep by the use of KI 
or Lugol ' s solution. 
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Using the method of Helmkamp et al. (1960) and low 
molar ratios of 0.5-1.0 (iodine:protein) rat IgG2a labelled with 
radioactive iodine had a significantly shorter half-life time 
than that of unlabelled IgG2a (having antibody to Ovalbumin) and 
IgG2a internally labelled with 14 C amino acids. It should be 
mentioned that in the rat the estimates of the half-life time of 
IgG were around 5 days when iodine was used as the label 
(Campbell et al. , 1956; Cohen, 1957; Weigle, 1957; Jeffay and 
Winzler, 1958 ; Farthring, Gerwing and Shewell, 1960; Kekki and 
Eisalo , 1964) as was that for IgG2a (Tada , Okumura, Platteau, 
Beckers and Bazin , 1975). The half-life times of the two 
alternative labels - antibody and 1 4 C - gave up to a 50% 
difference to the results obtained using iodine. This may be 
due to structural changes in the immunoglobulin molecule by the 
addition of iodine atoms, suggesting that the results obtained 
using iodinated proteins should be checked by the use of other 
techniques. 
As previously mentioned in Chapter 1 the catabolism 
of immunoglobulin is closely associated with the Fe portion of 
the immunoglobulin molecule. An interesting experiment would 
be the comparison of the turnover of Fab and Fe fragments 
labelled with radioactive iodine or 14C amino acids, as it is not 
~nown whether the different rates of turnover of iodine labelled 
Fab and Fe reflect a difference induced by the addition of 
iodine atoms to a critical site, or to a true difference in 
metabolic processing. 
• 
The three different labels used for measuring·half-
life times all have problems when interpreting results. 
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Radioactive iodine affects the antibody activity, probably the 
protein structure and when the protein molecule is catabolised 
free iodine is released to be reutilised. The antibody labels 
are the best in that they represent an endogenous in vivo 
labelling method but the techniques for quantitating antibody 
are not as sensitive as radioactive counting and the detection 
of antibody in the tissues etc. is extremely difficult (Freund, 
19 27) . The 14 c label when used as an endogenous label would 
appear to be the most useful, however the problems of reutilisa-
tion of 14 C after its release from the irnrnunoglobulin molecules 
cannot be overlooked. That the 14 C labelled IgG2a was derived 
I 
from an irnrnunocytoma producing IgG2a should be noted, but it is 
difficult to see how this could lead to wrong interpretations 
of the results obtained. 
The similar half-life times of the antibody IgG2a 
and the 14 C IgG2a sugg~sts that the elimination of 14 C atoms 
occurs in the form of co2 and that the very large di
lution of 
the 14 C atoms in the rat by cold C atoms prevents its 
reutilisation. G-200 Sephadex fractionations of serum collected 
12 days after the injection of 14 C IgG2a showed only a 7S peak 
of radioactivity. 
The ef fect of radioactive iodine on the antibody 
activity of sheep IgG2 appeared to be significant even at low I: 
protein ratios of 0.2:1.0. It may be that the iodine molecules 
that bind to tyrosine and tryptophane residues do so within the 
antigen binding site and reduce. the · antibody act.1 vi ty. Affinity 
labelling (Wofsy, Metzger and Singer, 1962; Singer and Thorpe, 
1968) and x-ray diffraction studies (Poljak, 1975) have shown 
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that tyrosines are predominant residues in the combining sites 
of many , if not all, antibodies. It appears likely then that 
the effect of iodination on antibody activity, at least in part, 
is due to the localisation of iodine atoms in a critical segment 
of the immunoglobulin molecule. 
CHAPTER 4 
CATABOLISM OF IgG2a IN THE RAT AND SHEEP 
The maJor irnrnunoglobulin in rat serum is IgG2a and 
it is relatively easy to obtain pure. Following antigenic 
challenge most of the antibody activity in rat serum is 
associated with I gG2a . For these reasons the catabolism of 
irnrnunoglobulin has been studied initially using IgG2a. 
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In this Chapter an attempt has been made to clarify 
the mechanism of irnrnunoglobulin catabolism, and to examine 
whether there is any 'specificity' in the catabolism of IgG2a 
in the rat. To determine whether irnrnunoglobulin catabolism is 
a specific mechanism or a general phenomenon associated with all 
plasma proteins , the turnover and tissue distribution of IgG2a 
has been compared to that of rat serum albumin (RSA), sheep 
IgG2 (IgG2) and polyvinyl pyrrolidone (PVP) in rats. Strain 
differences in the turnover of IgG2a in Hooded (HO) and DA rats 
and the metabolism of IgG2a, RSA and IgG2 in normal and IgG2a 
irnrnunocytoma bearing rats has also been studied. 
RESULTS 
Catabolism of IgG2a, RSA and PVP 
The turnover times of IgG2a , RSA and PVP are markedly 
different in the rat (Table 4 . 1) , a.nd the plasma· decay curves 
(Figure 4 .1) clearly reflect this, showing a rapid turnov·er of 
PVP and RSA compared to IgG2a. In order to check the molecular 
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Figure 4 . 1 . Plasma decay curves of rat IgG2a, rat serum 
albumin and polyvinyl pyrrolidone in normal male Wistar 
rats . 
TABLE 4.1 
Half-Life Time (Days) of IgG2a, RSA and PVP 
in Adult Male Wistar Rats. 
Values presented are means± s.e. 
IgG2a 
RSA 
PVP 
4.90 + 0.30 
2.26 + 0.05 
1.35 + 0.04 
size of the labelled molecules in the plasma rats were killed 
9 days after the original injection of radioiodinated protein 
and their plasma fractionated on G-200 Sephadex. A typical 
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G-200 profile is shown in Figure 4.2 and it can be seen that the 
labelled IgG2a lies directly under the IgG 7S peak (m.w. 160,000) 
while the labelled RSA lies directly under the 4S peak 
(m.w. 70,000). It may be concluded from this that the radiolabel 
is circulating on intact molecules of size properties identical 
to the originally injected molecules. 
To try and identify organs responsible for the catab-
olism of the radiolabelled proteins the tissue distribution of 
125 I IgG2a and 131 I RSA was followed after injecting these 2 
proteins into 24 rats (7 experimental groups) and killing them 
24 hours later. Before the tissues were collected for counting, 
rats were perfused with 300 ml~ of -~old saline (4 ° ) to remove 
the radioactivity in the intravascular compartment. It should 
be mentioned that the radioactivity found in the intestine in all 
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experiments presented includes that in the intestinal contents. 
However, when the intestine was counted with and without its 
contents there was little difference in the results obtained. 
The tissue distribution of IgG2a and RSA is given in Table 4.2. 
There was a large difference in the distribution of IgG2a 
compared to RSA in the liver, spleen and lymph nodes with much 
greater quantities of IgG2a appearing in these organs than 
expected after the plasma ratio of IgG2a and RSA was taken into 
account . Significantly less IgG2a than RSA appeared to be in 
the muscle and large intestine. 
When the distribution of 125 I IgG2a in various organs 
was followed in groups of 6 rats at 5 minutes, 1 hour, 12 hours, 
1 day, then at daily intervals to 10 days, after the injection 
of 125 I IgG2a, several organs contained large quantities of 
radioactivity following perfusion with 300 ml of cold saline. 
The total recovery of radioactivity in the organs counted as a 
percentage of the original injected dose after 5 minutes, 1 hour 
and 12 hours was 12.87, 9 . 62 and 5.47 respectively. For ease of 
presentation the value of each organ at these times has been 
shown as a proportion of 5%. Figure 4.3 shows that after 2 days 
the distribution of IgG2a in the various organs tends to 
stabilise, with significant levels of radioactivity being found 
.in the lung, liver, kidney, small and large intestine, spleen 
and thyroid suggesting that these organs may be closely related 
with catabolism of IgG2a. When the total counts in the tissues 
sampled were plotted against time on semi-logarithmic graph 
paper (Figure 4 . 4), the half-life tjme of 1 25 IgG2a calculated 
from the tissue decay after allowing for equilibration .was 5.98 
days which is similar to that calculated for the plasma decay 
of 125 I IgG2a . 
TABLE 4. 2 
Tissue Distribution of and 
,i , I 
24 Hours after the 
~ 
. • S... \.:,..~I \ r __.. Intravenous InJection oJ ~\X~Cv 
\JtI_ R.S A- , .... +o r\.O f rt\cl_. m.eJe... Wt~1"W ~ 
Values presented are means (% Dose/Organ) ± s.e. 
Organ IgG2a 
Liver 1.04 ± 0.10 
Kidney 0.20 + 0.04 
Small intestine 1.58 + 0.18 
La,f5e... intestine 0.56 + 0.06 
Lung 0.65 + 0.08 
Thymus 0.05 + 0.00 
Spleen 0.37 ± 0.03 
Lymph nodes 0.06 + 0.01 
Testis 0.44 + 0.07 
Muscle 0.05 + 0.01* 
Thyroid 3.27 + 0.38 
Plasma 4.06 + 0.20 
* % Dose/mg. 
Albumin 
0.42 + 0.05 
. 0.13 + 0.02 
1.28 + 0.22 
0.65 + 0.09 
0.44 + 0.08 
0.03 + 0.00 
0.11 + 0.01 
0.03 + 0.01 
0.34 + 0.06 
0.05 + 0.01 
5.37 + 0.78 
2.45 + 0.13 
Ratio 
IgG2a/Albumin 
2.48 
1.54 
1.23 
0.86 
1.48 
1.67 
3.36 . 
2.00 
1.29 
1.00 
0.61 
1.66 
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Figure 4.3. Tissue distribution of rat 125 ! IgG2a over 
10 days following its intravenous injection into normal male 
Wistar rats. The rats were perfused with 300 ml of saline 
(4°) prior to the removal of the tissues. The radioactivity 
in each organ represents the mean value of 6 rats. 
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of saline (4 ° ) prior to the r emoval of the tissues. The 
high total recovery of 14 . 78 % for 125 1 PVP should be noted . 
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By comparing Table 4.1 and Figure 4.5 it may be seen 
that the plasma decay of a radioiodinated molecule does not 
necessarily reflect the mechanism of catabolism of that molecule. 
When the turnover time of IgG2a is compared to RSA and PVP, 
it is PVP that is apparently eliminated from the body at the 
fastest rate . However , on looking at the tissue distribution of 
these 3 molecules 9 days after their intravenous injection the 
distribution of IgG2a , RSA and PVP is very different in the 
various organs . PVP tends to distribute in the liver and spleen 
in quite high amounts . 
Catabolism of Rat IgG2a and Sheep IgG2 in Rats 
To determine the relative importance of inununoglobulin 
structure in inununoglobulin ,catabolism, sheep IgG2 turnover has 
been compared to that of rat IgG2a. Both of these molecules 
a re of a similar size and charge and their handling in vivo by 
rats should assist in determining the specificity of inununo-
globulin turnover. From the plasma decay curves (Figure 4.6) 
the turnover of IgG2 (T~ = 4.86 ± 0.21, mean (days) ± s.e.) 
was quicker than that of IgG2a (6.26 ± 0.30, mean (days) ± s.e.). 
It has been pointed out that the half-life time yields little 
more than a numerical figure in respect to the mechanism of 
.turnover, therefore the tissue distribution of these two 
molecules was followed simultaneously in groups of 4-10 rats at 
the following times after their intravenous injection: 5 min, 
1 hour , 12 hours , 1 day, and thereafter at 1 day intervals to 
14 days. Prior to the removal of the various organs the rats 
were perfused with 300 mls of cold saline. The tissue. distri-
bution of the 2 proteins was similar in most of the tissues 
(Figure 4.7, Appendix 4 . 1) , however, after 3 days IgG2 appeared 
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Figure 4.7. The distribution of rat 125 I IgG2a and sheep 
131 I IgG2 ove r 14 days in the liver, spleen, smal l i ntestine 
and mesenteric lymph nodes following their intravenous 
injection into normal male Wistar rats. The rats were 
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to accumulate much more than IgG2a in the spleen, lymph nodes 
and liver and this was clearly seen in the distribution of 
131 I IgG2 and 125 I IgG2a in the small intestine, suggesting 
different metabolic processes for the 2 proteins. 
Catabolism of IgG2a in Adult Sheep 
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The turnover of 131 I IgG2 and 1 25 I IgG2a labelled at 
a molar ratio of 0 . 5 (I:protein) was followed in 4 adult sheep 
by the intravenous injection of 2 mg of these 2 proteins. The 
thyroids of the sheep were blocked by the intravenous injection 
of KI for each of the 3 days before the injection of radio-
iod i nated protein and then every 3 days after injection. On the 
final day of the experiment the sheep were killed and their 
thyroids checked for radioactivity. At most 2% of the total 
injected dose of isotope resided in the thyroid. 
The plasma decay of 131 I IgG2 and 125 I IgG2a is shown 
in Figure 4 . 8 over 13 days. The half-life time of IgG2 was 
10 . 69 days whereas the IgG2a was quickly eliminated from the 
circulation after 5 days , in a manner depicting a typical immune 
response . The sheep clearly distinguished between the 2 proteins 
with the sheep IgG2 being turned over as an endogenous immuno-
ilobulin while the rat IgG2a was recognised as a foreign protein 
and removed from the circulation . 
Catabolism of IgG2a in HO and DA Rats 
In this experiment HO and DA IgG2a were prepared from 
serum by elution on DEAE-Sephadex with 0.01M phosphate buffer, 
pH 8 . 0 . The IgG2a was then labelled with 125 I or 131 I. As the 
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results for labelling the IgG2a with 125 I or 131 I were identical 
the results for the two isotopes have been pooled. When the 
half-life times of the HO and DA IgG2a were compared in 6 HO and 
DA rats (Table 4.3) the strain differences in IgG2a appeared to 
be unimportant , the only difference being in the rat strains in 
which the turnover was studied. The results suggest that DA 
rats have a faster turnover of IgG2a than do HO rats. 
TABLE 4 . 3 
Half-Life Time (Days) of HO IgG2a and DA IgG2a 
in HO and DA Rats. 
Values presented are means+ s.e. 
Rat Strain 
Injected 
Irnrnunoglobulin Injected 
HO IgG2a DA IgG2a 
HO 5 . 67 ± 0 . 12 5.63 ± 0.10 
DA 4.11 + 0.53 4.24 + 0.17 
The tissue distribution of the radioiodinated HO and 
DA IgG2a was examined in HO and DA rats 9 days after their 
~ntravenous injection . Prior to removal of the tissues for 
counting , the rats were perfused with 300 ml of cold saline (4 °) 
to remove the radioactivity in the intravascular compartment. 
Identical distribution patterns were observed for both HO and 
DA IgG2a in HO and DA rats (Figure 1.9) when the·ratio of 
HO/DA IgG2a was compared in the 2 rat strains. Intere$tingly, 
more HO IgG2a was found in the liver, kidney and spleen in the 
2 rat strains than DA IgG2a. However, there was no specificity 
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Figure 4.9. Tissue distribution of Hooded 125 I IgG2a and 
DA 131 I IgG2a in Hooded and DA rats 9 days after their intra-
venous injection. The rats were perfused with 300 ml of 
saline (4 ° ) prior to the removal of the tissues. The values 
presented represent mean± s.e. of the ratio of H0 125 IgG2a 
to DA 131 I IgG2a in each organ. 
in the tissue distribution of HO IgG2a in HO rats or DA IgG2a 
in DA rats. 
Catabolism of Rat IgG2a, Sheep IgG2 and RSA in Rats 
Bearing an IgG2a Immunocytoma 
The plasma decay and tissue distribution of rat 
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IgG2a , sheep IgG2 and RSA were studied in normal and tumour bearing 
Lou/M rats. To confirm that the behaviour of the radioiodinated 
IgG2a was not a property of the iodine isotope, the turnover of 
IgG2a internally labelled with 14 C amino acids was also studied 
in normal and tumour bearing Lou/M rats. 
To see if there was any specificity in the turnover 
of IgG2a in rats bearing an IgG2a immunocytoma, the plasma decay 
of 125 I IgG2a and 131 I RSA was followed in 6 rats over a 48 hour 
period and the tissue distribution of these 2 proteins determined 
24 and 48 hours after injection. Rats were perfused with 300 mls 
of cold saline (4°) immediately after killing, prior to counting 
the radioactivity in the tissues. The disappearance of 
125 I IgG2a 
and 131 I RSA from the plasma of the tumour bearing rats was much 
quicker than that in the 6 control rats (Figure 4.10). The ratio 
of IgG2a/RSA in the plasma of tumour bearing rats at 24 hours 
was much lower than in the normal rats (Table 4.4, cf also 
Table 4.2) suggesting that the IgG2a disappeared from the circu-
lation of the tumour bearing rats at a much quicker rate than in 
the control rats. It is important to note that the amount of 
RSA in the plasma of tumour bearing rats at 24 hours was also 
siynificantly decreased although not as drastically as IgG2a. 
The tissue distribution of 125 I IgG2a and 131 I RSA 48 hours after 
injection was similar to that at 24 hours. The tissue distribution 
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Figure 4.10. The plasma disappearance of rat 125 I IgG 2a 
and 131 I RSA in normal and IgG2a immunocytoma bearing Lou/ M 
rats over 48 hours. 
TABLE 4.4 
Tissue Distribution of IgG2a and RSA (% Dose/Organ) 24 Hours after their Intravenous 
Injection into Normal and Tumour Bearing Male Lou/M Rats. 
Normal Ratio Tumour Bearing 
Organ 
IgG2a RSA IgG2a/RSA IgG2a RSA 
Liver 0.68 ± 0.00 0.36 ± 0.01 1.89 0.74 ±
 0.04 0.40 ± 0.02 
Kidney 0.09 ± 0.00 0.06 ± 0.00 1.50 0.21 ± 0 : 11 -
0.17 ± 0.90 
Small Intestine 0.50 ± 0.03 0.98 ± 0.03 1.67 
\ 
0.99 ± 0.02 0.75 ± 0.05 
Large Intestine 0.43 ± 0.03 0.35 ± 0.00 1.23 0.71 ± 0.14 
0.71 ± 0.12 
Lung 0.59 ± 0.02 0.36 ± 0.03 1.64 0.17 ± 0.07 
0.14 ± 0.05 
Thymus 0.05 ± 0.00 0.04 ± 0.00 1.25 0.03 ± 0.00 
0.03 ± 0.00 
Spleen 0.10 ± 0.00 0.05 ± 0.00 2.00 0.43 ± 0.06 
0.30 ± 0.03 
Lymph Nodes 0.05 ± 0.00 0.03 ± 0.00 1.67 0.07 ± 0.00 
0.05 ± 0.00 
Testis 0.84 ± 0.01 0.60 ± 0.00 1.40 0.43 ± 0.07 
0.40 ± 0.05 
Muscle *0.10 ± 0.00 0.10 ± 0.00 1.00 0.04 ± 0.00 
0.06 ± 0.00 
Thyroid 0.61 ± 0.04 1.05 ± 0.04 0.58 0.78 ± 0.03 
0.85 ± 0.05 
Plasma 5.59 ± 0.00 3.18 ± 0.01 1.76 3.38 ± 0.33 
2.54 ± 0.16 
Tumourt 7.82 ± 0.91 6.98 ± 0.82 
* % Dose/mg t 9.65 % of body weight 
Ratio 
IgG2a/RSA 
1.85 
1.24 
1.32 
1.00 
1.22 
1.00 
1.43 
1.40 
1.08 
0.67 
0.92 
1.33 
1.13 
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of these 2 radioiodinated proteins was similar in the normal and 
tumour bearing rats except that a large amount of both proteins 
was found in the tumours (Table 4.4). 
A similar experiment was done using rat IgG2a and 
sheep IgG2 labelled with 131 I and 125 I respectively to determine 
whether the rapid turnover of IgG2a in rats bearing an IgG2a 
immunocytoma was specific for IgG2a or .any immunoglobulin. The 
plasma disappearance of 131 I IgG2a and 125 I IgG2 in 3 tumour 
bearing rats was much quicker than that in 3 normal rats 
(Figure 4 . 11) and their rates of removal were similar suggesting 
that in rats bearing an IgG2a immunocytoma there is a tendency 
for the removal of immunoglobulin in preference to other serum 
proteins , e . g . RSA . The tissue distribution of 131 I IyG2a 
is shown in Figure 4 . 12 and the ratio of IgG2a/IgG2 in normal 
and tumour bearing rats is presented in Table 4 . 5. The ratio 
of IgG2a/IgG2 in the various tissues can be seen to be similar 
suggesting their removal from the circulation at equal rates. 
Following the injection of 14 C labelled IgG2a into 3 
normal and 3 IgG2a immunocytoma bearing rats the ~a, 6t c:ltfa..ff~e.e..., 
f~,.,_ ~ pl~ -o~ ~in the tumour bearing rats was significantly faster than 
that in normal rats (Figure 4 . 13). The radioactivity in the 
,plasma and tissue samples of the normal and tumour bearing rats 
was measured using a Tri-Carb Sample Oxidiser. The tissue 
distribution of 14 C IgG2a in 3 tumour bearing rats and 3 normal 
rats after perfusion with 300 mls of cold saline (4°) compared 
to that in normal and tumour bearing rats inj ect~d with 
1
~
5 I IgG2a is shown in Figure 4.12, 48 hours after their 
injection . It is clear that a significant quantity of radioactiv-
ity was associated with the tumour regardless of whether 
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Figure 4.12. Tissue distribution of rat 125 I IgG2a and 
rat 14 C IgG2a 48 hours after their intravenous injection 
into normal and IgG2a immunocytoma bearing Lou/M rats. 
The rats were perfused with 300 ml of saline (4°) prior 
to the removal of the tissues. 
TABLE 4. 5 
Ratio of Sheep IgG2/Rat IgG2a in Normal and Tumour Bearing Rats 
48 Hours after their Intravenous Injection. 
Values presented are means± s.e. 
Normal Tumour Bearing 
Ratio IgG2 Ratio IgG2 IgG2a IgG2a 
Liver 0.99 + 0.02 0.93 + 0.01 
Kidney 1.42 + 0.14 1.22 + 0.09 
Lung 1.60 + 0.03 1.72 + 0.17 
Small Intestine 1.53 + 0.13 1.60 + 0.08 
Large Intestine 1.74 + 0.04 1.35 + 0.08 
Thymus 1.58 + 0.02 1.66 + 0.03 
Spleen 1.31 + 0.06 1.23 + 0.06 
Lymph Nodes 2.07 + 0.11 2.14 + 0.30 
Testis 1.74 + 0.07 1.67 + 0.16 
Muscle 2.01 + 0.01 1.70 + 0.09 
Thyroid 0.66 + 0.09 0.66 + 0.00 
Tumour+ 1.54 + 0.01 
Plasma 1.62 + 0.03 1.70 + 0.01 
t 15.4% of body weight. 
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The plasma disappearance of rat 14 C IgG2a 
in normal and IgG2a immunocytoma bearing Lou/M rats over 
48 hours. Each point represents the mean value of 3 rats. 
radioactive iodine or carbon was used as the label for 
IgG2a. 
DISCUSSION 
100 
From the results presented here the mechanism of 
catabolism of IgG2a in the rat appeared to be a specific process 
for IgG2a. The degree of specificity is unclear because HO and 
DA IgG2a behaved in a similar manner in both HO and DA rats 
but a heterologous immunoglobulin, sheep IgG2 and other antigens 
were clearly processed in a manner different to that of IgG2a. 
It is clear that the use of heterologous immuno-
globulins for in vivo metabolism studies is not appropriate, 
as the mechanism of catabolism of autologous or isologous IgG 
is entirely different to the catabolism of heterologous IgG, 
which may occasionally have some similarity in structure to 
homologous IgG. The results presented here also show that the 
mechanism of catabolism of IgG is different from that of serum 
albumin suggesting the existence of a specialised structure on 
IgG allowing for its continuous degradation. 
The significance of tissue distribution data for 
.analysing the mechanism of protein metabolism in animals is 
illustrated by the differences observed in the turnover rate 
and tissue distribution of IgG2a, RSA and PVP in rats. The 
studv of the tissue distribution of protein molecules is by no 
means new as Haurowitz (1961, 1968) .. showed that · in animals with 
prolonged antibody synthesis, the antigen was retained. in various 
tissues £or a longer period. An attempt was made to examine 
the tissue distribution of imrnunoglobulin by extracting antibody 
101 
molecules from tissues after the injection of alloantiserum 
against B. typhosus into normal rabbits (Freund, 1927). These 
studies showed that agglutinins against B. typhosus accumulated 
in the liver, spleen, kidney and lungs of rabbits in much greater 
amounts than in the uterus and skin. Since then no further 
studies of this nature have been done on tne tissue distribution 
of immunoglobulin or other serum proteins except for a study by 
Hawkins (1961) who suggested that the spleen, liver and kidney 
were important for the catabolism of 35 S-labelled rat serum 
albumin in rats. Most other studies have been of a qualitative 
nature and have looked at the metabolism of hormones (Dupont, 
Kastin, Labrie, Pelletier, Puviani and Schally, 1975) and 
antigens (Ada and Williams, 1966; Mitchell, 1966; Hulme, 
Dykes, Appleyard and Arkell, 1968; Morgan and Soothill, 1974) 
~ 
including 51 Cr- labelled erythrocytes (Warr and Sljivi~, 1974). 
However, most of the studies done on the localisation of proteins 
etc. in the tissues have failed to remove the labelled protein 
from the intravascular compartment and it is critical that this 
is done by perfusion of the whole animal at low temperatures 
with isotonic solutions to allow interpretation of results. 
The problems of reutilisation of radioactive labels 
have been discussed in Chapter 3 and it is likely that the tissue 
,distribution of radioiodinated proteins in the rat reflects 
the true situation, uncomplicated by significant quantities of 
free radioactive iodine in the tissues. The problem of the 
reutilisation of 14 C released from labelled proteins is much 
more complex in that 1 4 C may fipd its way into 6lher proteins , 
and this shortcoming must be considered when interpreting· 
results. 
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The accumulation of IgG2a in comparison with albumin 
in the liver , spleen and lymph nodes suggests that these organs 
are important in the catabolism of IgG2a. Previous studies 
(cf review by McFarlane, 1964) have shown that the catabolic 
site of IgG is in close relationship with the intravascular 
compartment and these three organs fulfill this condition. It is 
interesting that Freund and Whitney (1928) showed that by 
perfusing rabbits passively immunised with antibodies against 
B. typhosus , it was relatively easy to remove antibodies from 
the liver and spleen compared to the skin and uterus. From this 
Freund and Whitney (192 8 ) concluded that the liver and spleen 
act as reservoirs of antibody and that when the antibody concen-
tration in the b l ood fell , antibody would be released from these 
organs. The proposition that these organs may be responsible 
for the catabolisffi of antibody molecules was not considered by 
them. 
The tissue localisation of the radioiodinated 
proteins , rat IgG2a and sheep IgG2 in rats represents either 
whole molecules or metabolites of these 2 proteins and the 
differences in the tissues reflect that they are handled differ-
ently. This difference can be explained by the antigenicity of 
the molecules as in the first 3 days after their injection there 
~~much greater quantities of IgG2 compared to IgG2a in the 
spleen and lymph nodes. Later on, much l~rger quantities of 
IgG2 were found in the intestine compared to IgG2~. It is 
suggested that this radioactivity was in the form of metabolites.· 
The mechanism of catabolism of endogenous immuno-
globulin must involve a recognition system that is unique for 
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autologous immunoglobulin. This is best illustrated by the 
turnover of rat IgG2a and sheep IgG2 in the sheep·, where rat 
IgG2a, although an immunoglobulin similar in its physicochemical 
properties to sheep IgG2, was eliminated from the circulation as 
if an antigen. Dixon (1957) has previously stressed that 2 
different types of catabolism exist, one for the elimination of 
homologous immunoglobulin called non-immune catabolism, which 
is characterised by a logarithmic elimination, and another for 
the elimination of heterologous immunoglobulin called immune 
catabolism, typified by the production of antibody molecules 
against the injected protein which results in its rapid elimina-
tion from the circulation . However, Dixon (1957) didn't 
consider the manner in which non-immune catabolism took place, 
and although it may be called non-inunune catabolism, it obviously 
requires a system which has the ability to recognise self-
proteins. 
Binaghi, Oriol and Boussac-Aron (1967) reported that 
rabbits made antibodies against Fe and Fab fragments of hetero-
logous immunoglobulins whereas guinea pigs and rats only produce 
Fe antibodies against heterologous immunoglobulin suggesting 
species differences in the degree of antigenicity of heterologous 
immunoglobulins. This explains the observation that in the rat 
. sheep IgG2 is processed in a manner similar to rat IgG2a and 
that no antibodies are made against it, while in the sheen rat 
IgG2a is removed from the circulation by the active production 
of antibodies against it. 
The observation in the rat that strain differences 
did not affect the catabolic rate or the tissue distribution 
of rat IgG2a suggests that the recognition system for catabolism 
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does not recognise such suhtle differences as would be present 
in these molecules. It was interesting though that DA rats 
turned over IgG2a at a much faster rate than did HO rats. 
This was probably due to the stress caused to the DA rats when 
blood samples were obtained for the 14 day period of study. 
In most experiments involving blood sampling, the rats did not 
lose weight during the period of study and were not unduly 
stressed, however the DA rats lost about 10% of their initial 
body weight while the HO rats in the same time period did not 
lose any weight. 
The affinity of IgG2a for the tumours of rats bearing 
an IgG2a immunocytoma raises the possibility that the tumour 
cells may have a binding site that allows the recognition of 
IgG2a molecules. Obviously further studies are needed to 
determine whether this is important in the regulation of antibody 
metabolism. 
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CHAPTER 5 
PROTEIN METABOLISM IN THE FOETUS 
r------~ 
• I 
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The development of techniques for cannulating blood 
vessels and lymphatics in foetal sheep has enabled the study of 
foetal development especially in the last half of gestation. 
In particular research has concentrated on the circulatory 
system, protein -metabolism, and the development of the endocrine 
and immune systems . Physiological features of the foetus which 
differ from those of the adult derive from the dependence of the 
foetus on the dam for nutrients, the elimination of metabolites 
via the placenta and the development of the foetus in an 
environment free of infectious agents. 
In this Chapter studies on the metabolism of plasma 
proteins in foetal sheep are reported. An immunoelectrophoretic 
pattern of foetal and adult sheep serum developed against rabbit 
anti-sheep serum and acrylamide gel electrophoretic patterns of 
foetal and adult sheep serum are shown in Figure 5.1. These 
electrophoretograms illustrate that the sheep foetus possesses 
most of the plasma proteins except the immunoglobulins. The 
character of the foetal plasma proteins may not be identical to 
those in the adult but they do cross react with antisera raised 
against adult sheep serum. 
The development of immunological competence in foetal 
sheep has been extensively studied (Silverstein, Uhr, Kraner 
and Lukes, 1963; Silverstein, Prendergast and Kraner, 1964) 
especially after Schinckel and Ferguson (1953) showed that 
foetal sheep could reject skin allografts. The sequence 
in which various immunological reactions appear during develop-
ment in utero appears to be correlated with the development 
of lymphocytes and their appearance in the circulation 
Figure 5.1. Immunoelectrophoretic pattern of serum from 
a normal 110 day old foetal sheep (top well) showing the 
complete absence of they-globulins. The bottom well 
contained normal adult sheep serum and the precipitin 
arcs were developed using rabbit antiserum to adult sheep 
serum. 
..-Albumin 
• IgG 
• Macroglobulin 
·- Origin 
Foetus Foetus Lamb Lamb Sheep 
Polyacrylamide gel electrophoretic patterns (Pharmacia 
Fine Chemicals, Uppsula, Sweden) of sera from foetal, new-
born and adult sheep. The gels were run at a pH of 8.3. 
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(Silverstein and Kraner, 1965; Silverstein and Prendergast, 
1970). Recently evidence has been presented suggesting that 
in foetal sheep between 64-82 days of age there is sufficient 
maturation of the immune system to allow foetuses to respond 
to most antigens (Fahey, 1976). 
The effect of thymectomy on foetal sheep has been 
described by several workers (Kraner, 1965; Cole and Morris, 
1971). The immune responses of lambs thymectomised in utero 
60-80 days after conception have been compared to control lambs 
and although lymphoid tissue maturation in the thymectomised 
lambs was not as pronounced as in the contro~s the animals 
survived and grew normally (Morris, 1973). 
It is of interest that the lymphoid tissue of the 
newborn lamb is much more immunologically mature than that of 
the mouse or rat at birth and is capable of exhibiting a wide 
range of immunological responses, meaning that cells concerned 
in the immune response develop and differentiate in the sheep 
foetus in a germfree environment in the absence of any antigenic 
stimuli. Figure 5.2 shows the degree of lymphoid development 
in normal and antigenically challenged foetal sheep at 125 days 
of age. The antigenically challenged foetus has a more mature 
.lymphoid system compared to that of the normal foetus. 
Immunoglobulin passively administered to foetal sheep 
does not appear to be catabolised (Brandon, 1976). However this 
study wa s bas e d on the use of the .radioactive isotope s 
1 25 I 
and 131 I which are reutilised upon breakdown of the protein 
molecules and may affect the structure of protein molecules. 
Experiments have been done to follow the metabolism of 
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Figure 5.2. (A) The spleen of a normal foetus at 125 days gestation 
(Methyl green pyronin staining x 110). 
(B) The spleen of an antigenically challenged foetus at 
125 days gestation showing an increased number of cells surrounding 
the arterioles (Methyl green pyronin staining x 110). 
(C) The mesenteric lymph node of a normal foetus at 125 
days gestation (Methyl green pyronin staining x 110). 
(D) The mesenteric lymph node of an antigenically 
challenged foetus at 125 days gestation showing the presence of 
primary follicles (Methyl green pyronin staining x 37). 
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immunoglobulin in the normal foetus with irnrnunoglobulin having 
antibody activity to KLH or OVA. In an attempt to examine the 
• 
effect of lhe degree of maturation of lymphoid tissue on irnrnuno-
globulin catabolism, the turnover of radioiodinated immunoglobulin 
and immunoglobulin possessing antibody activity has been studied 
in antigenically stimulated foetal sheep . It was also important 
to know whether or not serum proteins other than irnrnunoglobulin 
are catabolised in foetal sheep and for this reason the turnover 
of albumin has also been studied. 
CATABOLISM OF IgG IN FOETAL SHEEP 
Experimental Protocol 
Antibody IgG was injected into the circulation of 
100 day old foetuses through indwelling cannulae inserted into 
either the jugular vein or carotid artery. The plasma decline 
of the antibody activity was followed over the next 30-40 days 
of gestation. IgGl possessed antibody to KLH (IgGlaKLH) and 
IgG2 had antibody to Ovalbumin (IgG2aOVA), making it possible to 
study the fate of both IgGl and IgG2 in the same foetus. 
When the turnover of IgG was studied in antigenically 
.stimulated foetuses, the challenge antigens were either CRBC 
or KLH . The plasma decay of radioiodinated IgGl and IgG2 
prepared from normal sheep serum as well as the plasma decay of 
IgGl having antibody activity was followed to monitor the effect . 
of antigenic stimulation on the tu~nover of non-specific 
imrnunoglobulin . 
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RESULTS 
Non-Primed Foetus 
The plasma decay of IgG2aOVA after injection is shown 
in Figure 5.3 for one foetus over 38 days. A few days after 
injection of the antibody, the titre decreased linearly on a 
log 2n scale. The half
-life times were calculated using the fall 
in titre from 5 days after the injection of antibody to allow 
for equilibration of the protein molecules between the intra-
vascular and extravascular compartments. Antibody values in 
Tables 5.1 and 5 . 2 represent the mean value of the titre 2 days 
before and after the time shown. Appendix 5.1 shows the change 
that occurs in the plasma volume of the sheep foetus between 
75 and 150 days of gestation. These... data ha11e., been taken from thos~ 
of Barcroft and Kennedy (1939) and Barcroft (1946). It is 
important to note that the change in plasma volume over this 
n period is linear on a 2 scale (Figure 5.4). The half-life times 
calculated from the decline in plasma of IgGlaKLH ang IgG2 a OVA 
titres have mean values of 17.43 and 14.13 days respectively 
(Table 5.1, 5.2). However, when the plasma titres are corrected 
for changes in plasma volume linear regressions cannot be fitted 
to the data. In most cases there is no fall at all in the plasma 
·titres once corrected. "Estimated half-life times" (Tables 5 .1, 
5.2) represent the calculation of half-life time for plasma titre 
decline corrected for the plasma volume change in the foetus over 
the period of sampling and were calculated by using the change i n 
titre from 5 days after inject~on of the antibody to the last day 
that a plasma sample was obtained. These results are shown in 
Tables 5 .1 and 5.2, and represent a minimum half-life time. 
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Figure 5.3. Plasma decay curve of sheep IgG2 aOVA for 
Foetus 27. It may be seen that after a few days the titre 
decreased in a linear manner. 
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TABLE 5 .1 
Plasma Decay of IgGi aKLH in Non-Primed Foetal Sheep 
Plasma titre (2n) Blood Age at T~ volume Corrected 
which titre. Foetus 
samples Time after injection (days) (days) change Mean of (uncor- during No. 
obtained 5 final 1 5 10 15 20 25 30 35 40 rected) experiment (days) (min) (2n) 5 days 
1 114-123 7.0 6.0 6.0 5.5 - - - - - - * 0 .18 5.68 
22 106-140 7.0 6.0 6.0 6.0 6.0 5.5 5.0 5.0 5.0 23.31 1.33 6.33 
27 107-141 8.0 7.0 7.0 7.0 6.0 5.5 5.5 5.5 5.0 5.0 16.47 1.33 6.33 
30 110-132 5.5 3 .0 3.0 3.0 2.0 2.0 12.50 0 .78 2.78 
* Not valid 
** Estimated T~ calculated using the formula: No. of days samples collected after day 5 
Change in titre 
Change in 
Estimated 
titre T~** 
during (days) 
experiment 
- 0 .32 15.63 
+0.33 co 
-0. 6 7 43 . 28 
- 0 . 22 77.27 
TABLE 5.2 
Plasma Decay of IgG2 aOVA in Non-Primed Foetal Sheep 
Age at Plasma titre (2n) Blood Corrected 
which T~ volume titre. Foetus 
samples (days) change Mean of No. Time after injection (days) (uncor- during 
obtained final 5 rected) experiment (days) (min) 1 5 10 15 20 25 30 35 40 (2n) 5 days 
1 114-123 6.0 4.0 2.5 2.5 - - - - - - * 0.18 2.68 
22 106-140 6.5 6.0 4.0 4.0 3.5 3.0 2.5 2.0 11.67 1.33 3.33 
27 107-141 6.0 5.0 4.0 4.0 4.0 3.0 3.0 2.0 ,2.0 2.0 14.01 1.33 3.33 
30 110-132 6.0 5.0 4.0 3.0 3.0 3.0 16.67 0.78 3.78 
* Not valid 
** Estimated T~ calculated using the formula: No. of days samples collected after day 5 
Change in titre 
Change in Estimated titre 
T~** during (days) 
experiment 
+0.18 00 
-0.67 43.28 
-0.67 43.28 
-0. 22 77.27 
n 
2.5 
2.0 
2 n ( Blood Volume) 1.5 
x 160 mis 
1.0 
0.5 
100 110 120 130 140 150 
GESTATIONAL AGE (Days) 
Figure 5.4. The change in the plasma volume of foetal sheep 
between 100 and 150 days of age. The data on the plasma 
volume\Jle,~ taken from studies by Barcroft and Kennedy (1939) 
and Barcroft (1946). 
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As linear regressions cannot be fitted to any of the plasma decay 
curves once corrected, the true half-life time should be considered 
as infinity. The half-life time of IgGl and IgG2 in adult sheep 
is approximately 10 days (cf. Chapter 6) and it may be concluded 
that when antibody activity is used as a marker for IgG in foetal 
sheep very little if any IgGl and IgG2 is catabolised. This 
result is similar to that obtained when IgGl and IgG2 were 
labelled with radioactive iodine. 
Appendix 5.2 shows the changes in the haematocrit 
percentages, the total nucleated cell counts and the polymorpho-
nuclear cell counts over the period of sampling in the four 
foetuses used to estimate the turnover times of IgGlaKLH and 
IgG2aOVA. After the injection of antibody IgG a transient 
increase in the white blood cell counts and a small increase in 
the polymorphonuclear cell number were observed but these usually 
returned to pre-injection values within a few days. 
Antigenically Challenged Foetus 
The half-life time of IgGl labelled with 125 1 was 
determined in 4 foetuses which had received a primary injection 
9 
of 10 CRBC. The half-life time was not estimated until at 
least 11 days after the injection of antigen. The mean half-
life time of IgGl calculated from the plasma decay curves in the 
four foetuses, was 17.84 days (Table 5.3). After correction for 
dilution by changes in plasma volume over the period of study 
the half-life time was not significantly different from infinity . 
That the 4 foetuses responded to the injection of CRBC is 
illustrated in Appendix 5.3 where it can be seen that all four 
TABLE 5. 3 
Plasma Decay of Radioiodinated Sheep IgGl in Foetal Sheep 
Challenged with a Primary Injection of 10 9 CRBC i.v. 
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Foetus Gestational Period o
f T~ Blood Volume Isotope No. Age (Days) Decay (Days) Change 
23 87-140 106-118 16.99 1.00-+l.49 
26 89-121 106-118 13.10 1.00-+l.49 
46 103-144 120-132 20.63 1.00-+l.49 
51 105-144 120-132 20.63 1.00-+l.49 
foetuses showed a typical primary response when haemagglutinating 
antibody was followed over the period of study. As is shown in 
Appendix 5.4, the main classes of antibody pro~uced were IgM and 
IgGl. The changes in the haematocrit, total nucleated cell 
count and total polymorphonuclear cell count during the experi-
mental period are shown in Appendix 5.5, with an increase in the 
cell counts being observed in the peripheral blood. 
The plasma decay of IgGl prepared from normal sheep 
serum and labelled with 125 I was studied in 2 foetuses which had 
previously received 2 injections of 10 9 CRBC 12 days apart. 
The mean half-life time of IgGl in these two foetuses was 16.25 
days (Table 5.4). After correction for the plasma volume changes 
the half-life times were not significantly different from 
infinity . That the foetuses responded to the two injections of 
CRBC was confirmed by measuring the haemagglutinating antibody 
over the period of sampling (Appendix 5 .6 ). Compared to the 
peak titre of the primary challenge the secondary response was 
much greater in magnitude. The IgM , IgGl and IgG2 concentrations 
112 
TABLE 5.4 
Plasma Decay of Radioiodinated Sheep IgGl in Foetal Sheep 
Challenged with a Primary and Secondary Injection of 10 9 CRBC i~v. 
Foetus Gestational Period of T~ Blood Volume Isotope No. Age (Days) (Days) Change Decay 
28 93-135 123-135 14.44 1.00-+l.49 
38 98-145 123-139 18 . 04 1.00-+l.70 
in the plasma following challenge are shown in Appendix 5.4. 
It was possible t o confirm the results obtained in the 
secondary challenged foetus where radioactive iodine was used, 
by challenging 2 foetuses with primary and secondary injections of 
1 mg of KLH twelve days apart and then following the decline in 
plasma titre of IgGl having antibody activity to Ovalbumin. It 
was difficult to obtain samples for long periods of time in this 
experiment and the sampling times of the 2 foetuses were not 
sufficiently long to allow accurate estimations. However, after 
correction for changes in the plasma volume the half-life times 
appeared to be infinity (Table 5.5). After injection of KLH a 
typical immune response was observed and the changes in the 
.i'mmunoglobulin concentrations in the serum are given in Appendix 
5 • 4 • 
Foetus 
No . 
64 
75 
Age at 
which 
samples 
obtained 
127-139 
123-134 
* Not valid . 
TABLE 5.5 
Plasma Decay of IgGlaOVA in Foetal Sheep Challenged 
with a Primary and Secondary Injection of 1 mg KLH 
Blood Corrected 
volume 
titre 
change 
Plasma titre (2n) 
Mean of T~ during final Time after injection (days) 
5 
(min) 
7 
5 
1 
6 
3 
5 10 
6 6 
2 2 
12 
experiment 5 days (2n) 
5 * 0.32 5.32 
co 0.23 2.23 
Change in Estimated 
titre T\ during (days) 
experiment 
-0.68 10 . 29 
+0.23 co 
CATABOLISM OF SERUM ALBUMIN IN FOETAL SHEEP 
To determine whether foetal sheep catabolise serum 
proteins they produce in utero 3 foetuses were injected with 
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125 I labelled sheep serum albumin (SSA). The albumin used was 
obtained from a commercial source and further purified using 
column chromatography or prepared from normal adult sheep serum 
by column chromatography. Figure 5.5 shows the plasma decay 
pattern of 125 I SSA in a foetus . The mean half-life time for 
sheep serum albumin was 15 . 52 days (Table 5.6). After correction 
for changes in plasma volume the half-life times were 36.10 days 
for Foetus 3, 57 . 75 days for Foetus 39 and statistically infinity 
for Foetus 16. The half-life time of SSA in adult sheep is 
approximately 10 days. The size 
TABLE 5 . 6 
Plasma Decay of Radioiodinated Sheep Serum Albumin 
in Foetal Sheep 
Foetus Gestational Period of T~ Blood Volume Isotope No. Age (Days) (Days) Change Decay 
3 101-129 106-128 13.30 1.004-2.08 
39 101-134 106-134 15.20 1.004- 2.56 
16 101-141 123-141 18.04 1.004-1.81 
distribution of the serum albumin molecules in foetal plasma 
collected 20 days after the injection of labelled protein was 
' 
checked using G-200 Sephadex columns. It is clear (Figure 5.6) 
that the radioactivity resided exclusively in the 4S peak and 
that no alteration in the size properties of the molecules had 
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Figure 5.5. Plasma decay curve of 125 I SSA for Foetus 3. 
The plasma radioactivity can be seen to fall in a linear 
fashion and there is no indication of immune elimination 
of the SSA. 
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Figure 5.6. G-200 Sephadex optical density profile of serum 
from Foetus 3 20 days after the intravenous injection of 
125 I SSA. The 125 I can be seen to reside exclusively in the 
4S region. 
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occurred over 20 days in the foetal circulation. 
Foetuses 3 and 39 exhibited what appeared to be an 
immune response to the SSA injected. Evidence for this is 
the gradual increase in the total nucleated cell count and the 
polymorph count in the blood several days after the injection of 
125 I albumin (Appendix 5.7). It is not known whether adult 
serum albumin is different from foetal albumin or the addition 
of iodine atoms to adult albumin renders the adult serum albumin 
antigenic. However, the double diffusion in agar patterns of 
adult serum and foetal serum against rabbit anti-adult sheep 
serum albumin serum showed complete crossreactivity of the adult 
and foetal albumin suggesting no difference between them. 
Further evidence that albumin in foetal sheep is 
turned over, albeit very slowly in comparison to adult sheep 
was the tissue distribution of 125 I albumin in Foetus 39, 30 
days after injection. Approximately 40% of the injected dose of 
125 I was found in the thyroid suggesting that a significant 
amount of breakdown of 125 I albumin had occurred. 
DISCUSSION 
It has been previously shown that catabolism of IgG 
does not occur in foetal sheep when radioiodinated IgG is 
injected into the circulation and that this situation 
does not change when the concentration of immunoglobulin is 
elevated to high levels by the ~nfusion of massiV~ amounts of 
iminunoglobulin (Brandon, 1976). However, in that study· the radio-
isotopes 125 I and 131 I were used and significant reutilisation of 
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isotope may have occurred in the foetuses over the course of 
study . Radioiodination of proteins tends to change the ~tructure 
of protein molecules by the addition of iodine atoms which might 
be antigenic . This has been shown by the ability to make specific 
antisera to the hormones T3 and T4 which differ by only one iodine 
atom . 
To rule out these two problems IgG having antibody 
activity to Ovalbumin and KLH was prepared from hyperimmunised 
adult sheep serum on DEAE-Sephadex columns. The results 
illustrate that the half-life times of the two proteins in the 
foetal circulation, once corrected ror changes in plasma volume 
over the period o f study, were not statistically different from 
" infinity". This suggests that no catabolism of IgGl or IgG2 
occurred in the foetuses studied and confirms the results 
previously obtained with radioisotopes. 
To clarify the mechanism of the above phenomenon 
foetal sheep were challenged with antigen and non-specific 
immunoglobulin turnover studied, as a relationship between the 
catabolism of IgG and the degree of maturation of the lymphoid 
tissue may be crucial. In the challenged foetuses it appeared 
that catabolism of IgG does not occur although the results for 
the foetuses were variable . Following antigenic stimulation 
lymphoid tissue was much more mature than that in non-primed 
foetuses of a similar gestational age. The plasma antibody 
titres in foetuses, especially those challenged with a secondary 
injection of antigen were usually high. The variation between 
foetuses as to the amount of catabolism of IgG (both lab~lled 
with isotope and antibody) appeared to be related to the anti-
body titre , i.e. in high responding foetuses the half-life time 
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of IgG was shorter. 
Two important considerations following from the finding 
that normal foetuses do not catabolise IgG were that plasma 
proteins in general may not be catabolised in foetuses and 
secondly that a specific regulatory mechanism may exist for 
immunoglobulin catabolism with perhaps a close relationship 
existing between antigen, antigen induced lymphoid tissue and the 
turnover of specific antibody induced by the antigen. The 
metabolism of albumin was studied as a non-immunoglobulin plasma 
protein and surprisingly a very slow rate of albumin turnover was 
found suggesting that some sort of regulatory mechanism may 
exist in foetuses which prevents protein degradation. 
One obvious difference that there could be between the 
foetal and adult tissues is in their lysosomal enzymes. However 
as will be shown in Chapter 7 there is significant activity of 
the lysosomal enzymes in the liver, spleen, lymph nodes and 
plasma of foetal sheep. To explain why there is no catabolism 
of immunoglobulin and a very slow turnover of albumin it could 
be suggested that there is some sort of suppressive function 
preventing degradation. That the foetus can respond to 
injections of foreign proteins has been clearly shown in this 
Chapter and by others (Silverstein, et al, 1963; Fahey, 1976), 
meaning the suppressive action would have to be restricted to 
homologous and autologous serum proteins. 
That this phenomenon is unique to ruminants cannot be 
overlooked. The foetal sheep has a unique intestinal epithelium 
cell type (Smeaton, 1969) which has the ability to absorb from 
the intestinal lumen into the lymphatics large protein molecules 
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(at least up to a m.w. of 1,000,000), so it may be that in the 
foetal sheep, catabolism of plasma proteins occurs via the 
liver as will be shown in Chapter 6, but any protein excreted 
via the bile is reabsorbed back into the circulation from the 
intestine. In this sense the foetal sheep can be seen to be 
recirculating plasma proteins via the liver and intestine back 
to the circulation. 
The results suggest that there is not a simple 
relationship between synthesis and catabolism of plasma proteins, 
as the foetal sheep has the ability to synthesise SSA but not 
catabolise it as in the adult. Gitlin and Borges (1953) found 
that in patients with afibrinogenaemia, that while no synthesis 
of fibrinogen was observed the ability to catabolise fibrinogen 
was . normal , suggesting no relationship between synthesis and 
catabolism . In the present series of experiments the metabolism 
of only nonspecific immunoglobulin was studied following antigenic 
stimulation of foetal sheep. It may be that a relationship exists 
between the synthesis of a specific antibody following antigenic 
challenge and its subsequent catabolism. Details of this will 
be discussed in Chapter 8. 
The metabolic rate in a foetus is high compared to 
that of the adult, with oxygen consumption in the sheep foetus 
at 121-140 days gestation being 5.99 ± 0.16 ml/min/Kg (James 
et al . , 1972) and in adult sheep 3.67 - 5.67 ml/min/Kg (cf. 
Handbook of Respiration, National Academy of Sciences, National 
Research Council , 1958). Barcroft .. (1946) also reported that up 
to 110 days of gestation the oxygen consumption of foetal sheep 
was extremely high while after that time it was equal or slightly 
higher than adult sheep. All these studies suggest that the 
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foetal sheep is in a very active metabolic state and that the 
slower catabolic rate observed in foetal sheep may be due to 
an active suppressive mechanism. 
The initiation of catabolism of endogenous proteins 
may occur at birth. There is possibly a multitude of reasons 
for this happening. The changes in the plasma levels of several 
hormones just before birth may be sufficient for the initiation 
of catabolism especially the change in the plasma concentration 
of cortisol which increases significantly prior to birth 
(Wood, Pearce, Clegg, Weatherall, Robinson, Thorburn and Dawes, 
1976). The change in the oxygen concentration in the plasma at 
the time of delivery may also be crucial. The accumulation of 
co2 in the plasma is thought to stimulate the res
piratory 
centre in the brain of the foetus to start the mechanism of 
breathing. In a similar manner a shortage of oxygen to the body 
tissues may stimulate cells to catabolise endogenous proteins 
when an anaerobic state is reached and a shortage of amino acids 
occurs. The level of metabolites under anaerobic conditions 
also alters drastically and it may be that the high levels of 
co2 , NH 3 and lactic acid in the tissues are sufficient to
 
stimulate catabolism. 
Perhaps the most significant change that occurs at 
birth is in the portal circulation. Before birth the main 
circulatory system is the umbilical circulation to the liver 
(Franklin, Barclay and Prichard, 1940) but after birth the 
umbilical blood supply stops and b~ood flows from the intestinal 
region into the portal vein and then into the liver (Figure 5.7). 
Hence after birth, several different compounds, especially those 
absorbed from the intestine, will flow directly into the liver 
and this may initiate protein degradation. 
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Figure 5.7. Diagrammatic representation of the foetal 
circulation showing the unique blood circulation in the liver 
and heart. The umbilical vein supplies reoxygenated blood 
directly to the liver to then combine with blood from the 
portal and hepatic veins which pour directly i n to the vena 
cava inferior. This blood then circulates systemically 
after passing from the right hand side to the left hand side 
of the heart via the for amen ova le. The flow from the portal 
region to the liver is insignificant in the foetus. 
Modified from Gray's Anatomy (1 949). 
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CHAPTER 6 
CATABOLIC SITE 
Within days of the intravenous injection of radio-
iodinated IgG into an animal, equilibration of IgG occurs between 
the intravascular and extravascular compartments and a steady 
state is reached. Once a steady state is achieved it is possible 
to calculate the half-life time of the injected material and 
assume that a constant amount of radioactivity is removed from 
the circulation per day. In this Chapter the site of catabolism 
of IgG has been considered in both rats and sheep. The possible 
catabolic organs and cell types are shown in Figure 6.1 based on 
data from earlier Chapters and the published literature. 
RESULTS 
LIVER 
Six male Wistar rats were injected with IgG2a 
possessing antibody activity to human serum albumin (IgG2a-
aHSA) and 3 days later injected with 125 I HSA. After 5 minutes 
the rats were killed and perfused with 300 ml of cold saline. 
The importance of the liver as a catabolic site for 
IgG was assessed by injecting 14 C IgG2a into 3 male Lou/M rats 
whose bile duct had been cannulated. Radioactivity appearing 
in the bile was followed for 48 hours. 
To examine the importance of the liver in the catab-
olism of IgG and to determine whether metabolites of IgG could 
be detected in vivo , the corrunon bile duct, afferent hepatic lymph 
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Figure 6.1. Theoretical representation of the catabolisrn 
of rat IgG2a. 
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duct and the efferent prefemoral lymph duct of sheep were 
cannulated. To maintain the physiological status of the sheep, 
bile was returned to the common bile duct above its junction 
with the pancreatic duct. 
Tissue Distribution of Antibody IgG2a 
To serve as controls for this experiment 5 male 
Wistar rats were injected with normal IgG2a and 3 days later 
injected with 125 I HSA. Five minutes after the latter injection 
they were killed and perfused with 300 ml of cold saline. 
Another group of 6 rats were injected with an in vitro formed 
complex of 125 I HSA and IgG2a aHSA to assess the importance of 
complexes formed in vivo in the 5 minutes following the injection 
of 125 I HSA. Figure 6.2 shows the presence of 125 HSA in the liver 
of rats injected with IgG2aaHSA and those injected with IgG2a. When 
the distribution of IgG2a aHSA determined by injecting 125 I HSA 
was compared to that of 125 I IgG2a it appeared that IgG2a aHSA 
was predominately in the liver and spleen and not in the intestine. 
That this result may be attributed to the removal by the liver 
of immune complexes formed in the circulation and free 
125 I HSA was supported by the group of rats injected with the 
125 I HSA-aHSA IgG2a immune complex. However it is clear that the 
i'ntestine of rats did not accumulate immune complexes. 
Catabolism of IgG In Vivo 
Sheep 
Sheep in which a common bile duct shunt was established 
(Figure 2. 9) , and the afferent hepatic lymph duct and efferent pre femoral 
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Figure 6.2. Tissue distribution of rat IgG2a aHSA 3 days 
after its intravenous injection into normal male Wistar rats. 
The antibody IgG2a was detected in vivo by killing the rats 
5 minutes after the intravenous injection of 125 I HSA. As 
controls for this experiment one group of rats wc.c..S injected 
with IgG2a having no antibody to HSA and another group of 
rats v,)0...S. injected with an in vitro formed complex of 
IgG2a aHSA- 125 I HSA. For . comparison, the tissue distribution 
of 125 I IgG2a 3 days after its intravenous injection is 
included. Prior to the removal of tissues for radioactive 
counting all rats were perfused with 300 ml of saline (4°). 
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lymph duct cannulated, were injected intravenously with 3 mg of 
125 I IgG2. The radioactivity in the plasma,bile, hepatic 
lymph and prefemoral lymph were then followed. Urine and faeces 
were collected to determine the amount and character of radio-
activity in them. The plasma decay of IgG2 for one sheep is 
shown in Figure 6.3. No attempt was made to block the thyroids 
of sheep with KI as the metabolism of free iodine was considered 
to be important. The half-life time, fractional catabolic 
rate and daily loss of 125 I IgG2a through the bile is given in 
Table 6.1. When a bile shunt was used an estimation of bile flow 
for 24 hours was determined by disconnecting the bile shunt for 
5 minutes every day and accurately measuring the amount 
collected. It is possible that this may have led to an over-
estimation of bile flow as the ease of flow in the shunt may not 
parallel a 5 minute collection into a measuring cylinder. The 
flow rate of bile and the amount of radioactivity in it over 
varying periods of time is illustrated in Figure 6.4. One sheep 
from which the bile was continuously drained and not shunted back 
into the bile duct had a flow rate of approximately 28 ml/hour 
(Figure 6.4). This compares with a figure of 37.5 ml/hour 
obtained by Heath (1963). In sheep with a bile shunt the flow 
rate was about 8 times higher. Sheep with a bile shunt are more 
likely to be physiological experimental animals than sheep in 
.which bile is continuously drained away. The radioactivity lost 
via the bile each day in 3 sheep having bile shunts was 2.14 % 
of the total injected dose while the loss via the bile of a sheep 
continually drained was 0.55 % of the total injected dose per day · 
(Table 6.1, Figure 6.4). 
As mentioned in Chapter 3, the problem of radioactive 
iodine reutilisation is significant in sheep. This applies 
TABLE 6.1 
Metabolism of IgG2 in Adult Sheep. 
Values presented for plasma volume and half-life time represent means± s.e. 
Treatment 
*Normal 
t(n = 8) 
Bile Shunt 
(n = 3) 
Bile Drainage 
(n = 1) 
Hepatic Lymph 
Drainage 
(n = 3) 
Bile Shunt 
Free Iodine 
(n = 1) 
Sheep 
No . 
1 
2 
3 
4 
38 
57 
59 
61 
6 
8 
12 
15 
9 
11 
12 
13 
Period of 
isotope 
decav 
- avs 
13 
20 
7 
5-10 
20 for 
plasma 
decay 
7 
* Thyroids blocked with KI. 
t Number of sheep. 
Plasma 
volume 
( 1) 
1.98 + 
0.14 
1.02 + 
0.04 
1.00 
1.05 + 
0.11 
1.20 
T~ 
(Days) 
9.88 + 
0.83 
8.20 + 
1.46 
15.00 
8.25 + 
1.67 
FCR of 
intra vascular 
pool per day 
% 
7.01 
8.45 
4.62 
8.40 
Bile 
Flow 
(ml/hour) 
216 
28 
200 
% Loss of total 
injected dose 
in Bile per day 
2.14 
0.55 
Approximately 
20% 
tt FCR was calculated as described by Sterling (1951) and represents a minimum estimate. 
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Figure 6.3. Plasma decay curve of sheep 125 I IgG2 for 
Sheep 6 fitted with a bile shunt. 
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Figure 6.4. Radioactivy in bile and bile flow of 2 sheep 
fitted with a bile shunt (Sheep 6 and 8) and one sheep from 
which the bile was drained (Sheep 15) following the intra-
venous injection of sheep 125 I IgG2. 
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particularly to the bile shunt experiments reported here as 
free iodine absorbed by the intestine is returned to the circu-
lation via the portal vein, thus involving the liver in the 
reutilisation of free iodine. In an attempt to estimate the 
amount of free iodine in bile , one sheep having a bile shunt 
had free 131 I injected into the bile duct in the direction of 
the intestine . Figure 6 . 5 shows the presence of free iodine 
over 7 days in the plasma , bile and urine of this sheep. It 
can be seen that free iodine is reabsorbed via the intestine 
and at any one time approximately 15% of the radioactivity 
in the bile may be reutilised free iodine. This is best 
illustrated in Figure 6 . 6 which shows the character of radio-
activity in the bile. The sheep in which the bile was drained 
had 15% more precipitable radioactivity with 10% trichloroacetic 
acid (TCA) than the animals with a bile shunt. The sheep in 
which free iodine was injected into the intestine had only 
5% precipitable radioactivity suggesting 5% of reutilised 
iodine is found in bile at any one time associated with 
protein. The division of the non-precipitable iodine into 
organic (iodotyrosine) and inorganic phases (free iodine) was 
similar for the 3 different experimental treatments. 
Bile collected from sheep with bile shunts was 
.fractionated on Sephadex G-200 columns to check the size distri-
bution of the labelled protein. For this, 100 ml of bile was 
collected and concentrated on a Diaflo (Arnicon) using a PMlO 
membrane. A typical G-200 profile is illustrated in Figure 
6 . 7 , the bulk of radioactivity being in the 7s · region (i.e. 
whole labelled IgG molecules or slightly modified) but · th~re 
were also 2 small radioactive peaks. This means that the 60 % of 
precipitable radioactivity in bile from sheep with bile shunts 
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Figure 6.5. Changes in the radioactivity of the plasma, 
bile and urine of a sheep fitted with a bile shunt having 
131 I injected into the bile duct in the direction of the 
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with a bile shunt and injected intravenously with 125 ! 
IgG2 3 days previously and a sheep fitted with a bile shunt 
having 131 I injected into the bile duct in the direction of 
the intestine. 
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was predominantly radioiodinated IgG. The decay curves of 
radioactivity with time in the plasma, afferent hepatic lymph 
and prefemoral lymph arepresented in Figure 6.8. The equilibra-
tion of 1 25 I IgG2 between the plasma and afferent hepatic lymph 
occurred very quickly in contrast to the slower equilibration 
of the prefemoral lymph with the plasma pool. When 125 I IgG2 
and 131 I sheep serum albumin (SSA) were injected into a sheep 
simultaneously and the lymph to plasma ratios of IgG2 and SSA 
compared they were found to be equal in the afferent hepatic 
lymph. However, the lymph to plasma ratio of IgG2 was much lower 
than that of SSA in efferent prefemoral lymph (Table 6.2). The 
flow rates for afferent hepatic lymph and efferent prefemoral 
lymph were 1.8 ml and 2-5 ml per hour respectively. Of the 
TABLE 6.2 
Lymph to Plasma Ratios of IgG2 and SSA in Afferent Hepatic and 
Efferent Prefemoral Lymph in Sheep No. 11. 
Days after Hepatic Lymph Pre femoral Lymph 
Injection IgG2 SSA IgG2 SSA 
1 1.03 1.03 0.07 0.19 
2 1.47 1.51 0.60 0.67 
3 1.14 1.13 0.66 0.90 
6 1.21 1.30 0.63 0.71 
8 1.02 1.05 0.63 0.80 
radioactivi~y in afferent hepatic lymph 99-100 % was found to be 
precipitable with 10% TCA and G-200 Sephadex columns confirmed 
that in afferent hepatic lymph coll~cted 3 days -after the intra-
venous injection of 125 I IgG2 most of the radioactivity resided 
in the 7S peak (Figure 6.9). A very small amount of low 
molecular weight radioactivity was also found. 
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Figure 6.8. Radioactivity in the plasma, afferent hepatic 
and efferent prefemoral lymph of a sheep following the 
intravenous injection of sheep 1 25 I IgG2. 
Z 400 
0 
r-
u 
<{ 
~ 
u_ 
UJ 
u 
z 
<{ 
r-
r-
~ 
(/) 
z 
<{ 
~ 
r-
~ 
200 
0 
60 
80 
100 
0 
>, 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
N ' I I 
I I 
I I 
I \ 
I \ 
I \ 
_,, ~-----------------------~--------· 
--------------
7S 
20 40 60 80 
FRACTION NUMBER 
Figure 6. 9. G-200 Sephadex optical density profile {-) and 
the radioactivity in each fraction (---) of afferent hepatic 
lymph from Sheep 11 3 days after the intravenous injection 
of 1 2 5 I IgG2. 
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Rat 
The amount of radioactivity in the bile of 3 rats 
injected with 14 C IgG2a over a 48 hour period is presented in 
Table 6.3. 
TABLE 6. 3 
Excretion of Radioactivity into Bile after Injection of 
14 C IgG2a in Normal Male Lou/M Rats (%Dose/ml). 
Time 
after Rat 1 Rat 2 Rat 3 Mean injection 
(Hours) 
l 0.05 0.28 0.05 0.13 
2 0.01 0.28 0.05 0.11 
3 0.03 0.06 0.04 0.04 
4 0.05 0.08 0.02 0.05 
6 0.02 0.11 0.02 0.05 
12 0.02 0.10 0.03 0.05 
24 0.07 0.04 0.02 0.04 
48 0.06 0.05 0.02 0.04 
The minimum amount of radioactivity lost via the bile 
per day was 0.58% of the total injected dose. This was estimated 
by multiplying the mean radioactivity in the bile at 24 or 48 
hours by the flow rate of bile (0.04%/ml x 0.6 ml per hour). 
The concentration of IgG2a in the bile by the single radial 
immunodiffusion technique was 0.03 mg/ml, meani~g a daily loss 
of about 0.43 mg of IgG2a in the bile. 
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RETICULOENDOTHELIAL SYSTEM INCLUDING THE SPLEEN 
It is possible that the lymphoid tissue may be respon-
sible for the catabolism of irnrnunoglobulin, as the irnrnunoglobulins 
are the only serum proteins not synthesised by the liver paren-
chymal cells ·. The catabolic site for most of the serum proteins 
is thought to be the liver and an interesting consideration is 
that irnrnunoglobulin once synthesised in lymphoid tissues may 
subsequently be catabolised in these tissues. In Chapter 4 
a consistent finding was the association between radioiodinated 
IgG and the liver, spleen and lymph nodes. With these observa-
tions in mind an attempt was made to modify the degree of lymphoid 
development by neonatally thymectomising and splenectomising 
rats. The turnover of IgG2a and RSA was measured by following 
the plasma disappearance of radioiodinated IgG2a and RSA for 
periods of at least 9 days. The plasma decay of IgG2a possessing 
antibody to Ovalbumin was studied in 3 groups of HO rats to 
confirm the results obtained using radioiodinated IgG2a. 
Surprisingly, there was no difference in the half-life 
times of 125 I IgG2a, 131 RSA or IgG2a aOVA in thymectomised, 
splenectomised or control rats. On the final day of 
sampling the rats were killed and perfused with 300 ml of cold 
.~aline. The weight, sex and age of the rats together with half-
life times of IgG2a and RSA in the 3 groups are given in Table 6.4. 
Very little difference was observed in the organ weights of the 
3 groups of animals, however large differences were seen when the-
tissue distribution of 1 2 5 I IgG2a WpS studied (Figure 6.10). 
Thymectomised rats had significantly more 1 25 I IgG2a in the liver 
and spleen compared to the control rats, whereas splenectomised 
rats had an increased amount of 125 I IgG2a in the lymph nodes and 
Normal 
Neonatally 
Thyrnectomised 
Neonatally 
Splenectomised 
TABLE 6. 4 
Metabolism of IgG2a and RSA in normal, neonatally thyrnectomised and 
neonatally splenectomised rats. 
Values presented are Means± s.e. 
Strain Sex Lyrnpho- RBC T~ T~ Body WBC and No. and Weight Count cyte Count (IgG2a) (RSA) 
of Age (xl0- 7 /ml) Count -9; l) (Days) (Days) ( gm) (xlo- 7 /ml) (xlO m Animals (Days) 
Wistar Male 247±6 1.35±0.23 1.07±0.22 7.61±0.38 4.81±0.40 2.26±0.07 (n=ll) 80 
Wistar Female 180±6 - - - 4.51±0.26 1.96±0.06 (n=3) 140 
Female * HO 180±2 0.82±0.02 0.63±0.04 7.14±0.21 7.50±0.82 -(n=4) 130 
Wistar Male 7.31±0.32 4.58±0.23 2.06±0.03 212±12 1.28±0.18 0.94±0.25 (n=6) 80 
Wistar Female · 168±10 4.38±0.26 2.31±0.06 (n=3) 140 
Female 6.96±0.14 7.20±1.24* HO 170±10 0.70±0.05 0.50±0.04 -(n . 3) 130 
Wistar Male 4.79±0.16 1.95±0.07 226±13 - - -(n=3) 80 
HO Female 168±3 1.14±0.10 0.86±0.10 6.90±0.28 6.90±0.95* -(n=3) 130 
=cgG and IgG2a 
concentration 
in plasma 
(mg/ml) 
10.62±0.92 
5.40±0.45 
12.77±0.47 
6.46±0.43 
10.07±1.25 
5.56±0.52 
12.74±1.18 
6.26±0.68 
4.45±0.59 
3.14±0.58 
11.70±0.72 
6.86±0.42 
* Results obtained with IoG2aa OVA. 
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Figure 6.10. Tissue distribution of rat 1 25 r IgG2a 10 days 
after its intravenous injection into control, neonatally 
thymectomised and neonatally splenectomised male Wistar rats. 
Prior to the removal of the tissues the rats were perfused 
with 300 ml of saline (4 ° ). 
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liver when compared to the control rats. 
It is important when comparing the half-life times 
of IgG between different groups of experimental rats that the 
serum concentration of IgG is considered, as evidence has been 
presented showing that the serum concentration of IgG affects 
its turnover time (Brambell , 1966). The possibility existed 
that the serum immunoglobulin levels of thymectomised and 
splenectomised rats may have changed in comparison to the 
control rats . The concentrations of total IgG and IgG2a in the 
3 groups of animals were measured by the single radial immuno-
diffusion technique . The results for this are presented . in 
Table 6.4 . There was no significant difference in either total 
IgG or IgG2a concentration between thymectomised, splenectomised 
and control rats. 
DISCUSSION 
The liver is one of the most important sites of amino 
acid metabolism (Elwyn, 1970). It is the site of synthesis of 
all plasma proteins other than the immunoglobulins, of the non-
essential amino acids derived from keto-acids and of certain 
special products which are used in the liver or elsewhere, e.g . 
. glutathione, glutamine , taurine, carnosine and creatine. In 
catabolism , the liver is the chief site of deamination of amino 
acids to ammonia and keto-acids to carbohydrate or fatty acid 
precursors with eventual oxidation of the non-nitrogenous 
products for energy . 
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The liver also has a significant regulatory influence 
on the nitrogen economy of the organism as it is the first organ 
to process the incoming constituents of the portal blood, 
enabling it to act as a metabolic buffer. The liver is the 
largest organ in the reticu~oendothelial system and is capable 
of sequestering large amounts of foreign and endogenous protein. 
The concentration of lysosomal enzymes in the Kupffer cells is 
very high , with significant quantities of enzyme activity also 
being found in the parenchymal cells (Berg and Munthe-Kaas, 
1976). 
When the catabolism of endogenous proteins is considered 
the comparative amount of Kupffer and parenchymal cells in the 
liver is i~portant. It is likely that the catabolism of irnrnuno-
globulin occurs in both the parenchymal and Kupffer cells. The 
gross anatomy and the structural features of the liver are shown 
in Figure 6.11. Blood enters the liver from the portal vein and 
hepatic artery and then travels along the sinusoids to eventually 
leave via the central vein . While travelling through the 
sinusoids the blood components are exposed to the parenchymal 
cells . It is at this time that the liver parenchymal cells may 
remove components from the blood and catabolis e them. It is 
possible that any metabolites formed are then e xcreted into the 
.nile, and that some metabolites may find their way back into the 
systemic circulation via the hepatic vein. The s e me tabolite s 
would then be filtered out by the kidney. 
The importance of the liv.er in the catabolism o f 
protein has been suggested (Cohen et al., 1962; Sniderman 
et al., 1973) and the data o f Chapt e r 4, e s pec i a lly tha t o f 
BRANCH 
HEPATIC 
BILE DUCTULE 
VEIN 
DISSE 
Figure 6.11. Diagrammatic representation of the circulation 
of blood thro~gh a lobule of the liver. The sinusoids 
receive blood from both the hepatic and portal vein. The 
blood then enters the central vein which joins the vena 
cava inferior. Modified from Gray's Anatomy (1949). 
ENDOTHELIAL 
CE.LL 
Schema~ic diagram to show the anatomic pathway of bile 
secretion and the possible route to the hepatic lymph. The 
wide pores formed by the interendothelial spaces are 
illustrated. Bile is thought to be formed by the transfer 
of materials from the space of Disse to the hepatic cell 
cytoplasm (arrow 1) with the secretion of bile from the 
hepatic cell into the bile canaliculi (arrow 2). Some 
transfer of relatively small molecular weight materials 
(arrow 3) is thought to occur from the space of Disse 
through the narrow intercellular channel into thecanaliculus 
(from Ashworth and Sanders , 1960) . 
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the tissue distribution of 1 2 5 1 IgG2a in normal rats suggests 
that the liver is involved in the catabolism of immunoglobulin. 
This is further supported by the distribution of IgG2a a HSA 
in the liver of rats , although this experiment was complicated 
by the formation of immune complexes in the circulation which 
accumulated in the liver. It is likely that any protein 
entering the liver may be trapped and catabolised. The numerous 
fine villi which project into the space of Disse (Figure 6.11) 
and the formation of many small vesicles in the peripheral 
portion of the cytoplasm of hepatocytes suggests a high degree 
of membrane activity in these cells (Ashworth and Sanders, 
196 0). 
If the liver does catabolise labelled immunoglobulin, 
intermediates and metabolites of IgG may be found in the hepatic 
lymph (Figure 6.11). The other secretion in which metabolites 
or intermediate products may be found is in the bile, as it also 
represents a secretion of the liver. From the results presen-
ted about 2.1% of the total injected dose of radioactivity was 
excreted in the bile each day in sheep having bile shunts. 
The loss of radioactivity in the bile from one sheep in which 
bile was not returned to the animal was 0.55% of the total 
injected dose each day. This represents only 26% of the value 
for sheep having bile shunts. The character of the radioactivity 
in the bile from sheep with a bile shunt revealed that most of 
the radioactivity in the bile was on molecules in the 7S reg i on 
of a G-200 fractionation, suggesting that the liver excretes 
into the bile whole IgG2 molecules. Ther e were 2 o t her small 
radioactive peaks in the bile of these sheep a nd 40 % of the , · 
radioa ctivity was not precipita ble with 10 % TCA suggesting that 
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at least 40 % of the radioactivity in bile repre sents metabolites 
of 125 I IgG2a. 
The use of radioactive iodine in the bile studies 
complicated th) interpretation of the results as it was 
shown that in one sheep in which free radioactive iodine was 
injected into the intestine at least 5% of the free iodine was 
reutilised, and reappeared associated with plasma proteins. 
However when the data is critically viewed it would seem 
reasonable to conclude that no more than 15% or the radioactivity 
in bile represented reutilised iodine and that the remainder of 
the radioactivity in the bile represented that which has been 
turned over by the liver. 
After allowing for equilibration in the 3 sheep having 
bile shunts the mean absolute catabolic rate per day of 125 1 
IgG2 on day 20 was 1.51%. This value, when compared to the 
estimation of the total loss of radioactivity per day via the 
bile of 2.1%, implies that all the catabolism of 1 25 I IgG2 
per day can be explained by the radioactivity in bile. However, 
as previously mentioned, this figure is an overestimate as the 
bile flow in the sheep with shunts is most likely too high and 
the amount of radioactivity in the bile includes a significant 
amount of free radioactive iodine that has been reutilised. 
The· absolute catabolic rate per day in the sheep from which 
bile was drained was 2.77% on day 7 and the loss p e r day via 
the bile was 0.55%. Hence, 20 % of the turnover of IgG2 in 
this sheep could be accounted for by the loss via the bile. 
This estimate is uncomplicated by the reutilisation of fre e 
. . 
io9ine or an inaccurate bile flow. It should be mentiQned 
though that the sheep from which bile was drained canno t b e 
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considered physiological in the way sheep with bile shunts were. 
The failure to find the presence of any intermediate 
products or metabolites in the afferent hepatic lymph suggests 
that the degradation of 125 I IgG2 is extremely rapid, and that 
the IgG2 molecules are broken down completely. Free radioactive 
iodine in the liver is excreted preferentially into the bile. 
As the lymph to plasma ratios of IgG2 and SSA in the afferent 
hepatic lymph were similar, it would appear that a concentrating 
mechanism for IgG2 did not exist in the liver. However, 
significant quantities of IgG2 are removed by the liver so it is 
possible that the concentration of IgG2 on the hepatocytes may 
be considerably higher than that in the afferent hepatic lymph. 
That the hepatic sinusoids were freely permeable to large 
protein molecules was clearly shown by the lymph to plasma ratios 
of IgG2 and SSA in the afferent hepatic lymph compared to that 
of the efferent prefemoral lymph (Table 6.2). This has been 
shown previously by various workers (Morris, 1956a,b; Friedman, 
Byers and Omoto, 1956; Courtice, 1960) and was initially 
suggested by Starling (1894, 1909) who showed that lymph from the 
hepatic duct was rich in protein. 
In rats, when the loss of 14 C IgG2a in the bile is 
.considered, an estimate of the absolute catabolic rate per day 
of 7.79 % of the total injected dose per day can be estimated 
by assuming a half-life time of 8 days for IgG2a in male Lou/M 
rats (Chapter 3). As the amount of radioactivity in the bile 
per day was 0.58 % this implies that 7.45 % of the total catabolism 
per day can be explained via this route. This low estimate 
compared to that obtained for sheep can be explained 
in that the radioactivity in the bile of rats probably represents 
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only whole molecules of 14 C IgG2a. In contrast to radioactive 
iodine, intermediate products or metabolites of 14 C IgG2a are 
most likely undetectable, as when 14 C IgG2a is catabolised a 
significant amount of the 14 C isotope is lost as co 2 and would 
not be present in the bile. The use of 14 C IgG2a probably 
underestimates the catabolism of IgG2a by the rat liver when 
only the bile loss is considered. 
The metabolism of IgG labelled with radioactive iodine 
or antibody in neonatally thymectomised or splenectomised rats 
was similar to that in normal rats, the h0lf-life times of the 
labelled IgG2a being identical in the 3 groups of animals 
irrespective of their label. The tissue distribution of 
1 25 I IgG2a in the tissues of the 3 groups of rats showed consider-
able differences, and it may be that neonatal thymectomy and 
splenectomy may lead to compensatory functions by other lymphoid 
tissues. This would help explain the normal metabolism of IgG2a 
in these 2 groups of rats. 
One other possible catabolic site that has not been 
considered is the intestine. In a preliminary experiment the 
transfer of IgG2a into the intestine was studied by isolating 
an intestinal segment in situ and then cannulating this portion. 
A. constant flow of 2.0 ml/hour of isotonic saline was maintained 
through the intestinal segment for several hours. The amount 
of IgG2a secreted into the lumen was then measured by the single 
radial immunodiffusion technique. Variable results were obtained· 
as the amount of blood contamin~tion varied in the intestinal 
washings for different rats. The results suggest that·approxi-
mately 20 % of the catabolism of IgG2a may occur by loss of 
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IgG2a into the intestine. This result agrees with that of 
Andersen et al. (1963) who showed that about 20-30 % of the 
catabolism of IgG in the dog could be explained by the loss of 
IgG into the gut lumen . 
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CHAPTER 7 
CATABOLIC PROCESS 
The mechanism of irnrnunoglobulin degradation at the 
catabolic site(s) in vivo is not understood. Irnrnunoglobulin 
catabolism has been demonstrated in vitro (Fehr, LoSpalluto and 
Ziff , 1969; LoSpalluto et al., 1969) by enzymatic digestion of 
irnrnunoglobulin with intracellular proteases. Human IgG 
incubated with a neutral protease from human spleen yields 2 
major fragments with molecular weights of 50,000 and 
approximately 10,000. When an acid protease from the same 
source was used human IgG yielded 4 fragments, the 2 
maJor components having molecular weights of 150,000 and 100,000. 
Matas and Ghetie (1969) and Ghetie and Sulica (1970) reported 
that guinea pig peritoneal polymorphonuclear leucocytes had the 
ability to take up and degrade rabbit IgG and that a subcellular 
fraction isolated from rat and rabbit spleens had the ability to 
split rabbit IgG into fragments. It was also found (Ghetie and 
Matas , 1971) that a cathepsin-rich subcellular fraction isolated 
from rat liver had the ability to digest rabbit IgG. 
The initial step in irnrnunoglobulin catabolism is 
.probably binding to cell surfaces and as it is not known which 
cell type is responsible for catabolism)cell binding may 
indicate the site(s) of catabolism. Cytophilia or the binding 
of irnmunoglobulin to cells was first reported by Boyden and 
Sorkin (1960) but the biological significance of· this has not 
been considered. Some evidence does support a functional role 
for cytophilia. Two classes of irnrnunoglobulin (IgG and IgE) 
have cytophilic activity for autologous macrophages and 
occasionally for heterologous macrophages (Leslie and Cohen, 
1974) . 
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It has been suggested that the biological usefulness 
of cytophilic antibody resides in its capacity to opsonise 
soluble or particulate antigens to allow their phagocytosis 
(Berken and Benacerraf, 1966). Theoretically membrane bound 
antibody would be an effective device for concentrating antigens 
at the site of phagocytosis . Besides this several subclasses of 
IgG fix complement which would enhance phagocytic activity. 
The classical experiments on anaphylaxis by Dale (1913) 
and Weil (1914) were interpreted as evidence that anaphylactic 
antibodies were able to fix to certain cell types. This hypothesis 
has now been confirmed for IgE, however the original ideas of 
fixation were derived from experiments in guinea pigs with 
anaphylactic antibodies of the IgG class. It is now known that 
IgE binds to eosinophilic cells, mast cells and also lympho-
blastoid cells (Gonzalez-Molina and Spiegelberg, 1976) which 
leads to the release of chemical substances contributing to the 
inflammatory process. It is interesting to note that Ishizaka 
and Ishizaka (1971) showed that once homocytotrophic antibodies 
combined with receptors on the cell surface, they were protected 
from degradation. 
Other possible biological processes in which cytophilic 
antibody may be important are their cytotoxic activity after 
binding to target cells, their catabolism following attachment 
to the cells responsible for degradation, and in the inter-
relationship between irnrnunoglobulin and irnrnunoglobulin producing 
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cells where regulation may be related to cytophilia. Cytophilic 
phenomena are considered to be a property of the Fe region of 
immunoglobulin molecules (Berken and Benacerraf, 1966; Inchley, 
Grey and Uhr , 1970 ; Liew , 1971). Recently much attention has 
focussed on the "Fe receptor" present on lymphoid cell surfaces . 
• 
"Fe receptors " are defined as a binding site for antigen-
antibody complexes and it has been demonstrated that whole IgG 
molecules as well as Fe fragments can inhibit the binding of 
antigen-antibody complexes to lymphocytes (Basten et al., 1972; 
Modabber and Coons , 1972 ; Parish and Hayward, 1974; Basten, 
Miller , Abraham , Gamble and Chia, 1976; Chiao and Good, 1976). 
As previously mentioned in Chapter 1 the difficulty 
encountered in detecting intermediate products following the 
breakdown of immunoglobulin molecules has rendered research into 
immunoglobulin catabolism extremely difficult. Porter (1958) and 
Edelman et al . (1969) showed that enzymatic digestion of immuno-
globulin molecules was possible in vitro and that two maJor 
fragments were obtained following digestion with papain, i.e. 
Fe and Fab. The preparation of these fragments has greatly 
assisted in the understanding of immunoglobulin structure. 
not always possible to directly extrapolate from an in vitro 
. It lS 
situation to an in vivo one and when one looks for immunoglobulin 
,fragments such as Fe and Fabin vivo no comparable fragments can 
be found . Two groups of workers have succeeded in digesting 
immunoglobulin molecules in vitro with enzymes prepared from the 
animals ' own tissues (Fehr et al., 1969; LoSpalluto et al., 
1969; Motas and Ghetie, 1969; Ghetie and Sulica, 1970; 
, · 
Ghetie and Motas, 1971) but they failed to show the fo~mation of 
similar fragments using the enzymes papain and pepsin in vitro. 
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From results presented in earlier Chapters it would 
appear that the liver may be a site of catabolism, in particular 
the liver parenchymal cells , but as shown in Chapter 6 it was 
not possible to demonstrate "intermediate products" in afferent 
hepatic lymph which is in close proximity to the catabolic 
cells . 
For a complete understanding of the catabolic process 
it is important to assess the end products of catabolism as well 
as any intermediate ones. In the case of radioiodinated 
proteins this is relatively simple although complicated by 
reutilisation . However , this has already been dealt with in 
Chapter 3 where it was concluded that reutilisation of iodine 
isotopes is not a problem in rats. 
The end products of radioiodinated proteins are 
probably radioactive iodotyrosine or free radioactive iodine 
(McFarlane , 1964; Nakai, Otto, Kennedy and Whayne, 1976) both 
of these being excreted via the kidneys or intestine into urine 
and faeces respectively. 
In sheep free 131 I injected via the bile duct into the 
intestine was subsequently found in the urine, suggesting that 
it ·had been reabsorbed from the intestine to be excreted via the 
kidneys. For this reason the percentage of radioactivity in the 
faeces or urine does not truly represent the site of catabolism 
of the radioiodinated protein. 
In the case of 14 C labelled IgG2a the end prqducts of 
catabolism will be 14 co2 , 
14 C urea and several fragments of 14 C 
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labelled IgG2a. These metabolites do not appear to be reutilised 
and are not a problem in interpreting results (McFarlane, 1964). 
This allows an entirely different approach for studying IgG2a 
catabolism . 
Experimental Protocol 
The process of immunoglobulin catabolism has been 
studied in rats using 125 I IgG2a and 14 C IgG2a. Six male Wistar 
and 3 male Lou/M rats were injected with 125 I IgG2a and 14 C 
IgG2a respectively. After 3 days the rats were killed and 
perfused with 300 ml of saline (4°). After measuring the 
tissue distribution of radioactivity in the various tissues, 
cell suspensions were made from the livers, spleens and lymph 
nodes at 4°. The subcellular distribution of 125 I and 14 C 
was then determined. The tissue and subcellular distribution of 
14 C IgG2a was also studied in 3 male rats bearing an IgG2a 
immunocytoma . 
To substantiate the cellular and subcellular distri-
bution of IgG2a in vivo, 125 I IgG2a and 14 C IgG2a were incubated 
in vitro , with cell suspensions of the liver, spleen and lymph 
0 
nodes for 1 hour at 4 . The cell suspensions were then washed 
.4-6 times in Eagle's medium (4°). A further incubation of 2 hours 
at 37° was then done and the radioactivity determined in the cell 
pellet and supernatant (medium) after centrifugation. The cell 
suspensions were then homogenised at 4° and their subcellular 
fractions prepared by centrifugation (Chapter 2) ·. 
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The influence of the rate of catabolism on the cata-
bolic process was assessed by studying the turnover of 125 I IgG2a 
in 6 SPF and 6 Conventional male Wistar rats. Finally, in an 
attempt to explain the lack of immunoglobulin turnover in foetal 
sheep and to determine the importance of lysosomal enzymes in 
the catabolic process, the lysosomal enzyme activity was 
measured in foetal and adult sheep tissues and plasma. 
RESULTS 
Subcellular Distribution of 125 I IgG2a 
0 Cell suspensions were prepared at 4 in Eagle's 
medium from the livers and spleens of rats which had been injected 
with 125 I IgG2a three days previously. After washing the cell 
suspensions 6 times in Eagle's medium at 4°, significant 
quantities of radioactivity remained in the cells suggesting an 
association of 125 I IgG2a with the plasma membrane and/or 
other intracellular components. It was interesting that after 
separating the cell suspensions into phagocytic and non-
phagocytic cell types using the technique described by Rous and 
Beard (1934), 78.0% of the radioactivity in the liver cell 
suspension and 83.4% of that in the spleen suspension was found 
.associated with the non-phagocytic cells. 
The cell suspensions were divided into their various 
subcellular fractions (Chapter 2) to determine the distribution 
of radioactivity. Most of the radioactivity was· found in the 
cell membranes and cytoplasm (Figure 7.1). To examine . the 
distribution of cytoplasmic radioactivity in the liver cells, a 
G-200 Sephadex column separation was used. It can be seen in 
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Figure 7.1. Subcellular distribution of 125 I in cell 
suspensions prepared from the spleens and livers of male 
Wistar rats 3 days after the intravenous injection of 125 I 
IgG2a. The rats were perfused with 300 ml of saline (4°) 
prior to the removal of the organs and the cell suspensions 
washed 6 times (4°) before being homogenised in 0.25M 
sucrose. 
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Figure 7.2 that radioactivity resided in the 19S, 7S, 4S and a 
small molecular weight fraction. Figure 7.3 illustrates a 
G-200 Sephadcx fractionation of the spleen cell suspension of the 
100 , 000 X G X 60 mins supernatant suggesting the existence of 
intermediates and end products of 125 I IgG2a catabolism. 
The results obtained using 14 C IgG2a in vivo were the 
same as those shown for 125 I IgG2a in Figure 7.1. However, 
14 C IgG2a tended to reside more in the cell membrane, nuclear, 
mitochondrial and microsomal pellets than in the supernatant of 
the various fractions . The subcellular distribution of radio-
activity in the liver cells is shown in Figure 7.4. 
Binding and Subcellular Distribution of IgG2a In Vitro 
To confirm that immunoglobulin catabolism occurred in 
the liver , spleen and lymph nodes, 125 I IgG2a and 14 C IgG2a were 
incubated in vitro with cell suspensions of spleens or lymph 
nodes. When 125 I IgG2a was mixed for 1 hour at 4° with 2 x 10
8 
spleen or mesenteric lymph node cells from a normal male Wistar 
rat , 1-2% of the radioactivity remained associated with the cell 
suspension even after 4 to 6 extensive washings at 4°. The 
distribution of radioactive iodine in the spleen and lymph node 
0 
.cell suspensions after incubation at 37 for 2 hours is shown 
in Figure 7.5. Between 43-56 % of the radioactivity remained 
associated with the cell suspension, the remainder being found 
in the incubation medium. 
When cell homogenates were prepared from the. spleen 
and mesenteric lymph node cell suspensions, after the 2 hour 
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Figure 7.2. G-200 Sephadex optical density profile (~) and 
the radioactivity in each fraction (---) of the supernatant 
of the microsomal fraction of a cell suspension of a liver 
3 days after the intravenous injection of 125 I IgG2a into a 
male Wistar rat. 
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Figure 7.3. G-200 Sephadex optical density profile (-) and 
the radioactivity in each fraction (---) of the supernatant 
of the microsomal fraction of a cell suspension of a spleen 
3 days after the intravenous injection of 125 I IgG2a into a 
male Wistar rat. 
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Figure 7.4. Subcellular distribution of 14 C in a cell 
suspension prepared from the liver of a male Lou/M rat 
3 days after the intravenous injection of 14 C IgG2a. The 
rat was perfused with 300 ml of saline (4°) prior to the 
removal of the liver and the cell suspension washed 4 times 
(4 ° ) before being homogenised in 0.25M sucrose. 
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0 incubation at 37 , between 22.7 - 35.8 % of the intracellular 
radioactivity remained in the 100,000 X G X 60 mins supernatant 
(Figure 7.5), indicating that most of the radioactivity was in 
the cytoplasm of these cells. Iri order to identify the nature 
of the 125 I in the supernatant, a G-200 Sephadex column was 
run on the 100,000 X G X 60 mins supernatant of the mesenteric 
lymph node homogenate . The 125 I was found in a number of 
regions ranging from 19S to an extremely low molecular weight 
fraction (Figure 7 . 6) . This suggests that the original 125 I 
IgG2a molecules had been catabolised, and that the 125 I was 
incorporated into a number of compounds of varying molecular 
weights. 
In a similar experiment 14 C IgG2a was incubated at 
0 4 for 1 hour with spleen and liver cell suspensions. After 4 
washings at 4° with Eagle's medium, the spleen cell suspension 
contained 1 . 81% of the original radioactivity, while the liver 
cell suspension contained 0.68% of the initial radioactivity. 
This was similar to the results obtained using radioiodinated 
IgG2a. However, after incubating the cell suspensions at 37° 
for 2 hours all of the radioactivity was found in the supernatant, 
suggesting that the 14 C IgG2a which had been attached to the 
cell membrane at 4° was cast off into the incubation medium or 
.that the 14 C IgG2a may have been taken up by the cells and the 
radioactivity in the incubation medium represented mdetabolites. 
To answer this, the radioactivity in the medium was analysed by 
precipitation with 10% TCA. All of the radioactivity was found 
to be non-precipitable meaning that . the 14 C IgG2a had been 
catabolised (Table 7 . 1). 
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Figure 7.5. Subcellular distribution of 125 I in cell 
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Figure 7.6. G-200 Sephadex optical density profile (~) 
and the radioactivity in each fraction (---) of the super-
natant of the microsomal fraction of a cell suspension of 
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TABLE 7.1 
Metabolism of 14 C IgG2a in Spleen and Liver Cell Suspensions 
Cell suspension 
1 Hour, 4° with 14 C IgG2a 
4 times washing, Eagle's medium 
0 2 Hours, 37 
Supernatant 
100% 
TCA 
precipitated 
0% 
TCA 
non 
precipitated 
100% 
Cells 
0% 
Catabolism of 14 C IgG2a in Normal and IgG2a 
Immunocytoma Bearing Rats 
In Chapter 4 it was reported that in IgG2a immuno-
cytoma bearing rats, IgG2a appeared to be turned over more 
· quickly than in normal rats, suggesting that IgG2a immunocytoma 
cells may have the ability to bind and catabolise IgG2a. To 
study this, normal and IgG2a tumour bearing rats were injected 
with 14 C IgG2a and killed 3 days later. After perfusion of 
the rats with 300 mls of saline· (4 ° ) cell suspensions of the 
livers, spleens, lymph nodes and tumours were prepared. The cell 
suspensions were washed 4 times with Eagle's medium at 4° and 
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the radioactivity remaining in the cell suspensions determined 
using a Tri-Carb Sample Oxidiser. As shown in Table 7.2 a 
significant amount of radioactivity was associated with the 
tumour cell suspension. No differences were observed in the 
spleen , liver and lymph node cell suspensions of the normal and 
tumour bearing rats. 
TABLE 7 . 2 
Distribution of 14 C IgG2a in Normal and Tumour Bearing Rats, 
8 
72 Hours after Injection (Total Recovery per 10 cells as a 
Percentage of the Original Dose). 
Values presented are means± s.e. 
Organ Normal Rat Tumour Bearing Rat 
Spleen 0.02 + 0.00 0.02 + 0.00 
Liver 0.21 + 0.00 0.26 + 0.00 
Lymph nodes 0.07 + 0.00 0.05 + 0.00 
Tumour 0.37 + 0.00 
The subcellular distribution of radioactivity in the liver and 
spleen of the normal and tumour bearing rats was the same. Most 
'of the radioactivity in the subcellular components of the cell 
suspensions was associated with the cell pellets and not the 
supernatant . This was also observed in the subcellular distri-
bution of radioactivity in the tumour cell suspension. 
Catabolism of IgG2a in SPF and Conventional Male 
Wistar Rats 
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The turnover time and tissue distribution of 125 I 
IgG2a was studied in 6 SPF and 6 conventional male Wistar rats. 
The half-life time of 125 I IgG2a in the SPF rats was 9.25 days 
while that of the c..onventional rats was 5.90 days. The serum 
concentrations of IgG and IgG2a in the SPF rats were extremely 
low being 2.44 mg/ml and 0.18 mg/ml respectively. This suggests 
a relationship between the serum concentration of IgG2a and its 
catabolic rate. However, as pointed out previously, the degree 
of lymphoid maturation and the intestinal flora of SPF animals 
are very different from that of conventional rats. When the 
tissue distribution of 125 I IgG2a was determined, 2-3 times more 
radioactivity was found in the intestine and lymphoid tissues 
of SPF rats compared to the conventional rats. 
Lysosomal Enzyme Activity in Adult and Foetal Sheep 
The activity of the 3 lysosomal enzymes studied in 
foetal plasma and tissues was appreciable although not as high 
as that in adult plasma and tissues (Table 7.3). This was 
surprising as the tissues were taken from foetuses at 100-120 
days of gestation. 
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TABLE 7.3 
Lysosomal Enzyme Activities in Adult and Foetal Sheep Tissues and 
Plasma (µg chromogen released/hour/mg wet weight or µl of plasma) 
Values presented are means ± s.e. 
Adult 
(n = 3) 
Foetus* 
(n = 6) 
Liver 
Spleen 
Plasma 
Liver 
Spleen 
Plasma 
Acid 
phosphatase 
54.05±7.36 
71.54±6.20 
51.07±9.83 
50.16±3.89 
60.44±3.13 
25.30±6.44 
n = number of animals 
* Gestational age: 100-120 days 
s-
glucuronidase 
4.20±0.33 
1.40±0.53 
4.38±0.49 
1.42±0.36 
0.93±0.22 
3.32±0.69 
DISCUSSION 
N-acetyl-S 
glucosaminidase 
14.50±2.30 
11.30±1.80 
29.05±3.80 
12.99±0.76 
7.39±0.43 
19.93±1.71 
Evidence has been presented showing a close relation-
ship between the binding and catabolism of IgG2a and the liver, 
spleen and lymph nodes of rats. The presence of intermediate 
products and metabolites of IgG2a W()J; found within cells of the 
liver, spleen and lymph nodes. The ability of IgG2a to bind to 
these cells has been conclusively shown by the use of 125 I 
IgG2a and 14 C IgG2a in both in vivo and in vitro experiments. 
The problem of studying IgG2a catabolism in vivo was 
overcome partially by the removal of the organs, thought to 
be the sites of catabolism, into an in vitro environment. Prior 
to the removal of organs, rats were always perfused with 300 mls 
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of saline at 4° to remove most of the intravascular radioactivity. 
The cell suspensions were prepared at 4° and washed (4°) at least 
4 times in Eagle ' s medium. The only problem encountered in this 
system was the reduction in the cell number and cell viability 
at each washing . This applied particularly to the hepatocytes 
which were extremely fragile, and after 6 washings there was 
always a significant reduction in cell number. However, a 
significant amount of radioactivity remained associated with 
these cells . 
That the IgG2a was associated with non-phagocytic cell 
types was suggested by the division of the spleen and liver cell 
suspensions into phagocytic and non-phagocytic cells which 
showed that at least 8 0% of the radioactivity was associated with 
the non-phagocytic cell types. 
After subcellular fractionation the various tissues 
showed significant amounts of 125 I IgG2a in the cell debris, 
suggesting the association of IgG2a with a cell membrane 
receptor . Further ·evidence for this comes from the G-200 
Sephadex fractionations of the 100,000 X G X 60 mins supernatant 
which showed the existence of a radioactivity peak in the lOS 
region of both liver and spleen cell suspensions. This may 
~·epresent IgG2a combined with a receptor molecule. The radio-
activity found in the 4S and lower molecular weight regions 
probably represents radioiodide compounds which will be excreted 
from the cells and could be appropriately termed metabolites. 
When 14 C IgG2a was used in vivo significant quahtities 
of radioactivity were associated with cell suspensions of both 
the spleen and liver. This that the binding 
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of 125 I IgG2a to these cells in vivo ,s not attributable to the 
125 I atoms attached to the IgG2a molecules but ~ due to the 
existence of a receptor site on the IgG2a molecules. It is 
unlikely that the presence of 14 C atoms within an IgG2a molecule 
could lead to erroneous results. It was interesting that when 
14 C IgG2a was used most of the radioactivity was associated with 
the cell debris and nuclear fraction in the spleen cell suspension. 
This prevented the further division of the cell suspension into 
its subcellular components. Similarly with the liver cell 
suspensions, 72% of the radioactivity was found associated with 
the cell debris and nuclear fraction suggesting the binding of 
14 C IgG2a to cell membranes. When this cell suspension was 
divided into its subcellular components most of the radioactivity 
was found to reside with the pellet rather than in the super-
natant. This difference between the results using 125 I IgG2a 
and 14 C IgG2a may be explained in respect to the two isotopes 
In the case of 125 I IgG2a the end products of 
catabolism must be iodide compounds or iodide on a cell protein 
which would reside within the intracellular fluid. However, 
in the case of 14 C IgG2a, the end products are 14 co 2 and 
14 C urea 
which would be excreted into the extracellular fluid (in these 
/ 
experiments the medium) or be reutilised by the cells (Appendix 7.1) 
When 125 I IgG2a was used in vitro about 1-2% was bound 
to cell suspensions of the spleen and mesenteric lymph nodes after 
incubating at 4° for 1 hour. After incubation at 37° for 2 hours 
43% of the radioactivity in the spleen and 56 % in the mesenteric 
lymph node cells was found in the incubation medium suggesting 
that 125 I IgG2a had moved into the medium or that metaboiites 
of 125 I IgG2a were produced during the 2 hour incubation. To 
clarify this, the incubation media were precipitated with 
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10% TCA and about 80% of the radioactivity was found to be 
precipitable. This suggested that whole molecules of 125 I 
IgG2a or iodine containing proteins were present in high concen-
trations in the medium . Nevertheless, about 7% of the spleen 
and 12 % of the mesenteric lymph node radioactivity 
originally bound to the cells was non-precipitable suggesting 
that catabolism had occurred in the 2 hour incubation at 37°. 
Further evidence was gained when the 100,000 X G X 60 mins 
supernatant of mesenteric lymph node cells was fractionated on 
G-200 Sephadex and radioactive peaks of less than 7S were found. 
The use of 14 C IgG2a in vitro gave more conclusive 
results . Significant binding of 14 C IgG2a after incubation for 
0 1 hour at 4 , was found for both liver and spleen cell suspensions. 
However, after incubation at 37° for 2 hours most of the radio-
activity associated with the cells disappeared and was found in 
the incubation medium . All the radioactivity in the medium was 
non-precipitable with 10% TCA, suggesting the complete breakdown 
of all the 14 C IgG2a associated with the cell susoension. The 
difference between 125 I IgG2a and 14 C IgG2a in respect to the 
amount of radioactivity precipitable with 10% TCA can be 
explained in 2 ways . Firstly, the amount of 125 I IgG2a added to 
the cell suspensions was much greater than the amount of 14 C 
~gG2a and the complete catabolism of 14 C IgG2a may be due to 
the much smaller amount added to the cell suspension. Secondly, 
TCA precipitable 125 I may not represent IgG2a molecules but may 
be fragments of IgG2a or even other intracellular proteins. 
The possible cell types of the lymphoid tissue that 
bind IgG2a could be phagocytic cells or lymphocytes . The binding 
of IgG2a to these cells may be via the Fe portion of the 
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immunoglobulin molecule and it is possible that complement may 
accelerate this. That the binding of IgG2a was due to aggregates 
of IgG2a in the original injection material can be ruled out, 
as the IgG2a preparations were taken for the 7S peak of G-200 frac-
tionations and in the in vivo experimental tissues were not 
collected until 3 days after the injection of the 7S IgG2a. 
By studying the turnover of 14 C IgG2a in tumour bearing 
and normal Lou/M rats a strong association between 14 C IgG2a and 
the tumour producing IgG2a was shown. This suggests that 
14 C IgG2a is most lik~ly catabolised in tumour cells and this 
could be the explanation of the more rapid turnover of IgG2a 
in tumour bearing rats compared to normal rats. An important 
observation in the tumour bearing and normal rats was that the 
liver , spleen and lymph nodes behaved in a similar manner in 
/ 
both groups of rats, the only difference being that of the tumour. 
The catabolic rate of IgG2a in the SPF rats was very 
low , as was the serum concentration of IgG and IgG2a. However, 
these animals live. normally in conventional conditions and even 
after 6 months in normal conditions, they still have very low 
IgG and IgG2a serum levels. The factors controlling the cata-
bolic rate of IgG were discussed in Chapter 1. The general 
.metabolic rate of SPF rats is normal and the slow catabolic rate 
of IgG2a is obviously a specific phenomenon. Brambell (1966) 
suggested the existence of a saturable receptor to explain the 
concentration-catabolism effect with IgG, and that any IgG 
molecules attached to these receptors are not catabolised. It 
may be that in the SPF animals these receptor sites are found in 
the intestine and lymph nodes as 2-3 times the amount of radio-
activity was found in these tissues of the SPF animals compared 
~ 
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to the controls. 
Data ~ert,presented in Chapter 5 showing that very 
little if any catabolism of IgG occurs in foetal sheep. One 
explanation of this may be that an integral catabolic enzyme is 
absent in foetal sheep. To investigate this the lysosomal 
enzyme activity in the plasma and tissues of foetal sheep have 
been compared to that of adult sheep. Tissues and plasma were 
collected from normal foetal sheep 1 as well as from foetuses 
that had been primed with antigen, at various gestational ages. 
Lysosomal enzymes were monitored as it is known that the proteo-
lytic enzymes are included in the lysosomal fraction (Motas and 
Ghetie, 1969). From the results presented it could be postulated 
that the lysosomal enzymes were present in sufficient quantities 
in the foetus to allow catabolism. One explanation of the lack 
of turnover of IgG in foetal sheep is that some suppressive 
activity may exist which renders the activity of lysosomal 
enzymes for endogenous plasma proteins,particularly the cathepsin 
series inactive until birth. 
An experiment which should be done to confirm this is 
to incubate 125 I IgGl with lysosomal enzymes prepared from foetal 
and adult sheep tissues at acidic and neutral pH. However, in 
·preliminary experiments it was difficult to show catabolism of 
1 25 I IgG2a by adult lysosomal enzymes, even when incubated for 
20 hours at neutral pH. Partial catabolism of 125 I IgG2a was 
observed and a G-200 Sephadex fractionation of 125 I IgG2a with 
neutral pr9teinases from adult sheep liver is shown in Figure 7.7. 
By collection of urine and faeces from animals injected 
with 125 I IgG2a and 14 C IgG2a it has been found that for 
125 I IgG2a 
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Figure 7.7. G-200 Sephadex optical density profile (--) and 
the radioactivity in each fraction (---) of 500 µg sheep 
1 25 I IgGl digested with an adult sheep liver lysosomal 
fraction at pH 7.9 for 24 hours. 
75% of the radioactivity is excreted via the kidney into the 
urine, while the other 25% is excreted in the faeces (Figure 
6 • 1) • The urine contained significant quantities of radio-
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activity having a molecular size of less than RSA (Figure 7.8). 
Interestingly, when 14 C IgG2a was used, significant quantities 
of radioactivity were also found in the urine and faeces of rats. 
This probably represents 14 C urea and other 14 C compounds. 
From the results presented a model for the catabolisrn 
of irnrnunoglobulin is suggested (Figure 7.9). The initial step 
in the catabolisrn of irnrnunoglobulin is shown as the binding of 
irnrn.unoglobulin to the surf ace of cells. Likely cell types are 
the liver , spleen and lymph node cells and probably the 
character and class of irnrnunoglobulin is important in the 
binding to receptors . For instance , slightly altered or desial-
yated irnrnunoglobulin may attach preferentially to the receptors. 
Desialylated glycoproteins are removed preferentially from the 
circulation by the liver (Van Rijk and Van den Harner, 1976). The 
class of irnrnunoglobulin may also be important, as this model is 
proposed for IgG and the process of catabolisrn of the other classes 
of irnrnunoglobulin remains obscure. 
After attachment to the cell membrane the irnrnunoglobulin 
.molecules would be interiorised and subsequently degraded by the 
lysosomal enzymes within the cells. Several of the steps in the 
catabolic process could be rate limiting, but it is most likely 
that the binding of IgG to cells and the rate of interiorisation · 
are more important in the rate of turnover than · proteolysis within 
the cells. 
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Figure 7.8. G-200 Sephadex optical density profile (-) and 
the radioactivity in each fraction (---) of urine (5 times 
concentrated) obtained 3 days after the intravenous inject-
ion of rat 125 I IgG2a into a male Wistar rat. Most of the 
radioactivity was found to reside in fractions of less than 
4S in size. 
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Figure 7.9. Schematic diagram illustrating the process of 
immunoglobulin catabolism and its relationship to the immune 
response. 
CHAPTER 8 
CATABOLISM AND IMMUNOREGULATION 
It was mentioned in Chapter 1 that immunoglobulin 
catabolism may be important in immunoregulation in two ways. 
Firstly , it may regulate the serum levels of various classes 
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of immunoglobulins and secondly , immunoglobulin or its 
metabolites may affect immunoglobulin synthesis. No conclusive 
study has been performed which demonstrates that immunoglobulin 
or its metabolites regulate immunoglobulin synthesis. 
In foetal sheep , even after antigenic challenge, 
non-specific immunoglobulin (IgG having no antibody to the 
challenge antigen) was not catabolised (Chapter 5). This 
suggested that the only immunoglobulin catabolism that may 
occur in foetal sheep was that of specific antibody to the 
challenge antigen . To test this hypothesis foetal sheep were 
challenged with CRBC and the turnover of specific (IgGlaCRBC) 
and non-specific antibody (IgGlaRRBC) labelled with 125 I or 
131 I monitored . 
Experimental Protocol 
The carotid arteries and jugular veins of 3 100 day 
old foetal sheep were cannulated. A few days after the 
operation 10 9 CRBC were injected intravenously. One other foetus · 
received a secondary intravenou~ indection of 10 9 CRBC 12 days 
after the primary injection. At least 10-15 days after the 
final injection of antigen, IgGla CRBC and IgGla RRBC (prepared 
by affinity chromatography following the technique described 
by Avrameas and Ternynck (1969) and labelled with 125 I or 
131 I) were injected into the foetal circulation. The plasma 
radioactivity was followed for the next 10-20 days. Two of 
9 
the foetuses that had received a primary injection of 10 
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CRBC were killed on the final day of the experiment, perfused 
with 5 litres of saline (4°) and the radioactivity in the 
various tissues measured. 
RESULTS 
The plasma decay curves of 125 I IgGlaCRBC and 
131 I IgGlaRRBC for Foetus Y-3 are illustrated in .Figure 8.1. 
The half-life times of IgGlaCRBC and IgGlaRRBC were 8.46 + 1.05 
and 11.46 ± 1.09 days (means± s.e.) respectively in the 3 
foetuses challenged with a primary injection of CRBC (Table 8.1). 
After correction for changes in plasma volumes over the period 
of sampling, the corrected half-life times were 15.05 ± 3.11 
and 27.93 ± 6.38 days (means± s.e.) for IgGlaCRBC and 
IgGlaRRBC respectively. 
There were significant differences in the tissue 
distribution of the specific antibody and non-specific anti-
body in the 2 foetuses studied. In Foetus Y-10 there was 
significantly more IgGlaCRBC than IgGlaRRBC in the liver, 
spleen and lymph nodes while in Foetus Y-3 significantly more 
IgGlaCRBC was found in the liver (Figure 8.2). 
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Figure 8.2. Tissue distribution of sheep 125 I IgGl aRRBC 
I 
and sheep 131 I IgGl aCRBC following their intravenous 
injection into 2 foetal sheep previously challenged with a 
single injection of 10 9 CRBC. The foetuses were killed on 
the last day of experimentation and perfused with 5 litres 
of saline (4°) prior to the removal of their tissues. 
TABLE 8.1 
Plasma De cay of Spe cific and Non-Specific Antibody IgGl in Foeta l Sheep 
Challenged Intravenously with a Primary Injection of 109 CRBC. 
Gestational Foetus Age No. (Days) 
F-Y3 101-137 
F-Y8 87-140 
F-YlO 101-133 
Age at 
Inununi-
sation 
(Days) 
111 
90 
104 
Period Blood 
of Volume Isotope Change Decay 
124-137 l.OO 
-rl .53 
106-140 l.OO 
-rJ.11 
1.00 116-133 
-rl.76 
Samples 
Injected 
125 I Anti-
CRBC - IgGl 
131 I Anti-
RRBC-IgGl 
125 I Anti-
CRBC - IgGl 
131 I Anti-
RRBC-IgGl 
131I Anti-
CRBC - IgGl 
12sI Anti-
RRBC - IgGl 
T~ 
T~ Corrected 
(Days) (Days) 
6.55 9.65 
9.68 18.43 
8.66 15.07 
11.27 25.29 
10.18 20.44 
13.43 40.06 
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The turnover times of IgGlaCRBC and IgGlaRRBC in 
Foetus Y-9 (Table 8.2) which received both a primary and 
se~ondary challenge with CRBC, were similar to those obtained 
in the 3 foetuses which received a primary injection of CRBC. 
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TABLE 8.2 
Plasma Decay of Specific and Non-Specific Antibody IgGl in a Foetal Sheep 
Challenged Intravenously with a Primary and Secondary Injection of 109 CRBC 
Gestational Age at Period 
Foetus Age Irnrnuni- of 
sation Isotope No. (Days) (Days) Decay 
lo. 102 
F-Y9 95-140 126-140 
20. 114 
Blood 
Volume 
Change 
1.00 
-+1.59 
Samples 
Injected 
131I Anti-
CRBC - IgGl 
12sI Anti-
RRBC IgGl 
T~ 
(Days) 
7.90 
10.18 
T~ 
Corrected 
(Days) 
11.91 
21.05 
All foetuses responded to the injection of CRBC 
(see Appendices 8.1 and 8.2). Typical primary immune responses 
were observed in the 3 foetuses receiving a single injection of 
CRBC while a much greater increase in the titre of CRBC 
antibody was found in the plasma of the foetus which received 
a secondary injection of CRBC. 
DISCUSSION 
The plasma decay of specific antibody (aCRBC) was 
much faster than that of non-specific antibody (aRRBC) in the 
4 foetuses studied, suggesting a close relationship between 
immunoglobulin synthesis and catabolism. However, this relation-
ship would appear to be between the synthesis and degradation 
of antibody made to the challenge antigen. In this sense 
synthesis and catabolism of IgG in an adult animal can be 
looked upon as representing the summation of an undetermined 
number of specific processes between the synthesis and 
destruction of antibodies and antigens. 
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This finding also raises the possibility that the 
regulation of synthesis and degradation may be a function of 
the cells responsible for the production of antibody. This is 
further supported by the finding that increased amounts of 
specific antibody to CRBC were found in the spleen and lymph 
nodes of one foetus which had received a primary injection of 
CRBC . The importance of the liver in immunoglobulin catabolism 
has been shown in adult animals (Chapters 4, 7) and the results 
for the 2 foetuses, in which the distribution of specific 
antibody was followed, ·support the proposition that the liver 
is involved in the catabolism of immunoglobulin. However, 
there are no lymphoid cells in the adult liver that could 
regulate the synthesis and degradation of IgG molecules but 
the liver may remove IgG molecules from the circulation that 
have been slightly modified at other sites, possibly in the 
spleen, lymph nodes and lymphoid cells of the circulation. 
Two problems that arise in the experimental system 
used are the persistence of antigen (CRBC) in the foetus and 
the preparation of the specific antibody and non-specific 
,antibody by the use of affinity chromatography which may have 
altered their structure. From the results presented it would 
appear that the non-specific IgG is turned over more quickly 
than previously found (Chapter 5) but as the IgGlaCRBC and 
IgGlaRRBC were prepared at the same- time using identical tech-
niques this does not explain the much faster turnover of the 
specific antibody, but it does suggest that some of the 
156 
molecules have been altered and that the turnover of IgGl 
a RRBC may reflect this. The other possibility is that CRBC and 
RRBC share antigenic determinants and the priming of foetuses 
with CRBC may prime them also to RRBC. 
The problem of the persistence of the CRBC in the 
foetal sheep is not considered important as the immune response 
patterns to the CRBC show a typical response and it is likely 
that all the CRBC are removed from the circulation by the 
formation of antigen-antibody complexes formed prior to the 
commencement of the experiment. This was the reason that 
foetuses were not injected with the labelled IgG preparation 
until at least 10 days after the final injection of antigen so 
that the possibility of CRBC remaining in the foetuses was 
minimal. If the problem of the antigen remaining is a real 
one then it is unlikely that 'it can be overcome in foetal sheep 
as it is difficult to obtain daily blood samples from foetuses 
for more than 40 days after surgery. 
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CHAPTER 9 
GENERAL DISCUSSION 
Since the discovery of the turnover of plasma 
proteins by Schoenheimer et al. (1942) the biological signifi-
cance of this phenomenon has remained unresolved. One hypothesis 
commonly offered to explain the continual turnover of plasma 
proteins is that protein turnover is important in the nitrogen 
balance of animals. However, this fails to explain the 
different turnover time found for each individual plasma protein 
or the mechanism by which catabolism occurs. Other findings 
which further confuse the nitrogen metabolism theory are that 
the turnover of IgG is low in germfree and SPF animals (Fahey 
and Sell, 1965) and that in foetal sheep no catabolism of IgG 
occurs (Brandon, 1976). It would also appear that in tumours 
and growing animals there is not a high rate of protein 
degradation. All these studies suggest a different biological 
significance of plasma protein turnover. 
It seems reasonable that one possible role of protein 
turnover is the continuous renewal of body tissues. However, 
cells appear to have definite life spans and their elimination 
from the body is not random as it is for the plasma proteins. 
It may be a prerequisite for the modulation of organ 
development and growth that the degradation of proteins occurs 
in body tissues. It has been suggested (Schimke and Bradley, 
1977) that in growing animals one of the important functions of 
protein turnover is the elimination from the body of abnormal 
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proteins produced by the misreading of their DNA codes 
(Loftfield, 1963) and that the random elimination of proteins 
from the body could contribute greatly to this process. This 
suggests that before the immune system has developed the random 
degradation of protein molecules could be important as a non-
immune surveillance mechanism. ~~lo~~~~~ the phagocytic 
uptake by organisms of foreign materials is important as a 
defensive mechanism and appears before the ability to mount an 
immune response. The elimination by catabolism of abnormal 
proteins from the body could be considered akin to this process. 
However, these two processes cannot be identical 
as foetal sheep have the ability to mount an immune response 
against foreign materials as early as 35 days after conception 
(Silverstein and Prendergast, 1970) but do not catabolise the 
endogenous proteins, IgG and serum albumin, even after antigenic 
challenge. Hence, the non-immune surveillance mechanism would 
appear to be restricted to endogenous proteins and is probably 
random in its action. 
The catabolic process for endogenous proteins must 
involve some type of recognition system. Dixon (1957) concluded 
that homologous IgG was degraded in the same manner as endogenous 
proteins and called the phenomenon "non-immune catabolism". 
This mechanism may rely on the binding of IgG with receptors as 
it is not possible to explain the "specific" removal of say 
IgG2a in the rat. The recognition system for plasma proteins 
(which is not dependent on the molecular size) probably involves 
a mutual relationship between the radical part of proteins and 
the surface properties of the cells responsible for catabolism. 
To say that the turnover of IgG is different from all other 
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plasma proteins may be incorrect, as a mechanism that distinguishes 
self from non-self could possess the ability to catabolise self 
proteins at different rates. This would explain the multitude 
of different turnover times for the plasma proteins. The 
obvious site of recognition is the cell surface and it is possible 
that the plasma proteins have different binding affinities for 
the receptor sites as well as different rates of interiorisation. 
This function would not necessarily have to be a property of 
lymphoid tissues but could belong to any cells of the body 
that have the potential to react to different types of proteins 
or cells . This particularly applies to the liver parenchymal 
cells. 
Evidence presented here shows the importance of the 
liver in the catabolism of immunoglobulin. The absolute 
amount of IgG catabolism that occurs in the liver is arguable 
but in both in vivo and in vitro experiments an intimate 
association of IgG with the liver has been shown. Although the 
catabolic site(s) of IgG was difficult to determine the liver 
appeared to be the most significant organ. Much greater 
quantities of IgG were found in the liver than in most other 
organs and following the injection of radioiodinated IgG2 into 
sheep with a bile cannula a significant amount of radioactivity 
was found in the bile. This radioactivity was found associated 
with whole molecules of IgG2 as well as seve r al small molecular 
weight fragments. This was further supported by the finding 
of fragments or whole molecules of IgG2a in the bil e of rats 
injecte d with 14 C IgG2a. 
Conclusive evidence of the importance o f the liver 
was the isolation of 125 I IgG2a and 14 C IgG2a from the livers 
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of rats which had been injected 3 days earlier with 1251 IgG2a 
and 14 C IgG2a respectively. The rats were always perfused with 
at least 300 ml of saline (4°) prior to the removal of their 
livers and the liver cell suspensions were washed thoroughly 
0 
at least 4 times at 4 to remove any intercellular radioisotope-
labelled IgG2a. Any labelled IgG2a found was therefore 
associated with the cell membrane or intracellular contents. 
The subcellular distribution of this radioactivity showed the 
presence of intermediate and end products of 125 1 IgG2a and a 
significant amount of intracellular 14 C IgG2a. 
It has been demonstrated (Hudgin, Pricer, Ashwell, 
Stockert and Morell , 1974; Stockert, Morell and Scheinberg, 
1976) that by changing the structural features of certain glyco-
proteins to form galactos~l (by desialylation) or N-acetylgluco-
saminyl residues accelerated removal from the circulation by the 
liver occurs . This suggests that slight structural alterations in 
proteins may be critical in their turnover. 
Another important site of catabolism considered was 
that of the lymphoid tissues. It was shown that in vivo and 
in vitro IgG bound to various lymphoid tissues and was subsequently 
catabolised. However, neonatally thymectomised or splenectomised 
rats had similar IgG turnover times to normal rats. In the case 
of lymphoid tissues particularly lymphocytes, the catabolism of 
IgG is probably critical in the regulation of the immune 
response, as it is lymphoid tissues that synthesise IgG. This 
suggests that in irnrnunoregulation the cell surface may he the 
site of interaction. Hence, the significance of membrane bound 
irnrnunoglobulin needs to be considered critically, not only 
from a viewpoint of attachment to cells but as a macromolecule 
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of the membrane structure. 
Studies on the turnover of surface IgM on B-lymphocytes 
have shown the existence of 2 types of IgM shedding, one a rapid 
turnover with a half-life time of 4 hours and the other a 
much slower one with a half-life time of 20-80 hours (Vitteta 
and Uhr, 1972; Melchers and Cone, 1975; Melchers, Cone, 
Von Boehmer and Sprent, 1975). In the experiments reported here 
the turnover of membrane bound IgG was shown to be very rapid 
with the IgG being catabolised and shed into the incubation 
medium. This evidence was obtained using either 125 I IgG2a or 
14 C IgG2a. Ideally, the turnover of surface immunoglobulin 
should involve the surface immunoglobulin belonging to the 
cells, but the kinetics of labelled IgG perhaps shows the manner 
in which the cell surface immunoglobulins are turned over. It 
has not been conclusively shown whether cell surface IgG is 
derived from cells de novo or from the circulation. For 
instance, it is known that some IgG producing cells have no 
surface IgG. The use of IgG2a internally labelled with 14 C 
amino acids should prove valuable in future studies of IgG2a 
metabolism. 
The studies in foetal sheep definitely show that IgG 
is not catabolised. It would appear also that very little if 
any catabolism of serum albumin occurs. The lack of catabolism 
of IgG would appear to be a function of an active suppressive 
mechanism that restricts the action of lysosomal enzymes, some of 
lysosomal enzymes having been found in foetal sheep in sufficient 
quantities to allow protein catabolism. 
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In respect to the turnover of proteins being important 
for the removal of abnormal plasma proteins, it would have to 
be suggested that this function did not commence until after 
birth. However it appears to be a reasonable hypothesis that 
in the rapidly growing foetus an active catabolic mechanism is 
not required. This suggests that the regulation of catabolic 
enzymes may also be closely related to tumour growth. 
On looking at the turnover of IgG having antibody to 
the challenge antigen in foetal sheep, catabolism of IgG 
obviously occurred. This suggests a relationship between 
antibody synthesis and catabolism. The precise mechanism of 
this relationship is unknown but it may be that the catabolic 
rate of IgG varies during an immune response. The usual 
explanations offered for the decline in antibody synthesis 
following an immune response to an antigen are: a reduction in 
antibody-producing cells together with immunoglobulin catabolism; 
the removal of antibody from the circulation by the formation 
of antigen-antibody complexes and a fall in the synthetic rate 
of antibody; suppressor cells inhibiting the production of 
antibody; and a feedback effect on antibody synthesis by anti-
body itself. However, the results presented here support none 
of these hypotheses but suggest the turnover of specific antibody 
is greatly increased during an immune response. One explanation 
of this could be that newly synthesised antibody is processed 
as an abnormal plasma protein, evidence for this being suggested 
by the finding that antibodies (idiotypic) can be raised to 
other antibody molecules. 
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Appendix 4.1. The distribution of . rat 125 I IgG2a and sheep 
131 I IgGZ over 14 days in the kidney, thyroid, thymus and 
large intestine following their intravenous injection into 
normal male Wistar rats. The rats were perfused with 300 ml 
of saline (4 ° ) prior to the removal of the organs. 
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Appendix 5.1. The change in the blood volume of foetal sheep 
between 75 and 150 days gestation. The values were obtained 
from Barcroft and Kennedy (1939) and Barcroft (1946). 
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Appendix 5 . 2. Changes in the haematocrit (%), total 
nucleated cell count (~) and total polymorphonuclear cell 
count (---) in the blood of the 4 foetal sheep injected 
intravenously with IgGl a KLH and IgG2 a OVA. 
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Appendix 5.3. The appearance of agglutinating antibody to 
CRBC in the plasma of 4 foetal sheep challenged with a 
primary injection of 10 9 CRBC. 
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Appendix 5.4. Typical changes observed in the concentration 
of IgM, IgGl and IgG2 in the plasma of foetal sheep follow-
ing antigenic challenge with a primary and secondary 
injection of CRBC (Fl4) and KLH (F64). 
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Appendix 5 . 5 . Changes in the haema t ocrit (%) , total 
nucleated cell count (-) and to t al polymorphonuclear cell 
count (-- -} in the blood of 4 f oe tal s he e p in jected intra-
venously with 125 I sheep I gG l pre pared f rom normal sheep 
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Appendix 5.6. The appearance of agglutinating antibody to 
CRBC in the plasma of 2 foetal sheep challenged with a 
primary and secondary injection of 10 9 CRBC. 
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Appendix 5.7. Changes in the haernatocrit (%), total 
nucleated cell count (~) and total polyrnorphonuclear 
cell count (---) in the blood of 3 foetal sheep injected 
intravenously with 1 2 5 I SSA ( --+ ) . 
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Appendix 7.1. Role of the liver in protein metabolism 
(from Popper and Schaffner, 1957). 
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AJ212endix 8.1. The appearance of agglutinating antibody to 
CRBC in the plasma of 3 foetal sheep (F-Y3, F-YB, F-YlO) 
challenged with a primary injection of 10 9 CRBC and in 
1 foetus challenged with a primary and secondary injection 
of 10 9 CRBC (F-Y9). 
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Appendix 8.2. Changes in the concentration of IgM, IgGl and 
IgG2 in the plasma of foetal sheep following antigenic 
challenge with a primary injection of CRBC (F-Y8) and a 
primary and secondary injection of CRBC (F-Y9). 
